Medications for human use with a single active ingredient starting with the letter H-N.

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre H-N.

Updated | Mise à jour : 2021-07-04
∙ Product name | Nom du produit;
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Original market date | Date de commercialisation originale;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN
Monograph |
Monographie
HIBERIX;
haemophilus influenzae type b-prp and tetanus toxoid conjugate (prp-t) 10 mcg / 0.5 ml;
2012-10-25;
Intramuscular;
Powder For Solution;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02239200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62657
ULTRAVATE;
halobetasol propionate 0.05 % / w/w;
1993-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 01962728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13909
ULTRAVATE;
halobetasol propionate 0.05 % / w/w;
1993-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 01962701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13917
HALOPERIDOL LA;
haloperidol (haloperidol decanoate) 100 mg / ml;
1994-12-31;
Intramuscular;
Liquid;
28:16.08.08 – BUTYROPHENONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02130300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16902
TEVA-HALOPERIDOL;
haloperidol 0.5 mg;
1986-12-31;
Oral;
Tablet;
28:16.08.08 – BUTYROPHENONES;
Prescription;
TEVA CANADA LIMITED
DIN: 00363685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7128
TEVA-HALOPERIDOL;
haloperidol 1 mg;
1986-12-31;
Oral;
Tablet;
28:16.08.08 – BUTYROPHENONES;
Prescription;
TEVA CANADA LIMITED
DIN: 00363677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7129
TEVA-HALOPERIDOL;
haloperidol 10 mg;
1986-12-31;
Oral;
Tablet;
28:16.08.08 – BUTYROPHENONES;
Prescription;
TEVA CANADA LIMITED
DIN: 00713449
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7131
TEVA-HALOPERIDOL;
haloperidol 2 mg;
1986-12-31;
Oral;
Tablet;
28:16.08.08 – BUTYROPHENONES;
Prescription;
TEVA CANADA LIMITED
DIN: 00363669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7130
TEVA-HALOPERIDOL;
haloperidol 20 mg;
1988-12-31;
Oral;
Tablet;
28:16.08.08 – BUTYROPHENONES;
Prescription;
TEVA CANADA LIMITED
DIN: 00768820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8477
TEVA-HALOPERIDOL;
haloperidol 5 mg;
1984-12-31;
Oral;
Tablet;
28:16.08.08 – BUTYROPHENONES;
Prescription;
TEVA CANADA LIMITED
DIN: 00363650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5859
HALOPERIDOL INJ 5MG/ML USP;
haloperidol 5 mg / ml;
1989-12-31;
Intramuscular;
Liquid;
28:16.08.08 – BUTYROPHENONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 00808652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10026
HALOPERIDOL INJECTION;
haloperidol 5 mg / ml;
2011-09-19;
Intramuscular;
Solution;
28:16.08.08 – BUTYROPHENONES;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02366010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85088
HALOPERIDOL INJECTION, USP;
haloperidol 5 mg / ml;
2014-10-20;
Intramuscular;
Solution;
28:16.08.08 – BUTYROPHENONES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02406411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89112
TOPICAL HAPTEN GEL;
haptens 100 % / w/w;
2017-09-13;
Topical;
Gel;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
DORMER LABORATORIES INC.
DIN: 02466333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95467
TOPICAL HAPTEN LIQUID;
haptens 100 % / w/w;
2017-09-13;
Topical;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
DORMER LABORATORIES INC.
DIN: 02466368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95470
TOPICAL HAPTEN LIQUID;
haptens 20 % / w/w;
2017-09-13;
Topical;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
DORMER LABORATORIES INC.
DIN: 02466341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95469
TOPICAL HAPTEN GEL;
haptens 50 % / w/w;
2017-09-13;
Topical;
Gel;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
DORMER LABORATORIES INC.
DIN: 02466325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95465
HELIUM 100%;
helium 100 %;
1911-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
DIN: 00572888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5688
HELIUM USP 99%;
helium 99 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13883
PANHEMATIN;
hemin 268 mg / vial;
2018-12-05;
Intravenous;
Powder For Solution;
-;
Prescription , Schedule D;
RECORDATI RARE DISEASES CANADA INC
DIN: 02478765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96951
HEPARIN LEO 100UNIT/ML;
heparin sodium 100 unit / ml;
1984-12-31;
0-Unassigned;
Liquid;
20:12.04.16 – HEPARINS;
Ethical;
LEO PHARMA INC
DIN: 00727520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8042
HEPARIN LEO INJ 1000UNIT/ML;
heparin sodium 1000 unit / ml;
1987-12-31;
Intravenous , Subcutaneous;
Liquid;
20:12.04.16 – HEPARINS;
Ethical;
LEO PHARMA INC
DIN: 00453811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10526
HEPARIN SODIUM INJECTION, USP;
heparin sodium 1000 unit / ml;
2005-05-26;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02264315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74976
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE);
heparin sodium 1000 unit / ml;
2008-05-19;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 02303086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78841
HEPARIN SODIUM INJECTION, USP;
heparin sodium 10000 unit / ml;
2005-05-27;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02264307
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74973
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE);
heparin sodium 10000 unit / ml;
2008-05-19;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 02303108
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78843
HEPARIN SODIUM INJECTION USP;
heparin sodium 10000 unit / ml;
2013-03-01;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
PFIZER CANADA ULC
DIN: 02382326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86817
HEPARIN SODIUM INJECTION, USP;
heparin sodium 10000 unit / ml;
2013-05-20;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02392453
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87773
HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION;
heparin sodium 2 unit / ml;
1994-12-31;
Intravenous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
PFIZER CANADA ULC
DIN: 01990748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17227
HEPARIN SODIUM INJECTION USP;
heparin sodium 5000 unit / 0.5 ml;
2016-11-17;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Ethical;
STERINOVA INC.
DIN: 02456958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94407
HAVRIX – SUS IM 1440 ELISA UNITS/ML;
hepatitis a vaccine – inactivated 1440 unit / ml;
1996-12-31;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02187078
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20256
AVAXIM;
hepatitis a vaccine – inactivated 160 unit / 0.5 ml;
1999-05-27;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
SANOFI PASTEUR LIMITED
DIN: 02237792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61149
VAQTA;
hepatitis a vaccine – inactivated 50 unit / ml;
1996-11-10;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 02229702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47865
HAVRIX 720 JUNIOR;
hepatitis a vaccine – inactivated 720 unit / 0.5 ml;
1997-09-23;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02231056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50339
HYPERHEP B S/D;
hepatitis b immunoglobulin (human) 220 unit / ml;
1997-07-08;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
DIN: 02230738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50001
HYPERHEP B S/D;
hepatitis b immunoglobulin (human) 220 unit / ml;
2013-01-15;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
DIN: 02379465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86536
HEPAGAM B;
hepatitis b immunoglobulin (human) 312 unit / ml;
2007-08-13;
Intramuscular , Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
SAOL THERAPEUTICS RESEARCH LIMITED
DIN: 02290979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77637
RECOMBIVAX HB;
hepatitis b surface antigen (recombinant) 10 mcg / ml;
2001-04-11;
Intramuscular;
Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 02243676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67606
ENGERIX-B;
hepatitis b surface antigen (recombinant) 10 mcg / 0.5 ml;
2019-10-07;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02487020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97717
ENGERIX-B;
hepatitis b surface antigen (recombinant) 20 mcg / 1 ml;
2019-11-15;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
GLAXOSMITHKLINE INC
DIN: 02487039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97718
RECOMBIVAX HB;
hepatitis b surface antigen (recombinant) 40 mcg / ml;
2002-10-24;
Intramuscular;
Solution;
80:12.00 – VACCINES;
Schedule D;
MERCK CANADA INC
DIN: 02245977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70103
CYSVIEW;
hexaminolevulinate hydrochloride 100 mg / vial;
2015-12-14;
Intravesical;
Kit , Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
BIOSYENT PHARMA INC
DIN: 02436639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92096
STREPSILS ANAESTHETIC FORMULA;
hexylresorcinol 2.4 mg;
2001-10-01;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
RB HEALTH (CANADA) INC.
DIN: 02243888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67829
BRADOSOL LOZENGES EXTRA STRENGTH 3.5MG;
hexylresorcinol 3.5 mg;
1991-12-31;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
COLUMBIA LABORATORIES CANADA INC
DIN: 00895466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11321
HISTATROL;
histamine phosphate 0.275 mg / ml;
1984-12-31;
Intradermal;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
ALK-ABELLO INC
DIN: 00609706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5538
HISTATROL;
histamine phosphate 2.75 mg / ml;
1984-12-31;
Percutaneous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
ALK-ABELLO INC
DIN: 00609692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5537
HYMENOPTERA VENOM PRODUCT – HONEY BEE VENOM (550 MCG);
honey bee venom protein 550 mcg / vial;
1997-12-16;
Subcutaneous;
Powder For Solution;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
JUBILANT HOLLISTERSTIER LLC
DIN: 02220075
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43270
OCTAPLASMA;
human plasma proteins 14 g / 200 ml;
2012-05-31;
Intravenous;
Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02270013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75541
APO-HYDRALAZINE;
hydralazine hydrochloride 10 mg;
1990-12-31;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
APOTEX INC
DIN: 00441619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11047
JAMP-HYDRALAZINE;
hydralazine hydrochloride 10 mg;
2017-08-28;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02457865
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94490
MINT-HYDRALAZINE;
hydralazine hydrochloride 10 mg;
2018-04-13;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02468778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95730
APRESOLINE;
hydralazine hydrochloride 20 mg / ml;
1992-12-31;
Intravenous;
Solution;
24:08.20 – DIRECT VASODILATORS;
Prescription;
STERIMAX INC
DIN: 00723754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12237
APO-HYDRALAZINE;
hydralazine hydrochloride 25 mg;
1991-12-31;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
APOTEX INC
DIN: 00441627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11626
JAMP-HYDRALAZINE;
hydralazine hydrochloride 25 mg;
2017-08-28;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02457873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94491
MINT-HYDRALAZINE;
hydralazine hydrochloride 25 mg;
2018-02-16;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02468786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95731
APO-HYDRALAZINE;
hydralazine hydrochloride 50 mg;
1991-12-31;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
APOTEX INC
DIN: 00441635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11627
JAMP-HYDRALAZINE;
hydralazine hydrochloride 50 mg;
2017-08-28;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02457881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94492
MINT-HYDRALAZINE;
hydralazine hydrochloride 50 mg;
2018-02-16;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02468794
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95732
PMS-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 12.5 mg;
2005-12-22;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02274086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75953
APO-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 12.5 mg;
2009-07-02;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 02327856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81335
MINT-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 12.5 mg;
2014-07-23;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02425947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91057
TEVA-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 25 mg;
1968-12-31;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00021474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=778
APO-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 25 mg;
1975-12-31;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 00326844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4281
PMS-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 25 mg;
2003-12-10;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02247386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71631
HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 25 mg;
2011-02-08;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02360594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84556
MINT-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 25 mg;
2014-07-23;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02426196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91079
HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 25 mg;
2019-08-14;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
PRO DOC LIMITEE
DIN: 02486962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97711
TEVA-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 50 mg;
1968-12-31;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00021482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=812
APO-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 50 mg;
1974-12-31;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
APOTEX INC
DIN: 00312800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4280
PMS-HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 50 mg;
2003-12-10;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
PHARMASCIENCE INC
DIN: 02247387
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71632
HYDROCHLOROTHIAZIDE;
hydrochlorothiazide 50 mg;
2011-02-08;
Oral;
Tablet;
40:28.20 – THIAZIDE DIURETICS;
Prescription;
SANIS HEALTH INC
DIN: 02360608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84557
PDP-HYDROCODONE;
hydrocodone bitartrate 5 mg / 5 ml;
2009-03-21;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Narcotic (Cdsa I);
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02324253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80973
SOLU-CORTEF 1 GM ACT-O-VIAL;
hydrocortisone (hydrocortisone sodium succinate) 1 g / vial;
1967-12-31;
Intramuscular , Intravenous;
Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2222
SOLU-CORTEF 100 MG ACT-O-VIAL;
hydrocortisone (hydrocortisone sodium succinate) 100 mg / vial;
1958-12-31;
Intramuscular , Intravenous;
Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2219
SOLU-CORTEF 250 MG ACT-O-VIAL;
hydrocortisone (hydrocortisone sodium succinate) 250 mg / vial;
1962-12-31;
Intramuscular , Intravenous;
Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2220
SOLU-CORTEF 500 MG ACT-O-VIAL;
hydrocortisone (hydrocortisone sodium succinate) 500 mg / vial;
1966-12-31;
Intramuscular , Intravenous;
Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2221
CORTEF TABLETS 10MG;
hydrocortisone 10 mg;
1954-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=432
CORTENEMA;
hydrocortisone 100 mg / 60 ml;
1995-12-31;
Rectal;
Enema;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02112736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18968
SANDOZ HYDROCORTISONE;
hydrocortisone 2.5 % / w/w;
2019-06-04;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02469421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95822
CORTEF TABLETS 20 MG;
hydrocortisone 20 mg;
1954-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=433
HYDROVAL CREAM 0.2%;
hydrocortisone valerate 0.2 %;
2000-12-18;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN: 02242984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66824
HYDROVAL OINTMENT 0.2%;
hydrocortisone valerate 0.2 %;
2000-12-18;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN: 02242985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66825
DILAUDID;
hydromorphone hydrochloride 1 mg;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 00705438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6889
PMS-HYDROMORPHONE TAB 1MG;
hydromorphone hydrochloride 1 mg;
1991-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 00885444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11413
TEVA-HYDROMORPHONE;
hydromorphone hydrochloride 1 mg;
2011-11-16;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02319403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80489
APO-HYDROMORPHONE;
hydromorphone hydrochloride 1 mg;
2012-12-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02364115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84905
PMS HYDROMORPHONE SIROP 1MG/ML;
hydromorphone hydrochloride 1 mg / ml;
1991-12-31;
Oral;
Syrup;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 01916386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11870
HYDROMORPHONE HP 10;
hydromorphone hydrochloride 10 mg / ml;
1995-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02145928
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18323
HYDROMORPHONE HYDROCHLORIDE INJECTION USP;
hydromorphone hydrochloride 10 mg / ml;
2014-06-11;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PFIZER CANADA ULC
DIN: 02382636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86845
HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10;
hydromorphone hydrochloride 10 mg / ml;
2017-02-06;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02460610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94804
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP;
hydromorphone hydrochloride 10 mg / ml;
2020-11-10;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
FRESENIUS KABI CANADA LTD
DIN: 02491680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98169
HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE;
hydromorphone hydrochloride 100 mg / ml;
2018-06-20;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02468468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95689
HYDROMORPHONE HP FORTE INJECTION;
hydromorphone hydrochloride 1000 mg / 10 ml;
2001-12-10;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02244797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68787
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP – 12MG;
hydromorphone hydrochloride 12 mg;
1996-12-31;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02125366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20171
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP – 18MG;
hydromorphone hydrochloride 18 mg;
2001-07-03;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02243562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67480
DILAUDID;
hydromorphone hydrochloride 2 mg;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 00125083
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5939
PMS-HYDROMORPHONE TAB 2MG;
hydromorphone hydrochloride 2 mg;
1991-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 00885436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11428
TEVA-HYDROMORPHONE;
hydromorphone hydrochloride 2 mg;
2011-11-16;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02319411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80490
APO-HYDROMORPHONE;
hydromorphone hydrochloride 2 mg;
2012-12-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02364123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84906
HYDROMORPHONE HYDROCHLORIDE INJECTION USP;
hydromorphone hydrochloride 2 mg / ml;
1995-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02145901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18315
HYDROMORPHONE HYDROCHLORIDE INJECTION;
hydromorphone hydrochloride 2 mg / ml;
2017-02-06;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02460602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94803
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP;
hydromorphone hydrochloride 2 mg / ml;
2020-11-10;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
FRESENIUS KABI CANADA LTD
DIN: 02491699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98170
HYDROMORPHONE HP 20;
hydromorphone hydrochloride 20 mg / ml;
1995-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02145936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18325
HYDROMORPHONE HYDROCHLORIDE INJECTION USP;
hydromorphone hydrochloride 20 mg / 50 ml;
2019-09-18;
Intravenous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERINOVA INC.
DIN: 02485532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97577
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP – 24MG;
hydromorphone hydrochloride 24 mg;
1996-12-31;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02125382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20172
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP – 3MG;
hydromorphone hydrochloride 3 mg;
1995-12-31;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02125323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18556
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP – 30MG;
hydromorphone hydrochloride 30 mg;
1998-02-16;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02125390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43838
DILAUDID;
hydromorphone hydrochloride 4 mg;
1984-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 00125121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5940
PMS-HYDROMORPHONE TAB 4MG;
hydromorphone hydrochloride 4 mg;
1991-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 00885401
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11425
TEVA-HYDROMORPHONE;
hydromorphone hydrochloride 4 mg;
2011-11-16;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02319438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80491
APO-HYDROMORPHONE;
hydromorphone hydrochloride 4 mg;
2012-12-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02364131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84907
HYDROMORPH CONTIN;
hydromorphone hydrochloride 4.5 mg;
2011-04-14;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02359502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84452
HYDROMORPHONE HYDROCHLORIDE INJECTION USP;
hydromorphone hydrochloride 40 mg / 100 ml;
2019-08-28;
Intravenous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERINOVA INC.
DIN: 02485540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97578
HYDROMORPHONE HP 50;
hydromorphone hydrochloride 50 mg / ml;
1995-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02146126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18324
HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50;
hydromorphone hydrochloride 50 mg / ml;
2018-08-21;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02469413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95820
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP – 6MG;
hydromorphone hydrochloride 6 mg;
1995-12-31;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02125331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18558
DILAUDID;
hydromorphone hydrochloride 8 mg;
1989-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 00786543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9509
PMS-HYDROMORPHONE TAB 8MG;
hydromorphone hydrochloride 8 mg;
1991-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
DIN: 00885428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11363
TEVA-HYDROMORPHONE;
hydromorphone hydrochloride 8 mg;
2011-11-16;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02319446
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80492
APO-HYDROMORPHONE;
hydromorphone hydrochloride 8 mg;
2012-12-18;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
APOTEX INC
DIN: 02364158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84908
HYDROMORPH CONTIN;
hydromorphone hydrochloride 9 mg;
2011-04-14;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02359510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84453
ERFA HYDROQUINONE;
hydroquinone 4 % / w/w;
2020-03-13;
Topical;
Gel;
84:50.04 – DEPIGMENTING AGENTS;
Prescription;
ERFA CANADA 2012 INC
DIN: 02491702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98171
CYANOKIT;
hydroxocobalamin 5 g / vial;
2012-10-19;
Intravenous;
Powder For Solution;
92:12.00 – ANTIDOTES;
Prescription;
SERB S.A.
DIN: 02375370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86078
PLAQUENIL;
hydroxychloroquine sulfate 200 mg;
1957-12-31;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02017709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14735
APO-HYDROXYQUINE;
hydroxychloroquine sulfate 200 mg;
2002-12-13;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS;
Prescription;
APOTEX INC
DIN: 02246691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70886
MINT-HYDROXYCHLOROQUINE;
hydroxychloroquine sulfate 200 mg;
2014-06-10;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02424991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90966
JAMP HYDROXYCHLOROQUINE SULFATE;
hydroxychloroquine sulfate 200 mg;
2020-02-06;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02491427
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98143
VOLUVEN;
hydroxyethyl starch 130/0.4 6 %;
2006-09-18;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02278057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76364
VOLULYTE;
hydroxyethyl starch 130/0.4 6 %;
2011-05-16;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02357291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84242
HYDREA CAP 500MG;
hydroxyurea 500 mg;
1979-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
DIN: 00465283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3453
MYLAN-HYDROXYUREA;
hydroxyurea 500 mg;
2001-02-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02242920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66754
APO-HYDROXYUREA;
hydroxyurea 500 mg;
2003-10-22;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
DIN: 02247937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72247
HYDROXYZINE;
hydroxyzine hydrochloride 10 mg;
1986-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
AA PHARMA INC
DIN: 00646059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7393
NOVO-HYDROXYZIN;
hydroxyzine hydrochloride 10 mg;
1987-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00738824
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7442
ATARAX SYRUP 2MG/ML;
hydroxyzine hydrochloride 10 mg / 5 ml;
1956-12-31;
Oral;
Syrup;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00024694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=316
HYDROXYZINE;
hydroxyzine hydrochloride 25 mg;
1986-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
AA PHARMA INC
DIN: 00646024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7392
NOVO-HYDROXYZIN;
hydroxyzine hydrochloride 25 mg;
1987-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00738832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7443
HYDROXYZINE;
hydroxyzine hydrochloride 50 mg;
1986-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
AA PHARMA INC
DIN: 00646016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7391
NOVO-HYDROXYZIN;
hydroxyzine hydrochloride 50 mg;
1987-12-31;
Oral;
Capsule;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
TEVA CANADA LIMITED
DIN: 00738840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7444
HYDROXYZINE HYDROCHLORIDE INJECTION USP;
hydroxyzine hydrochloride 50 mg / ml;
1987-12-31;
Intramuscular;
Liquid;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 00742813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8118
BUSCOPAN;
hyoscine butylbromide 10 mg;
1976-12-31;
Oral;
Tablet;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 00363812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2481
BUSCOPAN;
hyoscine butylbromide 20 mg / ml;
1976-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
SANOFI CONSUMER HEALTH INC / SANOFI SANTE GRAND PUBLIC INC
DIN: 00363839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2483
HYOSCINE BUTYLBROMIDE INJECTION SANDOZ STANDARD;
hyoscine butylbromide 20 mg / ml;
1997-08-25;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02229868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48226
LACRISERT;
hyprolose 5 mg / insert;
2004-05-25;
Ophthalmic;
Insert;
52:13.00* – ARTIFICIAL TEARS;
Ethical;
BAUSCH HEALTH, CANADA INC.
DIN: 02250624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73543
ISOPTO TEARS 0.5%;
hypromellose 0.5 %;
1969-12-31;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
DIN: 00000809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=793
ISOPTO TEARS 1%;
hypromellose 1 %;
1970-12-31;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
DIN: 00000817
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=794
GENTEAL;
hypromellose 3 mg / ml;
1997-10-17;
Ophthalmic;
Solution;
52:13.00* – ARTIFICIAL TEARS;
Otc;
ALCON CANADA INC
DIN: 02231289
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50599
IMBRUVICA;
ibrutinib 140 mg;
2014-11-19;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
DIN: 02434407
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91874
JUNIOR STRENGTH ADVIL;
ibuprofen 100 mg;
2003-03-31;
Oral;
Tablet (Chewable);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02246403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70575
JUNIOR STRENGTH ADVIL FEVER FROM COLDS OR FLU;
ibuprofen 100 mg;
2009-11-05;
Oral;
Tablet (Chewable);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02328429
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81395
CHILDREN’S ADVIL;
ibuprofen 100 mg / 5 ml;
1997-11-03;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02232297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51742
CHILDREN’S MOTRIN;
ibuprofen 100 mg / 5 ml;
2000-09-15;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02242365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66076
CHILDREN’S IBUPROFEN SUSPENSION;
ibuprofen 100 mg / 5 ml;
2007-08-30;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PERRIGO INTERNATIONAL
DIN: 02280175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76585
CHILDREN’S ADVIL FEVER FROM COLDS OR FLU;
ibuprofen 100 mg / 5 ml;
2009-11-05;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02328437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81396
NOVO-PROFEN;
ibuprofen 200 mg;
1985-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
TEVA CANADA LIMITED
DIN: 00629324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6320
APO-IBUPROFEN;
ibuprofen 200 mg;
1984-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 00441643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10294
ADVIL CAPLETS;
ibuprofen 200 mg;
1992-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01933531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13452
ADVIL TABLETS;
ibuprofen 200 mg;
1993-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01933558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13625
MOTRIN 200MG;
ibuprofen 200 mg;
1972-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02186934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19585
ADVIL GEL CAPLETS;
ibuprofen 200 mg;
1997-05-05;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02230541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49613
ADVIL LIQUI-GELS;
ibuprofen 200 mg;
2000-10-02;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02241769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65432
IBUPROFEN CAPLETS 200 MG;
ibuprofen 200 mg;
2006-04-07;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02272857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75836
MOTRIN LIQUID GELS 200MG;
ibuprofen 200 mg;
2007-10-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02297582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78292
IBUPROFEN TABLETS;
ibuprofen 200 mg;
2010-03-05;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02314754
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80029
IBUPROFEN CAPLETS;
ibuprofen 200 mg;
2010-03-05;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02314762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80030
IBUPROFEN LIQUID CAPSULES;
ibuprofen 200 mg;
2011-03-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02357275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84240
IBUPROFEN TABLETS;
ibuprofen 200 mg;
2017-01-26;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02368072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85289
IBUPROFEN CAPLETS;
ibuprofen 200 mg;
2017-01-26;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02368080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85290
IBUPROFEN LIQUID GEL CAPSULES;
ibuprofen 200 mg;
2016-09-15;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 02376598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86208
IBUPROFEN;
ibuprofen 200 mg;
2015-12-23;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 02439689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92408
IBUPROFEN CAPLETS;
ibuprofen 200 mg;
2016-02-26;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 02439727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92412
ADVIL MINI-GELS;
ibuprofen 200 mg;
2019-07-30;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02485400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97565
IBUPROFEN LIQUID GELS;
ibuprofen 200 mg;
2021-03-22;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02494353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98438
APO-IBUPROFEN;
ibuprofen 300 mg;
1983-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 00441651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5433
MOTRIN 300MG;
ibuprofen 300 mg;
2002-05-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02242632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66413
IBUPROFEN;
ibuprofen 300 mg;
2016-09-21;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 02439697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92409
INFANTS’ MOTRIN;
ibuprofen 40 mg / ml;
1998-10-14;
Oral;
Drops;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02238626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62054
ADVIL PEDIATRIC DROPS;
ibuprofen 40 mg / ml;
2000-10-23;
Oral;
Drops;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02242522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66270
ADVIL PEDIATRIC DROPS FEVER FROM COLDS OR FLU;
ibuprofen 40 mg / ml;
2010-08-06;
Oral;
Drops;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02328445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81397
APO-IBUPROFEN;
ibuprofen 400 mg;
1983-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 00506052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5432
NOVO-PROFEN;
ibuprofen 400 mg;
1985-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
TEVA CANADA LIMITED
DIN: 00629340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6322
MOTRIN 400MG;
ibuprofen 400 mg;
2002-05-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02242658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66438
ADVIL EXTRA STRENGTH CAPLETS;
ibuprofen 400 mg;
2002-05-14;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02244577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68562
ADVIL EXTRA STRENGTH LIQUI-GELS;
ibuprofen 400 mg;
2004-06-21;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02248231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72567
EXTRA STRENGTH IBUPROFEN;
ibuprofen 400 mg;
2010-02-01;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02314770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80031
ADVIL MUSCLE AND JOINT;
ibuprofen 400 mg;
2011-11-07;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02355701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84091
EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES;
ibuprofen 400 mg;
2011-06-10;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02357283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84241
IBUPROFEN EXTRA STRENGTH CAPLETS;
ibuprofen 400 mg;
2011-08-05;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02368099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85291
MUSCLE & JOINT;
ibuprofen 400 mg;
2013-05-16;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02374226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85942
EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES;
ibuprofen 400 mg;
2012-07-15;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 02376601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86209
IBUPROFEN MUSCLE AND JOINT;
ibuprofen 400 mg;
2012-09-12;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02377101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86271
MOTRIN LIQUID GELS 400 MG;
ibuprofen 400 mg;
2012-07-30;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02378310
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86413
JAMP-IBUPROFEN;
ibuprofen 400 mg;
2014-01-07;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
JAMP PHARMA CORPORATION
DIN: 02401290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88621
ADVIL ARTHRITIS PAIN;
ibuprofen 400 mg;
2014-07-07;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02415623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90021
IBUPROFEN CAPLETS;
ibuprofen 400 mg;
2015-12-23;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
APOTEX INC
DIN: 02439735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92413
APO IBUPROFEN TAB 600MG;
ibuprofen 600 mg;
1984-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 00585114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5917
TEVA-PROFEN;
ibuprofen 600 mg;
1985-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00629359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6323
ADVIL 12 HOUR;
ibuprofen 600 mg;
2016-08-22;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 02443562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92825
CORVERT;
ibutilide fumarate 0.1 mg / ml;
2000-11-28;
Intravenous;
Solution;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
PFIZER CANADA ULC
DIN: 02242470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66196
FIRAZYR;
icatibant (icatibant acetate) 10 mg / ml;
2014-07-14;
Subcutaneous;
Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Prescription;
TAKEDA CANADA INC
DIN: 02425696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91034
VASCEPA;
icosapent ethyl 1 g;
2020-02-07;
Oral;
Capsule;
24:06.92 – MISCELLANEOUS ANTILIPEMIC AGENTS;
Prescription;
HLS THERAPEUTICS INC
DIN: 02495244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98517
IDARUBICIN;
idarubicin hydrochloride 1 mg / vial;
2014-11-04;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02410028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89467
PRAXBIND;
idarucizumab 50 mg / ml;
2016-05-24;
Intravenous;
Solution;
20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02454343
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94091
ZYDELIG;
idelalisib 100 mg;
2015-04-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02438798
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92318
ZYDELIG;
idelalisib 150 mg;
2015-04-21;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
GILEAD SCIENCES CANADA INC
DIN: 02438801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92319
ELAPRASE;
idursulfase 2 mg / ml;
2007-08-01;
Intravenous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02296314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78165
IFEX;
ifosfamide 1 g / vial;
2001-03-20;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
DIN: 02241357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64989
IFEX;
ifosfamide 3 g / vial;
2001-01-25;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAXTER CORPORATION
DIN: 02241356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64988
GLEEVEC;
imatinib (imatinib mesylate) 100 mg;
2005-04-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02253275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73824
APO-IMATINIB;
imatinib (imatinib mesylate) 100 mg;
2013-04-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
DIN: 02355337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84058
NAT-IMATINIB;
imatinib (imatinib mesylate) 100 mg;
2014-04-29;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02397285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88225
TEVA-IMATINIB;
imatinib (imatinib mesylate) 100 mg;
2013-04-02;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02399806
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88465
ACH-IMATINIB;
imatinib (imatinib mesylate) 100 mg;
2020-11-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02490986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98101
MINT-IMATINIB;
imatinib (imatinib mesylate) 100 mg;
2020-06-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02492334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98235
JAMP IMATINIB;
imatinib (imatinib mesylate) 100 mg;
2021-04-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02495066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98501
IMATINIB;
imatinib (imatinib mesylate) 100 mg;
2021-04-07;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02504596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99400
GLEEVEC;
imatinib (imatinib mesylate) 400 mg;
2004-10-25;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02253283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73825
APO-IMATINIB;
imatinib (imatinib mesylate) 400 mg;
2013-04-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
DIN: 02355345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84059
NAT-IMATINIB;
imatinib (imatinib mesylate) 400 mg;
2014-04-29;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02397293
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88226
TEVA-IMATINIB;
imatinib (imatinib mesylate) 400 mg;
2013-05-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02399814
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88466
ACH-IMATINIB;
imatinib (imatinib mesylate) 400 mg;
2020-11-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02490994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98102
MINT-IMATINIB;
imatinib (imatinib mesylate) 400 mg;
2020-06-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02492342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98236
JAMP IMATINIB;
imatinib (imatinib mesylate) 400 mg;
2021-04-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02495074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98502
IMATINIB;
imatinib (imatinib mesylate) 400 mg;
2021-04-07;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02504618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99401
CEREZYME;
imiglucerase 400 unit / vial;
2000-06-14;
Intravenous;
Powder For Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN: 02241751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65414
IMIPRAMINE;
imipramine hydrochloride 10 mg;
1976-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00360201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2444
IMIPRAMINE;
imipramine hydrochloride 25 mg;
1975-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00312797
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2211
IMIPRAMINE;
imipramine hydrochloride 50 mg;
1975-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00326852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2212
IMIPRAMINE;
imipramine hydrochloride 75 mg;
1989-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00644579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10008
ZYCLARA;
imiquimod 3.75 % / w/w;
2010-01-27;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02340445
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82603
VYLOMA;
imiquimod 3.75 % / w/w;
2011-04-19;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02365561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85046
ALDARA P;
imiquimod 5 %;
1999-07-05;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02239505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62979
TARO-IMIQUIMOD PUMP;
imiquimod 5 % / w/w;
2019-01-23;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02482983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97338
GAMMAGARD LIQUID;
immunoglobulin (human) 10 %;
2007-08-08;
Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
TAKEDA CANADA INC
DIN: 02279444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76503
PRIVIGEN;
immunoglobulin (human) 10 %;
2009-01-08;
Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02304619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78988
GAMMAGARD S/D;
immunoglobulin (human) 10 g / vial;
1997-08-22;
Intravenous;
Solution , Kit , Powder For Solution;
80:04.00 – SERUMS;
Schedule D;
TAKEDA CANADA INC
DIN: 02231471
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50795
GAMUNEX;
immunoglobulin (human) 10 g / 100 ml;
2003-10-22;
Intravenous , Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
DIN: 02247724
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72002
IGIVNEX;
immunoglobulin (human) 10 g / 100 ml;
2006-05-24;
Intravenous , Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
DIN: 02277921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76352
OCTAGAM 10%;
immunoglobulin (human) 100 mg / ml;
2013-04-04;
Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02380145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86598
PANZYGA;
immunoglobulin (human) 100 mg / ml;
2016-12-21;
Intravenous;
Solution;
80:04.00 – SERUMS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02456087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94293
GAMASTAN;
immunoglobulin (human) 18 %;
2020-03-27;
Intramuscular;
Solution;
80:04.00 – SERUMS;
Schedule D;
GRIFOLS THERAPEUTICS LLC
DIN: 02486598
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97678
HIZENTRA;
immunoglobulin (human) 200 mg / ml;
2011-10-13;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02370352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85549
CUVITRU;
immunoglobulin (human) 200 mg / ml;
2017-12-21;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
TAKEDA CANADA INC
DIN: 02461692
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94943
HIZENTRA;
immunoglobulin (human) 200 mg / ml;
2017-09-21;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02463059
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95095
HIZENTRA;
immunoglobulin (human) 200 mg / ml;
2017-09-21;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02463067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95096
HIZENTRA;
immunoglobulin (human) 200 mg / ml;
2021-05-13;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
CSL BEHRING CANADA INC
DIN: 02498251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98804
GAMMAGARD S/D;
immunoglobulin (human) 5 g / vial;
1997-08-22;
Intravenous;
Solution , Kit , Powder For Solution;
80:04.00 – SERUMS;
Schedule D;
TAKEDA CANADA INC
DIN: 02231470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50794
CUTAQUIG;
immunoglobulin g (human) 1 g / 6 ml;
2018-08-08;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02472996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96234
CUTAQUIG;
immunoglobulin g (human) 2 g / 12 ml;
2018-08-17;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02473011
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96236
CUTAQUIG;
immunoglobulin g (human) 4 g / 24 ml;
2018-08-15;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02473046
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96238
CUTAQUIG;
immunoglobulin g (human) 8 g / 48 ml;
2018-08-17;
Subcutaneous;
Solution;
80:04.00 – SERUMS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
DIN: 02473054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96239
IXIARO;
inact.japanese encephal virus(attenuat. strain sa14-14-2 produced in vero cells) 6 mcg / 0.5 ml;
2009-12-29;
Intramuscular;
Suspension;
80:12.00 – VACCINES;
Schedule D;
VALNEVA AUSTRIA GMBH
DIN: 02333279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81890
XEOMIN;
incobotulinumtoxina 100 unit / vial;
2009-07-21;
Intraglandular , Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
MERZ PHARMACEUTICALS GMBH
DIN: 02324032
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80952
XEOMIN COSMETIC;
incobotulinumtoxina 100 unit / vial;
2012-07-05;
Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
MERZ PHARMACEUTICALS GMBH
DIN: 02383489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86922
XEOMIN;
incobotulinumtoxina 50 unit / vial;
2012-07-04;
Intraglandular , Intramuscular;
Powder For Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription , Schedule D;
MERZ PHARMACEUTICALS GMBH
DIN: 02371081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85628
ONBREZ BREEZHALER;
indacaterol (indacaterol maleate) 75 mcg;
2012-03-05;
Inhalation;
Capsule;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02376938
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86250
LOZIDE;
indapamide 1.25 mg;
1995-12-31;
Oral;
Tablet;
40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SERVIER CANADA INC
DIN: 02179709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19089
MYLAN-INDAPAMIDE;
indapamide 1.25 mg;
1999-05-10;
Oral;
Tablet;
40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02240067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63577
APO-INDAPAMIDE 1.25 MG TABLETS;
indapamide 1.25 mg;
2002-11-08;
Oral;
Tablet;
40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
APOTEX INC
DIN: 02245246
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69270
MYLAN-INDAPAMIDE;
indapamide 2.5 mg;
1995-12-31;
Oral;
Tablet;
40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02153483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18065
APO-INDAPAMIDE 2.5MG TABLETS;
indapamide 2.5 mg;
1996-10-02;
Oral;
Tablet;
40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
APOTEX INC
DIN: 02223678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43381
SPY AGENT GREEN;
indocyanine green 25 mg / vial;
2019-06-04;
Interstitial , Intravenous;
Powder For Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
NOVADAQ TECHNOLOGIES ULC
DIN: 02483653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97402
SPY AGENT GREEN KIT FOR SPY ELITE;
indocyanine green 25 mg / vial;
2019-06-04;
Interstitial , Intravenous;
Kit , Powder For Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
NOVADAQ TECHNOLOGIES ULC
DIN: 02483661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97403
SPY AGENT GREEN KIT FOR ADVANCED IMAGING MODALITY (AIM) AND PINPOINT;
indocyanine green 25 mg / vial;
2019-06-04;
Interstitial , Intravenous;
Kit , Powder For Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
NOVADAQ TECHNOLOGIES ULC
DIN: 02483688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97404
SPY AGENT GREEN LYMPHATICS KIT FOR ADVANCED IMAGING MODALITY (AIM) AND PINPOINT;
indocyanine green 25 mg / vial;
2019-06-04;
Interstitial , Intravenous;
Kit , Powder For Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
NOVADAQ TECHNOLOGIES ULC
DIN: 02483696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97405
INDOCYANINE GREEN FOR INJECTION, USP;
indocyanine green 25 mg / vial;
2019-06-11;
Intravenous;
Powder For Solution;
36:18.00 – CARDIAC FUNCTION , 36:44.00 – LIVER FUNCTION;
Ethical;
DIAGNOSTIC GREEN GMBH
DIN: 02485796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97602
INDOCYANINE GREEN FOR INJECTION KIT;
indocyanine green 25 mg / vial;
2019-06-11;
Intravenous;
Kit , Powder For Solution;
36:18.00 – CARDIAC FUNCTION , 36:44.00 – LIVER FUNCTION;
Ethical;
DIAGNOSTIC GREEN GMBH
DIN: 02485826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97604
SPY AGENT GREEN KIT FOR SPY-PHI;
indocyanine green 25 mg / vial;
2020-12-03;
Interstitial , Intravenous;
Kit , Powder For Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
NOVADAQ TECHNOLOGIES ULC
DIN: 02498677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98842
SANDOZ INDOMETHACIN;
indomethacin 100 mg / sup;
1997-11-17;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02231800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51233
TEVA-INDOMETHACIN;
indomethacin 25 mg;
1980-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00337420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4129
MINT-INDOMETHACIN;
indomethacin 25 mg;
2017-04-03;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02461811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94956
TEVA-INDOMETHACIN;
indomethacin 50 mg;
1980-12-31;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00337439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4130
MINT-INDOMETHACIN;
indomethacin 50 mg;
2017-04-03;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02461536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94917
SANDOZ INDOMETHACIN;
indomethacin 50 mg / sup;
1997-11-17;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02231799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51232
REMICADE;
infliximab 100 mg / vial;
2001-06-14;
Intravenous;
Powder For Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
DIN: 02244016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67959
INFLECTRA;
infliximab 100 mg / vial;
2014-09-04;
Intravenous;
Powder For Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
DIN: 02419475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90410
RENFLEXIS;
infliximab 100 mg / vial;
2018-03-22;
Intravenous;
Powder For Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SAMSUNG BIOEPIS CO., LTD
DIN: 02470373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95936
AVSOLA;
infliximab 100 mg / vial;
2020-06-01;
Intravenous;
Powder For Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
DIN: 02496933
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98681
REMSIMA SC;
infliximab 120 mg / ml;
2021-06-04;
Subcutaneous;
Solution , Kit;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
CELLTRION HEALTHCARE CO LTD
DIN: 02511584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100077
IMUNOVIR;
inosine pranobex 500 mg;
2000-01-25;
Oral;
Tablet;
08:18.92 – MISCELLANEOUS ANTIVIRALS;
Prescription;
KORA HEALTHCARE
DIN: 02240713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64296
TEGSEDI;
inotersen (inotersen sodium) 284 mg / 1.5 ml;
2019-01-07;
Subcutaneous;
Solution;
92:18.00 – ANTISENSE OLIGONUCLEOTIDES;
Prescription;
AKCEA THERAPEUTICS, INC.
DIN: 02481383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97187
BESPONSA;
inotuzumab ozogamicin 0.9 mg / vial;
2018-05-03;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
DIN: 02473909
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96383
NOVORAPID;
insulin aspart 100 unit / ml;
2001-10-31;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02244353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68321
NOVORAPID;
insulin aspart 100 unit / ml;
2002-06-12;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02245397
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69441
NOVORAPID;
insulin aspart 100 unit / ml;
2012-05-04;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02377209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86282
FIASP;
insulin aspart 100 unit / ml;
2017-03-03;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02460408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94775
FIASP;
insulin aspart 100 unit / ml;
2017-03-03;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02460416
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94776
FIASP;
insulin aspart 100 unit / ml;
2017-03-03;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02460424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94777
TRURAPI;
insulin aspart 100 unit / ml;
2021-03-30;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02506564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99592
TRURAPI;
insulin aspart 100 unit / ml;
2021-03-30;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02506572
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99593
HUMULIN R (KWIKPEN);
insulin biosynthetic human br 100 unit / ml;
2014-03-03;
Intramuscular , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02415089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89971
TRESIBA;
insulin degludec 100 unit / ml;
2017-09-15;
Subcutaneous;
Solution;
68:20.08.16 – LONG-ACTING INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02467879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95623
TRESIBA;
insulin degludec 200 unit / ml;
2017-09-15;
Subcutaneous;
Solution;
68:20.08.16 – LONG-ACTING INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02467887
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95624
LEVEMIR PENFILL;
insulin detemir 100 unit / ml;
2005-11-14;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02271842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75736
LEVEMIR FLEXTOUCH;
insulin detemir 100 unit / ml;
2013-11-25;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02412829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89748
LANTUS;
insulin glargine 100 unit / ml;
2002-07-24;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02245689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69790
LANTUS;
insulin glargine 100 unit / ml;
2006-05-04;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02251930
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73683
LANTUS;
insulin glargine 100 unit / ml;
2007-09-24;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02294338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77967
BASAGLAR;
insulin glargine 100 unit / ml;
2015-12-18;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02444844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93005
BASAGLAR;
insulin glargine 100 unit / ml;
2017-08-18;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02461528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94916
TOUJEO SOLOSTAR;
insulin glargine 300 unit / ml;
2015-07-15;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02441829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92621
TOUJEO DOUBLESTAR;
insulin glargine 300 unit / ml;
2020-02-04;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02493373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98339
APIDRA;
insulin glulisine (recombinant dna origin) 100 unit / ml;
2008-09-22;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02279460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76506
APIDRA;
insulin glulisine (recombinant dna origin) 100 unit / ml;
2009-10-01;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02279479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76507
APIDRA;
insulin glulisine (recombinant dna origin) 100 unit / ml;
2008-09-22;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02294346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77968
HUMULIN R CARTRIDGE;
insulin injection human biosynthetic 100 unit / ml;
1992-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 01959220
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12569
NOVOLIN GE TORONTO;
insulin injection human biosynthetic 100 unit / ml;
1993-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02024233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14260
NOVOLIN GE TORONTO PENFILL;
insulin injection human biosynthetic 100 unit / ml;
1993-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02024284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14459
ENTUZITY KWIKPEN;
insulin injection human biosynthetic 500 unit / ml;
2017-10-20;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02466864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95524
HYPURIN REGULAR INSULIN PORK;
insulin injection pork 100 unit / ml;
2006-04-01;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
WOCKHARDT UK LIMITED
DIN: 02275872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76153
HUMULIN N (CARTRIDGE);
insulin isophane human biosynthetic 100 unit / ml;
1992-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 01959239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12570
NOVOLIN GE NPH;
insulin isophane human biosynthetic 100 unit / ml;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02024225
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14261
NOVOLIN GE NPH PENFILL;
insulin isophane human biosynthetic 100 unit / ml;
1993-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
NOVO NORDISK CANADA INC
DIN: 02024268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14266
HUMULIN N (KWIKPEN);
insulin isophane human biosynthetic 100 unit / ml;
2013-09-13;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02403447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88825
HYPURIN NPH INSULIN ISOPHANE PORK;
insulin isophane injection pork 100 unit / ml;
2006-04-01;
Intramuscular , Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
WOCKHARDT UK LIMITED
DIN: 02275864
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76152
HUMALOG;
insulin lispro 100 unit / ml;
1996-11-15;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02229704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47871
HUMALOG (CARTRIDGE);
insulin lispro 100 unit / ml;
1996-11-27;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02229705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47872
HUMALOG (KWIKPEN);
insulin lispro 100 unit / ml;
2013-08-14;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02403412
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88822
ADMELOG;
insulin lispro 100 unit / ml;
2019-11-22;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02469898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95877
ADMELOG SOLOSTAR;
insulin lispro 100 unit / ml;
2019-11-22;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02469871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95880
ADMELOG;
insulin lispro 100 unit / ml;
2019-11-22;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02469901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95881
HUMALOG;
insulin lispro 100 unit / ml;
2018-04-06;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02470152
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95912
HUMALOG 200 UNITS/ML KWIKPEN;
insulin lispro 200 unit / ml;
2015-09-14;
Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 02439611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92402
HUMULIN N;
insulin nph human dna origin 100 unit / ml;
1983-12-31;
Subcutaneous;
Suspension;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 00587737
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5326
HUMULIN R;
insulin semi synthetic human 100 unit / ml;
1983-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
68:20.08 – INSULINS;
Schedule D;
ELI LILLY CANADA INC
DIN: 00586714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5325
INTRON A;
interferon alfa-2b 6000000 unit / ml;
1998-12-10;
Intramuscular , Intravenous , Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS , 08:18.20 – INTERFERONS;
Prescription , Schedule D;
MERCK CANADA INC
DIN: 02238674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62105
REBIF;
interferon beta-1a 132 mcg / 1.5 ml;
2009-05-14;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02318261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80377
REBIF;
interferon beta-1a 22 mcg / 0.5 ml;
1998-02-23;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02237319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60641
AVONEX;
interferon beta-1a 30 mcg / 0.5 ml;
2005-12-02;
Intramuscular;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
BIOGEN CANADA INC
DIN: 02269201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75459
REBIF;
interferon beta-1a 44 mcg / 0.5 ml;
1998-02-24;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02237320
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60642
REBIF;
interferon beta-1a 66 mcg / 1.5 ml;
2009-05-14;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02318253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80376
BETASERON;
interferon beta-1b 0.3 mg / vial;
1995-12-31;
Subcutaneous;
Powder For Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
BAYER INC
DIN: 02169649
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19241
EXTAVIA;
interferon beta-1b 0.3 mg / vial;
2010-05-05;
Subcutaneous;
Powder For Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02337819
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82345
MICRO I;
iodide (sodium iodide) 100 mcg / ml;
1993-12-31;
Intravenous;
Liquid;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 01974548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13600
LIPIODOL ULTRA FLUID;
iodine (ethiodized oil) 380 mg / g;
1977-12-31;
Intracavitary , Parenteral (Unspecified);
Liquid;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
GUERBET
DIN: 00386685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2570
VISIPAQUE 270;
iodixanol 550 mg / ml;
1995-12-31;
Intra-Arterial , Intravenous;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
GE HEALTHCARE CANADA INC
DIN: 02145766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18685
VISIPAQUE 320;
iodixanol 652 mg / ml;
1995-12-31;
Intra-Arterial , Intravenous;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
GE HEALTHCARE CANADA INC
DIN: 02145774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18694
OMNIPAQUE 180;
iohexol 388 mg / ml;
1998-03-08;
Subarachnoidal;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
GE HEALTHCARE CANADA INC
DIN: 02172720
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44184
OMNIPAQUE 240;
iohexol 518 mg / ml;
1998-05-26;
Subarachnoidal , Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
GE HEALTHCARE CANADA INC
DIN: 02172739
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44185
OMNIPAQUE 300;
iohexol 647 mg / ml;
1998-03-05;
Subarachnoidal , Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
GE HEALTHCARE CANADA INC
DIN: 02172747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44186
OMNIPAQUE 350;
iohexol 755 mg / ml;
1998-03-05;
Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
GE HEALTHCARE CANADA INC
DIN: 02172755
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44187
ISOVUE 200 INJECTION;
iopamidol 41 %;
1998-01-08;
Intravenous;
Liquid;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BRACCO IMAGING CANADA
DIN: 02229013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43504
ISOVUE 300 INJECTION;
iopamidol 61 %;
1998-01-08;
Intravascular;
Liquid;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BRACCO IMAGING CANADA
DIN: 02229021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43505
ISOVUE MULTIPACK-300;
iopamidol 61 %;
2001-07-30;
Intravascular;
Liquid;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BRACCO IMAGING CANADA
DIN: 02242122
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65800
ISOVUE 370 INJECTION;
iopamidol 76 %;
1998-01-08;
Intravascular;
Liquid;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BRACCO IMAGING CANADA
DIN: 02229048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43506
ISOVUE MULTIPACK-370;
iopamidol 76 %;
2001-07-30;
Intravascular;
Liquid;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BRACCO IMAGING CANADA
DIN: 02242121
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65799
ULTRAVIST 300;
iopromide 62 %;
1994-12-31;
Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BAYER INC
DIN: 02078600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16179
ULTRAVIST 370;
iopromide 77 %;
1994-12-31;
Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
BAYER INC
DIN: 02078619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16180
CYSTO-CONRAY II;
iothalamate meglumine 172 mg / ml;
1978-12-31;
Urethral;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
LIEBEL-FLARSHEIM CANADA INC
DIN: 00397466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2949
CONRAY 60;
iothalamate meglumine 600 mg / ml;
1951-12-31;
Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
LIEBEL-FLARSHEIM CANADA INC
DIN: 00131237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=899
OPTIRAY 320;
ioversol 68 %;
1990-12-31;
Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
LIEBEL-FLARSHEIM CANADA INC
DIN: 01900854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11328
OPTIRAY 320 (ULTRAJECT);
ioversol 68 %;
1995-02-05;
Intravascular;
Solution;
36:68.00 – ROENTGENOGRAPHY;
Ethical;
LIEBEL-FLARSHEIM CANADA INC
DIN: 02035626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43604
YERVOY;
ipilimumab 5 mg / ml;
2012-03-08;
Intravenous;
Liquid;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
BRISTOL-MYERS SQUIBB CANADA
DIN: 02379384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86525
PMS-IPRATROPIUM;
ipratropium bromide 125 mcg / ml;
1997-10-29;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
PHARMASCIENCE INC
DIN: 02231135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50442
ATROVENT HFA;
ipratropium bromide 20 mcg / act;
2004-03-24;
Inhalation;
Metered-Dose Aerosol;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02247686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71950
PMS-IPRATROPIUM;
ipratropium bromide 21 mcg / act;
1999-04-15;
Nasal;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
PHARMASCIENCE INC
DIN: 02239627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63098
APO-IPRAVENT SOLUTION – INH 250MCG/ML;
ipratropium bromide 250 mcg / ml;
1994-12-31;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
APOTEX INC
DIN: 02126222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16947
TEVA-IPRATROPIUM STERINEBS;
ipratropium bromide 250 mcg / ml;
1998-03-04;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02216221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43176
PMS-IPRATROPIUM;
ipratropium bromide 250 mcg / ml;
1997-07-15;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
PHARMASCIENCE INC
DIN: 02231136
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50443
PMS-IPRATROPIUM;
ipratropium bromide 250 mcg / ml;
1997-10-29;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
PHARMASCIENCE INC
DIN: 02231244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50551
PMS-IPRATROPIUM;
ipratropium bromide 250 mcg / ml;
1997-10-29;
Inhalation;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
PHARMASCIENCE INC
DIN: 02231245
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50552
IPRAVENT;
ipratropium bromide 42 mcg / act;
2002-12-03;
Nasal;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
AA PHARMA INC
DIN: 02246084
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70219
AVAPRO;
irbesartan 150 mg;
1998-07-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02237924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61289
TEVA-IRBESARTAN;
irbesartan 150 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80191
PMS-IRBESARTAN;
irbesartan 150 mg;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02317079
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80258
SANDOZ IRBESARTAN;
irbesartan 150 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02328488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81400
IRBESARTAN;
irbesartan 150 mg;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02365200
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85005
IRBESARTAN;
irbesartan 150 mg;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02372371
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85751
IRBESARTAN;
irbesartan 150 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87093
TARO-IRBESARTAN;
irbesartan 150 mg;
2013-07-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02406829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89150
JAMP-IRBESARTAN;
irbesartan 150 mg;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02418207
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90278
MINT-IRBESARTAN;
irbesartan 150 mg;
2015-01-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02422999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90772
AVAPRO;
irbesartan 300 mg;
1998-07-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02237925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61290
TEVA-IRBESARTAN;
irbesartan 300 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316412
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80192
PMS-IRBESARTAN;
irbesartan 300 mg;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02317087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80259
SANDOZ IRBESARTAN;
irbesartan 300 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02328496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81401
IRBESARTAN;
irbesartan 300 mg;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02365219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85006
IRBESARTAN;
irbesartan 300 mg;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02372398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85752
IRBESARTAN;
irbesartan 300 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87094
TARO-IRBESARTAN;
irbesartan 300 mg;
2013-07-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02406837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89151
JAMP-IRBESARTAN;
irbesartan 300 mg;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02418215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90279
MINT-IRBESARTAN;
irbesartan 300 mg;
2015-01-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02423006
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90773
AVAPRO;
irbesartan 75 mg;
1998-06-22;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02237923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61288
TEVA-IRBESARTAN;
irbesartan 75 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02316390
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80190
PMS-IRBESARTAN;
irbesartan 75 mg;
2011-03-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02317060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80257
SANDOZ IRBESARTAN;
irbesartan 75 mg;
2011-03-21;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02328461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81399
IRBESARTAN;
irbesartan 75 mg;
2011-05-27;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PRO DOC LIMITEE
DIN: 02365197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85004
IRBESARTAN;
irbesartan 75 mg;
2011-10-18;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02372347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85748
IRBESARTAN;
irbesartan 75 mg;
2012-06-10;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87092
TARO-IRBESARTAN;
irbesartan 75 mg;
2013-07-24;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02406810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89149
JAMP-IRBESARTAN;
irbesartan 75 mg;
2014-01-15;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02418193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90277
MINT-IRBESARTAN;
irbesartan 75 mg;
2015-01-14;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02422980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90771
ONIVYDE;
irinotecan (irinotecan sucrose octasulfate) 4.3 mg / ml;
2017-10-04;
Intravenous;
Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SERVIER CANADA INC
DIN: 02467135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95553
IRINOTECAN HYDROCHLORIDE INJECTION USP;
irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20 mg / ml;
2013-05-06;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02357585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84269
IRINOTECAN HYDROCHLORIDE INJECTION;
irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20 mg / ml;
2015-05-28;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02412187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89675
IRINOTECAN HYDROCHLORIDE INJECTION USP;
irinotecan hydrochloride 20 mg / ml;
2006-02-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02258218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74343
IRINOTECAN FOR INJECTION;
irinotecan hydrochloride 20 mg / ml;
2008-10-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02312409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79791
IRINOTECAN;
irinotecan hydrochloride 20 mg / ml;
2014-03-07;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02410419
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89508
MONOFERRIC;
iron (iron isomaltoside 1000) 100 mg / ml;
2018-10-17;
Intravenous;
Solution;
20:04.04 – IRON PREPARATIONS;
Prescription;
PHARMACOSMOS A/S
DIN: 02477777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96866
VENOFER;
iron (iron sucrose) 20 mg / ml;
2001-06-05;
Intravenous;
Solution;
20:04.04 – IRON PREPARATIONS;
Prescription;
AMERICAN REGENT, INC
DIN: 02243716
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67648
PMS-IRON SUCROSE;
iron (iron sucrose) 20 mg / ml;
2021-01-12;
Intravenous;
Solution;
20:04.04 – IRON PREPARATIONS;
Prescription;
PHARMASCIENCE INC
DIN: 02502917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99244
FERRLECIT;
iron (sodium ferric gluconate complex in sucrose injection) 12.5 mg / ml;
2005-03-02;
Intravenous;
Liquid;
20:04.04 – IRON PREPARATIONS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02243333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67236
VELPHORO;
iron (sucroferric oxyhydroxide) 500 mg;
2019-11-20;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
DIN: 02471574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96073
SARCLISA;
isatuximab 100 mg / 5 ml;
2020-07-03;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02498235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98801
SARCLISA;
isatuximab 500 mg / 25 ml;
2020-07-03;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
DIN: 02498243
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98802
CRESEMBA;
isavuconazole (isavuconazonium sulfate) 100 mg;
2019-05-02;
Oral;
Capsule;
08:14.08 – AZOLES;
Prescription;
AVIR PHARMA INC.
DIN: 02483971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97432
CRESEMBA;
isavuconazole (isavuconazonium sulfate) 200 mg / vial;
2019-05-31;
Intravenous;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
AVIR PHARMA INC.
DIN: 02483998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97433
FORANE;
isoflurane 100 %;
1996-12-31;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
BAXTER CORPORATION
DIN: 02188856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20160
ISOFLURANE USP;
isoflurane 99.9 %;
1997-11-14;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02231929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51381
PDP-ISONIAZID;
isoniazid 100 mg;
1984-12-31;
Oral;
Tablet;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00577790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5718
PDP-ISONIAZID;
isoniazid 300 mg;
1984-12-31;
Oral;
Tablet;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00577804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5719
PDP-ISONIAZID;
isoniazid 50 mg / 5 ml;
1984-12-31;
Oral;
Solution;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00577812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5720
RESULTZ;
isopropyl myristate 50 % / w/w;
2006-09-01;
Topical;
Solution;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
ARALEZ PHARMACEUTICALS CANADA INC
DIN: 02279592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76520
ISOPROTERENOL HYDROCHLORIDE INJECTION USP;
isoproterenol hydrochloride 0.2 mg / ml;
1991-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.08.04 – NON-SELECTIVE BETA-ADRENERGIC AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 00897639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11642
ISOPROTERENOL HYDROCHLORIDE INJECTION USP;
isoproterenol hydrochloride 0.2 mg / ml;
2020-12-11;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.08.04 – NON-SELECTIVE BETA-ADRENERGIC AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02502615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99218
ISOPROTERENOL HYDROCHLORIDE INJECTION USP;
isoproterenol hydrochloride 1 mg / 5 ml;
2021-01-06;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.08.04 – NON-SELECTIVE BETA-ADRENERGIC AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02502623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99219
ISDN;
isosorbide dinitrate 10 mg;
1982-12-31;
Oral;
Tablet;
24:12.08 – NITRATES AND NITRITES;
Ethical;
AA PHARMA INC
DIN: 00441686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4730
ISDN;
isosorbide dinitrate 30 mg;
1982-12-31;
Oral;
Tablet;
24:12.08 – NITRATES AND NITRITES;
Ethical;
AA PHARMA INC
DIN: 00441694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4731
IMDUR;
isosorbide-5-mononitrate 60 mg;
1994-12-31;
Oral;
Tablet (Extended-Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
JUNO PHARMACEUTICALS CORP.
DIN: 02126559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16804
APO-ISMN;
isosorbide-5-mononitrate 60 mg;
2006-03-03;
Oral;
Tablet (Extended-Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
APOTEX INC
DIN: 02272830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75834
PMS-ISMN;
isosorbide-5-mononitrate 60 mg;
2007-11-08;
Oral;
Tablet (Extended-Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
PHARMASCIENCE INC
DIN: 02301288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78661
PRO-ISMN – 60;
isosorbide-5-mononitrate 60 mg;
2008-07-04;
Oral;
Tablet (Extended-Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
PRO DOC LIMITEE
DIN: 02311321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79692
ACCUTANE ROCHE;
isotretinoin 10 mg;
1983-12-31;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 00582344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5128
CLARUS;
isotretinoin 10 mg;
2005-04-01;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02257955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74319
EPURIS;
isotretinoin 10 mg;
2013-05-07;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02396971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88198
EPURIS;
isotretinoin 20 mg;
2013-05-07;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02396998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88199
EPURIS;
isotretinoin 30 mg;
2013-05-07;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02397005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88200
ACCUTANE ROCHE;
isotretinoin 40 mg;
1983-12-31;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 00582352
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5129
CLARUS;
isotretinoin 40 mg;
2005-04-01;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02257963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74320
EPURIS;
isotretinoin 40 mg;
2013-05-07;
Oral;
Capsule;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
CIPHER PHARMACEUTICALS INC
DIN: 02397013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88201
SPORANOX ORAL SOLUTION 10MG/ML;
itraconazole 10 mg / ml;
1997-07-28;
Oral;
Solution;
08:14.08 – AZOLES;
Prescription;
JANSSEN INC
DIN: 02231347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50656
JAMP ITRACONAZOLE ORAL SOLUTION;
itraconazole 10 mg / ml;
2019-07-31;
Oral;
Solution;
08:14.08 – AZOLES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02484315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97463
ODAN ITRACONAZOLE;
itraconazole 10 mg / ml;
2020-07-08;
Oral;
Solution;
08:14.08 – AZOLES;
Prescription;
ODAN LABORATORIES LTD
DIN: 02495988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98587
SPORANOX;
itraconazole 100 mg;
1993-12-31;
Oral;
Capsule;
08:14.08 – AZOLES;
Prescription;
JANSSEN INC
DIN: 02047454
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14518
MINT-ITRACONAZOLE;
itraconazole 100 mg;
2017-05-18;
Oral;
Capsule;
08:14.08 – AZOLES;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02462559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95031
LANCORA;
ivabradine (ivabradine hydrochloride) 5 mg;
2017-03-17;
Oral;
Tablet;
24:04.92 – MISCELLANEOUS CARDIAC DRUGS;
Prescription;
SERVIER CANADA INC
DIN: 02459973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94728
LANCORA;
ivabradine (ivabradine hydrochloride) 7.5 mg;
2017-03-17;
Oral;
Tablet;
24:04.92 – MISCELLANEOUS CARDIAC DRUGS;
Prescription;
SERVIER CANADA INC
DIN: 02459981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94729
KALYDECO;
ivacaftor 150 mg;
2012-11-27;
Oral;
Tablet;
48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02397412
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88237
KALYDECO;
ivacaftor 50 mg / sachet;
2015-09-14;
Oral;
Granules;
48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02442612
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92696
KALYDECO;
ivacaftor 75 mg / sachet;
2015-09-14;
Oral;
Granules;
48:14.12 – Cystic Fibrosis Transmembrane Conductance Regulator Potentiators;
Prescription;
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
DIN: 02442620
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92697
ROSIVER;
ivermectin 1 % / w/w;
2015-05-25;
Topical;
Cream;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Prescription;
GALDERMA CANADA INC
DIN: 02440342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92470
STROMECTOL;
ivermectin 3 mg;
2018-11-06;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Prescription;
MERCK CANADA INC
DIN: 02480557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97110
NINLARO;
ixazomib (ixazomib citrate) 2.3 mg;
2016-09-21;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02456796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94382
NINLARO;
ixazomib (ixazomib citrate) 3 mg;
2016-09-21;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02456818
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94383
NINLARO;
ixazomib (ixazomib citrate) 4 mg;
2016-09-21;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02456826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94384
TALTZ;
ixekizumab 80 mg / ml;
2016-08-11;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
DIN: 02455102
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94193
TALTZ;
ixekizumab 80 mg / ml;
2016-08-11;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
DIN: 02455110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94194
KETALAR;
ketamine (ketamine hydrochloride) 10 mg / ml;
1972-12-31;
Intramuscular , Intravenous;
Solution;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Narcotic (Cdsa I);
ERFA CANADA 2012 INC
DIN: 00224391
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1214
KETAMINE HYDROCHLORIDE INJECTION USP;
ketamine (ketamine hydrochloride) 10 mg / ml;
2003-02-05;
Intramuscular , Intravenous;
Solution;
28:04.00 – GENERAL ANESTHETICS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02246795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70995
KETALAR;
ketamine (ketamine hydrochloride) 50 mg / ml;
1972-12-31;
Intramuscular , Intravenous;
Solution;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Narcotic (Cdsa I);
ERFA CANADA 2012 INC
DIN: 00224405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1215
KETAMINE HYDROCHLORIDE INJECTION USP;
ketamine (ketamine hydrochloride) 50 mg / ml;
2003-02-04;
Intramuscular , Intravenous;
Solution;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02246796
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70996
NIZORAL;
ketoconazole 2 %;
1990-12-30;
Topical;
Shampoo;
84:04.08.08 – AZOLES;
Otc;
KRAMER LABORATORIES, INC
DIN: 02182920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44259
KETODERM CREAM 2%;
ketoconazole 2 %;
2002-05-23;
Topical;
Cream;
84:04.08.08 – AZOLES;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN: 02245662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69762
TEVA-KETOCONAZOLE;
ketoconazole 200 mg;
1999-06-30;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
DIN: 02231061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50343
APO-KETOCONAZOLE;
ketoconazole 200 mg;
1998-02-03;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
APOTEX INC
DIN: 02237235
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60554
KETOPROFEN-E;
ketoprofen 100 mg;
1989-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
DIN: 00842664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10134
KETOPROFEN SR;
ketoprofen 200 mg;
1995-12-31;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
DIN: 02172577
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19115
KETOPROFEN-E;
ketoprofen 50 mg;
1989-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
DIN: 00790435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10135
ACULAR LS;
ketorolac tromethamine 0.4 %;
2004-03-08;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
ALLERGAN INC
DIN: 02248722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73086
ACUVAIL;
ketorolac tromethamine 0.45 % / w/v;
2012-01-10;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
ALLERGAN INC
DIN: 02369362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85428
ACULAR LIQ 0.5%;
ketorolac tromethamine 0.5 %;
1992-12-31;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
ALLERGAN INC
DIN: 01968300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13121
KETOROLAC;
ketorolac tromethamine 0.5 %;
2002-12-06;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
DIN: 02245821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69937
TORADOL;
ketorolac tromethamine 10 mg;
1995-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
DIN: 02162660
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19348
APO-KETOROLAC;
ketorolac tromethamine 10 mg;
1998-07-03;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 02229080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43510
MINT-KETOROLAC;
ketorolac tromethamine 10 mg;
2019-06-28;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02461455
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94908
MAR-KETOROLAC;
ketorolac tromethamine 10 mg;
2017-08-16;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02465124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95332
TORADOL IM;
ketorolac tromethamine 10 mg / ml;
1996-10-16;
Intramuscular;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 02162644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44090
KETOROLAC TROMETHAMINE INJECTION USP;
ketorolac tromethamine 30 mg / ml;
1999-05-21;
Intramuscular;
Liquid;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02239944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63447
KETOROLAC TROMETHAMINE INJECTION, USP;
ketorolac tromethamine 30 mg / ml;
2002-05-23;
Intramuscular;
Liquid;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02244947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68945
KETOROLAC TROMETHAMINE INJECTION USP;
ketorolac tromethamine 30 mg / ml;
2014-05-29;
Intramuscular;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02390582
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87600
KETOROLAC TROMETHAMINE INJECTION, USP;
ketorolac tromethamine 30 mg / ml;
2016-04-26;
Intramuscular;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
JUNO PHARMACEUTICALS CORP.
DIN: 02443376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92801
ZADITOR;
ketotifen (ketotifen fumarate) 0.25 mg / ml;
2000-08-01;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
LABORATOIRES THEA
DIN: 02242324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66035
KETOTIFEN OPHTHALMIC SOLUTION;
ketotifen (ketotifen fumarate) 0.25 mg / ml;
2013-03-07;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
STERIMAX INC
DIN: 02400871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88567
ZADITEN;
ketotifen (ketotifen fumarate) 1 mg;
1990-12-31;
Oral;
Tablet;
04:92.00 – OTHER ANTIHISTAMINES;
Prescription;
TEVA CANADA LIMITED
DIN: 00577308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10832
ZADITEN;
ketotifen (ketotifen fumarate) 1 mg / 5 ml;
1990-12-31;
Oral;
Syrup;
04:92.00 – OTHER ANTIHISTAMINES;
Prescription;
TEVA CANADA LIMITED
DIN: 00600784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10860
TRANDATE;
labetalol hydrochloride 100 mg;
1996-07-30;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PALADIN LABS INC.
DIN: 02106272
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=29542
APO-LABETALOL;
labetalol hydrochloride 100 mg;
2001-03-16;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02243538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67456
RIVA-LABETALOL;
labetalol hydrochloride 100 mg;
2019-09-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02489406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97949
TRANDATE;
labetalol hydrochloride 200 mg;
1997-04-01;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PALADIN LABS INC.
DIN: 02106280
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=29543
APO-LABETALOL;
labetalol hydrochloride 200 mg;
2001-06-01;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02243539
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67457
RIVA-LABETALOL;
labetalol hydrochloride 200 mg;
2019-09-04;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02489414
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97950
LABETALOL HYDROCHLORIDE INJECTION USP;
labetalol hydrochloride 5 mg / ml;
1998-03-17;
Intravenous;
Liquid;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02231689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51066
LABETALOL HYDROCHLORIDE INJECTION USP;
labetalol hydrochloride 5 mg / ml;
2021-05-26;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
STERIMAX INC
DIN: 02385120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87077
LABETALOL HYDROCHLORIDE INJECTION USP;
labetalol hydrochloride 5 mg / ml;
2015-06-02;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02391090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87646
LABETALOL HYDROCHLORIDE INJECTION;
labetalol hydrochloride 5 mg / ml;
2018-06-02;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02457040
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94413
VIMPAT;
lacosamide 10 mg / ml;
2011-09-20;
Intravenous;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02357666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84276
VIMPAT;
lacosamide 100 mg;
2010-10-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02357623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84273
TEVA-LACOSAMIDE;
lacosamide 100 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02472910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96225
SANDOZ LACOSAMIDE;
lacosamide 100 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02474689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96486
AURO-LACOSAMIDE;
lacosamide 100 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02475340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96572
PHARMA-LACOSAMIDE;
lacosamide 100 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02478218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96893
MAR-LACOSAMIDE;
lacosamide 100 mg;
2019-10-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02487810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97797
JAMP-LACOSAMIDE;
lacosamide 100 mg;
2020-03-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02488396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97849
ACH-LACOSAMIDE;
lacosamide 100 mg;
2021-04-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02489295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97937
MINT-LACOSAMIDE;
lacosamide 100 mg;
2019-11-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02490552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98059
VIMPAT;
lacosamide 150 mg;
2010-10-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02357631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84274
TEVA-LACOSAMIDE;
lacosamide 150 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02472929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96226
SANDOZ LACOSAMIDE;
lacosamide 150 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02474697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96487
AURO-LACOSAMIDE;
lacosamide 150 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02475359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96573
PHARMA-LACOSAMIDE;
lacosamide 150 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02478226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96894
MAR-LACOSAMIDE;
lacosamide 150 mg;
2019-10-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02487829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97798
JAMP-LACOSAMIDE;
lacosamide 150 mg;
2020-03-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02488418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97850
ACH-LACOSAMIDE;
lacosamide 150 mg;
2021-04-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02489309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97938
MINT-LACOSAMIDE;
lacosamide 150 mg;
2019-11-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02490560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98060
VIMPAT;
lacosamide 200 mg;
2010-10-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02357658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84275
TEVA-LACOSAMIDE;
lacosamide 200 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02472937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96228
SANDOZ LACOSAMIDE;
lacosamide 200 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02474700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96488
AURO-LACOSAMIDE;
lacosamide 200 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02475367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96574
PHARMA-LACOSAMIDE;
lacosamide 200 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02478234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96895
MAR-LACOSAMIDE;
lacosamide 200 mg;
2019-10-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02487837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97799
JAMP-LACOSAMIDE;
lacosamide 200 mg;
2020-03-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02488426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97851
ACH-LACOSAMIDE;
lacosamide 200 mg;
2021-04-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02489317
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97939
MINT-LACOSAMIDE;
lacosamide 200 mg;
2019-11-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02490579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98061
VIMPAT;
lacosamide 50 mg;
2010-10-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02357615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84272
TEVA-LACOSAMIDE;
lacosamide 50 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02472902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96224
SANDOZ LACOSAMIDE;
lacosamide 50 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02474670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96485
AURO-LACOSAMIDE;
lacosamide 50 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02475332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96571
PHARMA-LACOSAMIDE;
lacosamide 50 mg;
2018-10-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02478196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96892
MAR-LACOSAMIDE;
lacosamide 50 mg;
2019-10-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02487802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97796
JAMP-LACOSAMIDE;
lacosamide 50 mg;
2020-03-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02488388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97848
ACH-LACOSAMIDE;
lacosamide 50 mg;
2021-04-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02489287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97936
MINT-LACOSAMIDE;
lacosamide 50 mg;
2019-11-25;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02490544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98058
RATIO-LACTULOSE;
lactulose 667 mg / ml;
1986-12-31;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
TEVA CANADA LIMITED
DIN: 00854409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12699
PMS-LACTULOSE SYR 667MG/ML;
lactulose 667 mg / ml;
1996-10-16;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
PHARMASCIENCE INC
DIN: 00703486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=38260
APO-LACTULOSE;
lactulose 667 mg / ml;
2001-02-19;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
BAJAJ MEDICAL, LLC
DIN: 02242814
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66642
PHARMA-LACTULOSE;
lactulose 667 mg / ml;
2004-06-23;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
PHARMASCIENCE INC
DIN: 02247383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71628
JAMP-LACTULOSE;
lactulose 667 mg / ml;
2008-06-20;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
JAMP PHARMA CORPORATION
DIN: 02295881
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78124
TEVA-LACTULOSE;
lactulose 667 mg / ml;
2010-11-15;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
TEVA CANADA LIMITED
DIN: 02331551
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81724
LACTULOSE;
lactulose 667 mg / ml;
2013-10-09;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
SANIS HEALTH INC
DIN: 02412268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89682
PMS-LACTULOSE-PHARMA;
lactulose 667 mg / ml;
2018-04-02;
Oral;
Solution;
40:10.00 – AMMONIA DETOXICANTS;
Otc;
PHARMASCIENCE INC
DIN: 02469391
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95818
3TC;
lamivudine 10 mg / ml;
1995-12-31;
Oral;
Solution;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02192691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19615
HEPTOVIR;
lamivudine 100 mg;
1998-12-02;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02239193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62649
APO-LAMIVUDINE HBV;
lamivudine 100 mg;
2012-09-21;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02393239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87847
3TC;
lamivudine 150 mg;
1995-12-31;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02192683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19614
APO-LAMIVUDINE;
lamivudine 150 mg;
2012-05-18;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02369052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85400
JAMP LAMIVUDINE;
lamivudine 150 mg;
2021-03-16;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02507110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99652
3TC;
lamivudine 300 mg;
2003-09-09;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02247825
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72120
APO-LAMIVUDINE;
lamivudine 300 mg;
2012-05-18;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
APOTEX INC
DIN: 02369060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85401
JAMP LAMIVUDINE;
lamivudine 300 mg;
2021-03-16;
Oral;
Tablet;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02507129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99653
HEPTOVIR;
lamivudine 5 mg / ml;
1999-03-30;
Oral;
Solution;
08:18.08.20 – NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02239194
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62650
LAMICTAL;
lamotrigine 100 mg;
1995-12-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02142104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17201
APO-LAMOTRIGINE;
lamotrigine 100 mg;
2002-03-18;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02245209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69224
PMS-LAMOTRIGINE;
lamotrigine 100 mg;
2003-04-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02246898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71125
TEVA-LAMOTRIGINE;
lamotrigine 100 mg;
2004-01-16;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72569
MYLAN-LAMOTRIGINE;
lamotrigine 100 mg;
2005-04-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02265508
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75096
LAMOTRIGINE-100;
lamotrigine 100 mg;
2008-03-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02302985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78830
LAMOTRIGINE;
lamotrigine 100 mg;
2010-02-16;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02343029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82851
AURO-LAMOTRIGINE;
lamotrigine 100 mg;
2012-06-13;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02381362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86719
LAMOTRIGINE;
lamotrigine 100 mg;
2014-10-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02428210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91269
LAMICTAL;
lamotrigine 150 mg;
1995-12-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02142112
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17160
APO-LAMOTRIGINE;
lamotrigine 150 mg;
2002-03-18;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02245210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69225
PMS-LAMOTRIGINE;
lamotrigine 150 mg;
2003-04-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02246899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71126
TEVA-LAMOTRIGINE;
lamotrigine 150 mg;
2004-01-16;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72570
MYLAN-LAMOTRIGINE;
lamotrigine 150 mg;
2005-04-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02265516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75097
LAMOTRIGINE-150;
lamotrigine 150 mg;
2008-03-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02302993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78831
LAMOTRIGINE;
lamotrigine 150 mg;
2010-02-16;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02343037
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82852
AURO-LAMOTRIGINE;
lamotrigine 150 mg;
2012-06-13;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02381370
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86720
LAMOTRIGINE;
lamotrigine 150 mg;
2014-10-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02428229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91270
LAMICTAL;
lamotrigine 2 mg;
2001-09-13;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02243803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67741
LAMICTAL;
lamotrigine 25 mg;
1995-12-31;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02142082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17203
APO-LAMOTRIGINE;
lamotrigine 25 mg;
2002-03-18;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02245208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69223
PMS-LAMOTRIGINE;
lamotrigine 25 mg;
2003-04-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02246897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71124
TEVA-LAMOTRIGINE;
lamotrigine 25 mg;
2004-01-16;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72568
MYLAN-LAMOTRIGINE;
lamotrigine 25 mg;
2005-04-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02265494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75095
LAMOTRIGINE-25;
lamotrigine 25 mg;
2008-03-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02302969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78826
LAMOTRIGINE;
lamotrigine 25 mg;
2010-02-16;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02343010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82850
AURO-LAMOTRIGINE;
lamotrigine 25 mg;
2012-06-13;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02381354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86718
LAMOTRIGINE;
lamotrigine 25 mg;
2014-10-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02428202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91268
LAMICTAL;
lamotrigine 5 mg;
1999-06-02;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02240115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63629
TAKHZYRO;
lanadelumab 300 mg / 2 ml;
2018-10-31;
Subcutaneous;
Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02480948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97159
TAKHZYRO;
lanadelumab 300 mg / 2 ml;
2021-01-18;
Subcutaneous;
Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Prescription , Schedule D;
TAKEDA CANADA INC
DIN: 02505614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99498
SOMATULINE AUTOGEL;
lanreotide (lanreotide acetate) 120 mg / syr;
2007-02-22;
Subcutaneous;
Solution (Extended Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
DIN: 02283417
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76902
SOMATULINE AUTOGEL;
lanreotide (lanreotide acetate) 60 mg / syr;
2007-02-22;
Subcutaneous;
Solution (Extended Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
DIN: 02283395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76900
SOMATULINE AUTOGEL;
lanreotide (lanreotide acetate) 90 mg / syr;
2007-02-22;
Subcutaneous;
Solution (Extended Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
IPSEN BIOPHARMACEUTICALS CANADA INC
DIN: 02283409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76901
PREVACID;
lansoprazole 15 mg;
1995-12-31;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA PHARMACEUTICALS AMERICA INC
DIN: 02165503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18515
PREVACID FASTAB;
lansoprazole 15 mg;
2006-11-24;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA PHARMACEUTICALS AMERICA INC
DIN: 02249464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73429
TEVA-LANSOPRAZOLE;
lansoprazole 15 mg;
2009-11-02;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02280515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76617
APO-LANSOPRAZOLE;
lansoprazole 15 mg;
2009-06-03;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
DIN: 02293811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77919
MYLAN-LANSOPRAZOLE;
lansoprazole 15 mg;
2010-06-18;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02353830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83904
LANSOPRAZOLE;
lansoprazole 15 mg;
2010-11-23;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02357682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84278
SANDOZ LANSOPRAZOLE;
lansoprazole 15 mg;
2012-07-03;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02385643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87127
LANSOPRAZOLE;
lansoprazole 15 mg;
2012-06-11;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87138
TARO-LANSOPRAZOLE;
lansoprazole 15 mg;
2013-03-22;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02402610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88746
RIVA-LANSOPRAZOLE;
lansoprazole 15 mg;
2014-06-12;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02422808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90746
LANSOPRAZOLE;
lansoprazole 15 mg;
2015-01-13;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02433001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91737
M-LANSOPRAZOLE;
lansoprazole 15 mg;
2019-12-13;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02489805
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97988
PREVACID;
lansoprazole 30 mg;
1995-12-31;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA PHARMACEUTICALS AMERICA INC
DIN: 02165511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18516
PREVACID FASTAB;
lansoprazole 30 mg;
2005-12-01;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA PHARMACEUTICALS AMERICA INC
DIN: 02249472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73430
TEVA-LANSOPRAZOLE;
lansoprazole 30 mg;
2009-11-02;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02280523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76618
APO-LANSOPRAZOLE;
lansoprazole 30 mg;
2009-06-03;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
DIN: 02293838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77920
MYLAN-LANSOPRAZOLE;
lansoprazole 30 mg;
2010-06-18;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02353849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83905
LANSOPRAZOLE;
lansoprazole 30 mg;
2010-11-22;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02357690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84279
LANSOPRAZOLE;
lansoprazole 30 mg;
2011-06-07;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02366282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85113
SANDOZ LANSOPRAZOLE;
lansoprazole 30 mg;
2012-07-03;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02385651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87128
TARO-LANSOPRAZOLE;
lansoprazole 30 mg;
2013-03-22;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02402629
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88747
LANSOPRAZOLE;
lansoprazole 30 mg;
2013-10-23;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02410389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89503
RIVA-LANSOPRAZOLE;
lansoprazole 30 mg;
2014-06-12;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02422816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90747
LANSOPRAZOLE;
lansoprazole 30 mg;
2015-02-11;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PHARMASCIENCE INC
DIN: 02433028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91739
M-LANSOPRAZOLE;
lansoprazole 30 mg;
2019-12-13;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MANTRA PHARMA INC
DIN: 02489813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97989
NAT-LANTHANUM;
lanthanum (lanthanum carbonate dihydrate) 1000 mg;
2020-07-21;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02498774
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98846
NAT-LANTHANUM;
lanthanum (lanthanum carbonate dihydrate) 250 mg;
2020-07-21;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02498731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98843
NAT-LANTHANUM;
lanthanum (lanthanum carbonate dihydrate) 500 mg;
2020-07-21;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02498758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98844
NAT-LANTHANUM;
lanthanum (lanthanum carbonate dihydrate) 750 mg;
2020-07-21;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02498766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98845
FOSRENOL;
lanthanum (lanthanum carbonate hydrate) 1000 mg;
2006-12-06;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02287188
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77261
FOSRENOL;
lanthanum (lanthanum carbonate hydrate) 250 mg;
2006-12-06;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02287145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77258
FOSRENOL;
lanthanum (lanthanum carbonate hydrate) 500 mg;
2006-12-06;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02287153
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77259
FOSRENOL;
lanthanum (lanthanum carbonate hydrate) 750 mg;
2006-12-06;
Oral;
Tablet (Chewable);
40:18.19 – PHOSPHATE-REMOVING AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02287161
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77260
TYKERB;
lapatinib (lapatinib ditosylate monohydrate) 250 mg;
2009-06-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02326442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81179
ALDURAZYME;
laronidase 0.58 mg / ml;
2004-08-12;
Intravenous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN: 02254506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73940
VITRAKVI;
larotrectinib (larotrectinib sulfate) 100 mg;
2020-11-13;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
DIN: 02490323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98038
VITRAKVI;
larotrectinib (larotrectinib sulfate) 20 mg / ml;
2019-09-04;
Oral;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
DIN: 02490331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98039
VITRAKVI;
larotrectinib (larotrectinib sulfate) 25 mg;
2020-11-13;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
DIN: 02490315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98037
XALATAN;
latanoprost 50 mcg / ml;
1997-07-28;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
UPJOHN CANADA ULC
DIN: 02231493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50823
TEVA-LATANOPROST;
latanoprost 50 mcg / ml;
2011-10-13;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
TEVA CANADA LIMITED
DIN: 02254786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73994
APO-LATANOPROST;
latanoprost 50 mcg / ml;
2011-10-03;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
APOTEX INC
DIN: 02296527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78185
RIVA-LATANOPROST;
latanoprost 50 mcg / ml;
2015-05-11;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02341085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82663
SANDOZ LATANOPROST;
latanoprost 50 mcg / ml;
2011-12-06;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02367335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85213
GD-LATANOPROST;
latanoprost 50 mcg / ml;
2011-10-03;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
UPJOHN CANADA ULC
DIN: 02373041
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85817
MED-LATANOPROST;
latanoprost 50 mcg / ml;
2015-01-09;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02426935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91148
JAMP LATANOPROST;
latanoprost 50 mcg / ml;
2020-02-07;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02453355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93988
MONOPROST;
latanoprost 50 mcg / ml;
2018-01-03;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
LABORATOIRES THEA
DIN: 02456230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94312
LATANOPROST OPHTHALMIC SOLUTION;
latanoprost 50 mcg / ml;
2020-06-26;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
TELIGENT CANADA INC
DIN: 02489570
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97965
VYZULTA;
latanoprostene bunod 0.024 % / w/v;
2019-05-17;
Ophthalmic;
Solution;
52:40.28 – PROSTAGLANDIN ANALOGS;
Prescription;
BAUSCH & LOMB INC
DIN: 02484218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97453
ARAVA 10MG;
leflunomide 10 mg;
2000-03-29;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02241888
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65558
APO-LEFLUNOMIDE;
leflunomide 10 mg;
2004-09-14;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
APOTEX INC
DIN: 02256495
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74173
TEVA-LEFLUNOMIDE;
leflunomide 10 mg;
2004-12-21;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02261251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74665
SANDOZ LEFLUNOMIDE;
leflunomide 10 mg;
2006-08-15;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02283964
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76953
LEFLUNOMIDE;
leflunomide 10 mg;
2010-06-15;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02351668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83692
LEFLUNOMIDE;
leflunomide 10 mg;
2013-11-28;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02415828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90041
ACCEL-LEFLUNOMIDE;
leflunomide 10 mg;
2019-09-19;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
ACCEL PHARMA INC
DIN: 02478862
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96957
ARAVA 100 MG;
leflunomide 100 mg;
2000-03-29;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02241890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65560
ARAVA 20 MG;
leflunomide 20 mg;
2000-03-29;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02241889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65559
APO-LEFLUNOMIDE;
leflunomide 20 mg;
2004-09-14;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
APOTEX INC
DIN: 02256509
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74174
TEVA-LEFLUNOMIDE;
leflunomide 20 mg;
2004-12-21;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02261278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74666
SANDOZ LEFLUNOMIDE;
leflunomide 20 mg;
2006-08-15;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02283972
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76954
LEFLUNOMIDE;
leflunomide 20 mg;
2010-06-15;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02351676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83693
LEFLUNOMIDE;
leflunomide 20 mg;
2013-11-28;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02415836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90042
ACCEL-LEFLUNOMIDE;
leflunomide 20 mg;
2019-09-19;
Oral;
Tablet;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription;
ACCEL PHARMA INC
DIN: 02478870
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96958
DAYVIGO;
lemborexant 10 mg;
2020-11-06;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
EISAI LIMITED
DIN: 02507374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99676
DAYVIGO;
lemborexant 5 mg;
2020-11-06;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
EISAI LIMITED
DIN: 02507366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99675
REVLIMID;
lenalidomide 10 mg;
2008-02-19;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02304902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79017
REVLIMID;
lenalidomide 15 mg;
2008-10-10;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02317699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80322
REVLIMID;
lenalidomide 2.5 mg;
2016-12-20;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02459418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94664
REVLIMID;
lenalidomide 20 mg;
2015-09-28;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02440601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92497
REVLIMID;
lenalidomide 25 mg;
2008-10-10;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02317710
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80324
REVLIMID;
lenalidomide 5 mg;
2008-02-19;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
DIN: 02304899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79016
LENVIMA;
lenvatinib (lenvatinib mesylate) 10 mg / dose;
2016-03-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02450321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93646
LENVIMA;
lenvatinib (lenvatinib mesylate) 12 mg / dose;
2019-10-21;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02484129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97445
LENVIMA;
lenvatinib (lenvatinib mesylate) 14 mg / dose;
2016-03-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02450313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93645
LENVIMA;
lenvatinib (lenvatinib mesylate) 18 mg / dose;
2018-05-08;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02468239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95664
LENVIMA;
lenvatinib (lenvatinib mesylate) 20 mg / dose;
2016-03-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02450305
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93644
LENVIMA;
lenvatinib (lenvatinib mesylate) 24 mg / dose;
2016-03-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02450291
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93643
LENVIMA;
lenvatinib (lenvatinib mesylate) 4 mg / dose;
2019-10-21;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02484056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97438
LENVIMA;
lenvatinib (lenvatinib mesylate) 8 mg / dose;
2018-05-08;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
DIN: 02468220
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95663
PREVYMIS;
letermovir 20 mg / ml;
2017-12-20;
Intravenous;
Solution;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02469367
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95815
PREVYMIS;
letermovir 20 mg / ml;
2017-12-20;
Intravenous;
Solution;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02469405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95819
PREVYMIS;
letermovir 240 mg;
2017-12-20;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02469375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95816
PREVYMIS;
letermovir 480 mg;
2017-12-20;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
MERCK CANADA INC
DIN: 02469383
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95817
FEMARA 2.5MG;
letrozole 2.5 mg;
1997-09-02;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02231384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50695
PMS-LETROZOLE;
letrozole 2.5 mg;
2010-04-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02309114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79471
ACH-LETROZOLE;
letrozole 2.5 mg;
2010-05-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02338459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82411
TEVA-LETROZOLE;
letrozole 2.5 mg;
2013-07-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02343657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82909
SANDOZ LETROZOLE;
letrozole 2.5 mg;
2010-04-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02344815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83029
APO-LETROZOLE;
letrozole 2.5 mg;
2012-06-11;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
DIN: 02358514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84356
JAMP-LETROZOLE;
letrozole 2.5 mg;
2011-09-30;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02373009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85813
MAR-LETROZOLE;
letrozole 2.5 mg;
2013-01-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02373424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85857
BIO-LETROZOLE;
letrozole 2.5 mg;
2013-02-12;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BIOMED PHARMA
DIN: 02392496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87776
RIVA-LETROZOLE;
letrozole 2.5 mg;
2014-02-11;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02398656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88359
LETROZOLE;
letrozole 2.5 mg;
2013-02-14;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02402025
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88690
NAT-LETROZOLE;
letrozole 2.5 mg;
2015-02-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02421585
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90623
CCP-LETROZOLE;
letrozole 2.5 mg;
2017-07-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELLCHEM PHARMACEUTICALS INC.
DIN: 02459884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94719
LETROZOLE;
letrozole 2.5 mg;
2021-03-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02504472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99389
LEUCOVORIN CALCIUM INJECTION;
leucovorin (leucovorin calcium) 10 mg / ml;
1994-12-31;
Intramuscular , Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Prescription;
TEVA CANADA LIMITED
DIN: 02087316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18209
LEUCOVORIN CALCIUM INJECTION USP;
leucovorin (leucovorin calcium) 10 mg / ml;
1997-05-09;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Prescription;
PFIZER CANADA ULC
DIN: 02182998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44265
LEUCOVORIN CALCIUM INJECTION USP;
leucovorin (leucovorin calcium) 10 mg / ml;
1997-08-07;
Intramuscular , Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Prescription;
PFIZER CANADA ULC
DIN: 02183005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44266
LEUCOVORIN CALCIUM INJECTION;
leucovorin (leucovorin calcium) 10 mg / ml;
2019-09-19;
Intramuscular , Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Prescription;
GENERIC MEDICAL PARTNERS INC
DIN: 02480042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97064
LEDERLE LEUCOVORIN;
leucovorin (leucovorin calcium) 5 mg;
1996-10-25;
Oral;
Tablet;
92:12.00 – ANTIDOTES;
Prescription;
PFIZER CANADA ULC
DIN: 02170493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44146
RIVA LEUCOVORIN;
leucovorin (leucovorin calcium) 5 mg;
2019-12-02;
Oral;
Tablet;
92:12.00 – ANTIDOTES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02493357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98337
MINT-LEUCOVORIN;
leucovorin (leucovorin calcium) 5 mg;
2021-01-12;
Oral;
Tablet;
92:12.00 – ANTIDOTES;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02496828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98666
LUPRON DEPOT;
leuprolide acetate 11.25 mg / syr;
1999-09-13;
Intramuscular;
Powder For Suspension, Sustained-Release;
68:18.08 – GONADOTROPINS;
Prescription;
ABBVIE CORPORATION
DIN: 02239834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63321
LUPRON DEPOT;
leuprolide acetate 22.5 mg / syr;
1997-01-29;
Intramuscular;
Powder For Suspension, Sustained-Release;
68:18.08 – GONADOTROPINS;
Prescription;
ABBVIE CORPORATION
DIN: 02230248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48922
ELIGARD;
leuprolide acetate 22.5 mg / syr;
2003-12-01;
Subcutaneous;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02248240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72577
ZEULIDE DEPOT;
leuprolide acetate 22.5 mg / vial;
2019-10-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
VERITY PHARMACEUTICALS INC.
DIN: 02462699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95052
LUPRON DEPOT;
leuprolide acetate 3.75 mg / syr;
1992-12-31;
Intramuscular;
Powder For Suspension, Sustained-Release;
68:18.08 – GONADOTROPINS;
Prescription;
ABBVIE CORPORATION
DIN: 00884502
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13443
ZEULIDE DEPOT;
leuprolide acetate 3.75 mg / vial;
2019-10-08;
Intramuscular;
Powder For Suspension, Sustained-Release , Kit;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
VERITY PHARMACEUTICALS INC.
DIN: 02429977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91439
LUPRON DEPOT;
leuprolide acetate 30 mg / syr;
1999-09-13;
Intramuscular;
Powder For Suspension, Sustained-Release;
68:18.08 – GONADOTROPINS;
Prescription;
ABBVIE CORPORATION
DIN: 02239833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63320
ELIGARD;
leuprolide acetate 30 mg / syr;
2004-04-29;
Subcutaneous;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02248999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73384
ELIGARD;
leuprolide acetate 45 mg / syr;
2005-08-15;
Subcutaneous;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02268892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75428
LUPRON;
leuprolide acetate 5 mg / ml;
1985-12-31;
Subcutaneous;
Solution;
68:18.08 – GONADOTROPINS;
Prescription;
ABBVIE CORPORATION
DIN: 00727695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7367
LUPRON DEPOT;
leuprolide acetate 7.5 mg / syr;
1989-12-31;
Intramuscular;
Powder For Suspension, Sustained-Release;
68:18.08 – GONADOTROPINS;
Prescription;
ABBVIE CORPORATION
DIN: 00836273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10318
ELIGARD;
leuprolide acetate 7.5 mg / syr;
2003-12-01;
Subcutaneous;
Powder For Suspension, Sustained-Release;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02248239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72576
PDP-LEVETIRACETAM;
levetiracetam 100 mg / ml;
2019-10-30;
Intravenous;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02490439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98048
PDP-LEVETIRACETAM;
levetiracetam 100 mg / ml;
2020-05-01;
Oral;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02490447
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98049
SANDOZ LEVETIRACETAM;
levetiracetam 1000 mg;
2018-06-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02462028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94976
KEPPRA;
levetiracetam 250 mg;
2003-07-23;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02247027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71262
TEVA-LEVETIRACETAM;
levetiracetam 250 mg;
2005-12-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02274183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75964
APO-LEVETIRACETAM;
levetiracetam 250 mg;
2006-10-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02285924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77141
PRO-LEVETIRACETAM – 250;
levetiracetam 250 mg;
2013-06-06;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02311372
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79695
LEVETIRACETAM;
levetiracetam 250 mg;
2010-07-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02353342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83854
AURO-LEVETIRACETAM;
levetiracetam 250 mg;
2012-02-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02375249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86064
LEVETIRACETAM TABLETS;
levetiracetam 250 mg;
2013-03-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02399776
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88462
JAMP-LEVETIRACETAM;
levetiracetam 250 mg;
2013-04-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02403005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88784
NAT-LEVETIRACETAM;
levetiracetam 250 mg;
2015-07-22;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02440202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92458
LEVETIRACETAM;
levetiracetam 250 mg;
2015-07-22;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02442531
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92688
LEVETIRACETAM;
levetiracetam 250 mg;
2016-11-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02454653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94136
SANDOZ LEVETIRACETAM;
levetiracetam 250 mg;
2017-08-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02461986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94973
RIVA-LEVETIRACETAM;
levetiracetam 250 mg;
2019-04-12;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02482274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97274
KEPPRA;
levetiracetam 500 mg;
2003-07-23;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02247028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71263
TEVA-LEVETIRACETAM;
levetiracetam 500 mg;
2005-12-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02274191
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75965
APO-LEVETIRACETAM;
levetiracetam 500 mg;
2006-10-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02285932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77142
PRO-LEVETIRACETAM – 500;
levetiracetam 500 mg;
2009-06-16;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02311380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79696
LEVETIRACETAM;
levetiracetam 500 mg;
2010-07-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02353350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83855
AURO-LEVETIRACETAM;
levetiracetam 500 mg;
2012-03-15;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02375257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86065
LEVETIRACETAM TABLETS;
levetiracetam 500 mg;
2013-03-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02399784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88463
JAMP-LEVETIRACETAM;
levetiracetam 500 mg;
2013-04-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02403021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88785
NAT-LEVETIRACETAM;
levetiracetam 500 mg;
2015-07-22;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02440210
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92459
LEVETIRACETAM;
levetiracetam 500 mg;
2015-07-22;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02442558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92689
LEVETIRACETAM;
levetiracetam 500 mg;
2016-11-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02454661
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94137
SANDOZ LEVETIRACETAM;
levetiracetam 500 mg;
2017-08-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02461994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94974
RIVA-LEVETIRACETAM;
levetiracetam 500 mg;
2019-04-12;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02482282
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97275
KEPPRA;
levetiracetam 750 mg;
2003-07-23;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UCB CANADA INC
DIN: 02247029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71264
TEVA-LEVETIRACETAM;
levetiracetam 750 mg;
2005-12-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02274205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75966
APO-LEVETIRACETAM;
levetiracetam 750 mg;
2006-10-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
DIN: 02285940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77143
PRO-LEVETIRACETAM – 750;
levetiracetam 750 mg;
2009-10-08;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02311399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79697
LEVETIRACETAM;
levetiracetam 750 mg;
2010-07-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02353369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83856
AURO-LEVETIRACETAM;
levetiracetam 750 mg;
2012-02-14;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
DIN: 02375265
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86066
LEVETIRACETAM TABLETS;
levetiracetam 750 mg;
2013-03-20;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02399792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88464
JAMP-LEVETIRACETAM;
levetiracetam 750 mg;
2013-04-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02403048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88786
NAT-LEVETIRACETAM;
levetiracetam 750 mg;
2015-07-22;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
NATCO PHARMA (CANADA) INC
DIN: 02440229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92460
LEVETIRACETAM;
levetiracetam 750 mg;
2015-07-22;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02442566
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92690
LEVETIRACETAM;
levetiracetam 750 mg;
2016-11-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02454688
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94138
SANDOZ LEVETIRACETAM;
levetiracetam 750 mg;
2017-08-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02462001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94975
RIVA-LEVETIRACETAM;
levetiracetam 750 mg;
2019-04-12;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02482290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97276
CARNITOR;
levocarnitine 100 mg / ml;
1995-12-31;
Oral;
Solution;
40:20.00 – CALORIC AGENTS;
Prescription;
LEADIANT BIOSCIENCES, INC
DIN: 02144336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19094
ODAN LEVOCARNITINE;
levocarnitine 100 mg / ml;
2019-11-18;
Oral;
Solution;
40:20.00 – CALORIC AGENTS;
Prescription;
ODAN LABORATORIES LTD
DIN: 02492105
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98210
CARNITOR;
levocarnitine 200 mg / ml;
1995-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Prescription;
LEADIANT BIOSCIENCES, INC
DIN: 02144344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18903
CARNITOR;
levocarnitine 330 mg;
1995-12-31;
Oral;
Tablet;
40:20.00 – CALORIC AGENTS;
Prescription;
LEADIANT BIOSCIENCES, INC
DIN: 02144328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18931
QUINSAIR;
levofloxacin (levofloxacin hemihydrate) 240 mg / 2.4 ml;
2016-12-12;
Inhalation;
Solution;
08:12.18 – QUINOLONES;
Prescription;
HORIZON THERAPEUTICS IRELAND DAC
DIN: 02442302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92667
APO-LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 250 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
APOTEX INC
DIN: 02284707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77026
SANDOZ LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 250 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02298635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78395
ACT LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 250 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
TEVA CANADA LIMITED
DIN: 02315424
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80096
RIVA-LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 250 mg;
2020-04-06;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02492725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98271
APO-LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 500 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
APOTEX INC
DIN: 02284715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77027
SANDOZ LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 500 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02298643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78396
ACT LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 500 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
TEVA CANADA LIMITED
DIN: 02315432
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80097
LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 500 mg;
2013-11-28;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PRO DOC LIMITEE
DIN: 02415879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90046
RIVA-LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 500 mg;
2020-04-06;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02492733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98272
SANDOZ LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 750 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02298651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78397
ACT LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 750 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
TEVA CANADA LIMITED
DIN: 02315440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80098
APO-LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 750 mg;
2009-06-24;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
APOTEX INC
DIN: 02325942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81129
RIVA-LEVOFLOXACIN;
levofloxacin (levofloxacin hemihydrate) 750 mg;
2020-04-06;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02492741
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98273
LEVOFLOXACIN IN 5% DEXTROSE INJECTION;
levofloxacin 5 mg / ml;
2011-12-23;
Intravenous;
Solution;
08:12.18 – QUINOLONES;
Prescription;
PFIZER CANADA ULC
DIN: 02314932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80046
FETZIMA;
levomilnacipran (levomilnacipran hydrochloride) 120 mg;
2016-04-22;
Oral;
Capsule (Extended Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ALLERGAN INC
DIN: 02441004
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92536
FETZIMA;
levomilnacipran (levomilnacipran hydrochloride) 20 mg;
2015-11-19;
Oral;
Capsule (Extended Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ALLERGAN INC
DIN: 02440970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92533
FETZIMA;
levomilnacipran (levomilnacipran hydrochloride) 40 mg;
2015-11-19;
Oral;
Capsule (Extended Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ALLERGAN INC
DIN: 02440989
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92534
FETZIMA;
levomilnacipran (levomilnacipran hydrochloride) 80 mg;
2016-04-22;
Oral;
Capsule (Extended Release);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ALLERGAN INC
DIN: 02440997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92535
PLAN B;
levonorgestrel 1.5 mg;
2015-07-23;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Otc;
FOUNDATION CONSUMER HEALTHCARE, LLC
DIN: 02293854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77922
CONTINGENCY ONE;
levonorgestrel 1.5 mg;
2015-08-31;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Otc;
MYLAN PHARMACEUTICALS ULC
DIN: 02425009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90967
BACKUP PLAN ONESTEP;
levonorgestrel 1.5 mg;
2016-06-07;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Otc;
APOTEX INC
DIN: 02433532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91790
KYLEENA;
levonorgestrel 19.5 mg;
2017-01-10;
Intrauterine;
Insert (Extended-Release);
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
DIN: 02459523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94684
MIRENA;
levonorgestrel 52 mg;
2001-02-22;
Intrauterine;
Insert (Extended-Release);
68:12.00 – CONTRACEPTIVES;
Prescription;
BAYER INC
DIN: 02243005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66845
SYNTHROID;
levothyroxine sodium 100 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19601
ELTROXIN;
levothyroxine sodium 100 mcg;
1998-11-27;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02213206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36946
SYNTHROID;
levothyroxine sodium 112 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02171228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19589
SYNTHROID;
levothyroxine sodium 125 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172119
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19594
SYNTHROID;
levothyroxine sodium 137 mcg;
2003-11-01;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02233852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=53868
SYNTHROID;
levothyroxine sodium 150 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19598
ELTROXIN;
levothyroxine sodium 150 mcg;
1974-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02213214
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36947
SYNTHROID;
levothyroxine sodium 175 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172135
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19600
SYNTHROID;
levothyroxine sodium 200 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172143
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19597
ELTROXIN;
levothyroxine sodium 200 mcg;
1997-04-02;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02213222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36948
LEVOTHYROXINE SODIUM FOR INJECTION;
levothyroxine sodium 200 mcg / vial;
2019-11-15;
Intramuscular , Intravenous;
Powder For Solution;
68:36.04 – THYROID AGENTS;
Prescription;
AVIR PHARMA INC.
DIN: 02461714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94948
SYNTHROID;
levothyroxine sodium 25 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172062
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19588
SYNTHROID;
levothyroxine sodium 300 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172151
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19596
SYNTHROID;
levothyroxine sodium 50 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172070
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19587
ELTROXIN;
levothyroxine sodium 50 mcg;
1951-12-30;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02213192
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36945
LEVOTHYROXINE SODIUM FOR INJECTION;
levothyroxine sodium 500 mcg / vial;
2002-08-27;
Intramuscular , Intravenous;
Powder For Solution;
68:36.04 – THYROID AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02245948
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70072
LEVOTHYROXINE SODIUM FOR INJECTION;
levothyroxine sodium 500 mcg / vial;
2018-09-26;
Intramuscular , Intravenous;
Powder For Solution;
68:36.04 – THYROID AGENTS;
Prescription;
AVIR PHARMA INC.
DIN: 02461722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94949
SYNTHROID;
levothyroxine sodium 75 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172089
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19595
SYNTHROID;
levothyroxine sodium 88 mcg;
1996-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
BGP PHARMA ULC
DIN: 02172097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19599
LIDODAN ENDOTRACHEAL NON-AEROSOL SPRAY;
lidocaine (lidocaine hydrochloride) 10 mg / act;
1998-07-22;
Topical;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ODAN LABORATORIES LTD
DIN: 02231147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50454
SOLARCAINE FIRST AID LIDOCAINE SPRAY;
lidocaine 0.5 %;
1990-12-31;
Topical;
Aerosol;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
BAYER INC
DIN: 01923986
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12266
XYLOCAINE SPRAY;
lidocaine 10 mg / act;
1993-12-31;
Oral;
Spray, Metered Dose;
52:16.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02003767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14240
BIKINI ZONE;
lidocaine 2 %;
1997-10-30;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
CCA INDUSTRIES, INC.
DIN: 02231578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50944
MAXILENE 4;
lidocaine 4 %;
2003-05-15;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
RGR PHARMA LTD.
DIN: 02244533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68513
LIDOCAINE;
lidocaine 4 %;
2019-05-21;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
THE MENTHOLATUM COMPANY OF CANADA LTD
DIN: 02485311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97557
XYLOCAINE OINTMENT 5%;
lidocaine 5 %;
1954-12-31;
Topical;
Ointment;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00001961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=211
LIDODAN OINTMENT 5%;
lidocaine 5 %;
1994-12-31;
Topical;
Ointment;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ODAN LABORATORIES LTD
DIN: 02083795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17236
MAXILENE 5;
lidocaine 5 %;
2003-05-15;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
RGR PHARMA LTD.
DIN: 02245939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70063
TOPICAINE 5;
lidocaine 5 %;
2009-03-01;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
ESBA LABORATORIES INC
DIN: 02322560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80801
NANONUMB;
lidocaine 5 %;
2020-01-20;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
ALERA SKIN CARE PRODUCTS INC.
DIN: 02439670
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92407
DR. NUMB;
lidocaine 5 % / w/w;
2013-10-08;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
SHINPHARMA INC
DIN: 02354527
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83969
JAMPOCAINE 5%;
lidocaine 5 % / w/w;
2014-05-14;
Topical;
Ointment;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JAMP PHARMA CORPORATION
DIN: 02386836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87241
ZENSA;
lidocaine 5 % / w/w;
2016-05-20;
Topical;
Cream;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
ALERA SKIN CARE PRODUCTS INC.
DIN: 02449684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93551
STUD 100;
lidocaine 9.6 % / w/w;
1997-07-15;
Topical;
Spray, Metered Dose;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
POUND INTERNATIONAL LTD.
DIN: 01901532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=46020
AFTERBURN;
lidocaine hydrochloride 0.5 %;
1995-12-31;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
TENDER CORPORATION
DIN: 02122286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18014
SOLARCAINE MEDICATED FIRST AID LOTION;
lidocaine hydrochloride 0.5 %;
1997-05-12;
Topical;
Lotion;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
BAYER INC
DIN: 02229827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48182
SOLARCAINE MEDICATED LIDOCAINE GEL;
lidocaine hydrochloride 0.5 %;
2006-02-01;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
BAYER INC
DIN: 02268361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75376
BURN RELIEF GEL WITH LIDOCAINE;
lidocaine hydrochloride 0.72 %;
2005-06-15;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
PRIME ENTERPRISES INC
DIN: 02262215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74760
EQUATE AFTER SUN GEL WITH LIDOCAINE;
lidocaine hydrochloride 0.8 %;
2018-03-05;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
FRUIT OF THE EARTH, INC
DIN: 02471833
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96104
LIDOCAINE INJECTION BP;
lidocaine hydrochloride 1 % / w/v;
2021-06-09;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
AURO PHARMA INC
DIN: 02462443
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95020
XYLOCAINE 1%;
lidocaine hydrochloride 10 mg / ml;
1954-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00001732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=585
LIDOCAINE HYDROCHLORIDE INJECTION USP;
lidocaine hydrochloride 10 mg / ml;
1990-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 00884154
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12645
XYLOCAINE 1%;
lidocaine hydrochloride 10 mg / ml;
2009-01-23;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02302411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78773
LIDOCAINE HYDROCHLORIDE INJECTION USP;
lidocaine hydrochloride 10 mg / ml;
2015-06-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02421984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90668
LIDOCAINE HYDROCHLORIDE INJECTION USP;
lidocaine hydrochloride 10 mg / ml;
2015-11-25;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02422018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90670
XYLOCARD;
lidocaine hydrochloride 100 mg / 5 ml;
1974-12-31;
Intravenous;
Solution;
24:04.04.08 – CLASS IB ANTIARRYTHMICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00001937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4478
LIDODAN VISCOUS 2%;
lidocaine hydrochloride 2 %;
1994-12-31;
Buccal;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Otc;
ODAN LABORATORIES LTD
DIN: 01968823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16823
WATER-JEL BURN JEL-2%;
lidocaine hydrochloride 2 %;
1994-12-31;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
ZEE MEDICAL
DIN: 02144409
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31582
BAND-AID BRAND ANTISEPTIC WASH;
lidocaine hydrochloride 2 %;
2002-03-01;
Topical;
Liquid;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02244468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68438
LIDOCAINE INJECTION BP;
lidocaine hydrochloride 2 % / w/v;
2021-06-09;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
AURO PHARMA INC
DIN: 02462451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95021
CATHEJELL;
lidocaine hydrochloride 20 mg / g;
2012-05-25;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
PHARMAZEUTISCHE FABRIK MONTAVIT GES M.B.H.
DIN: 02370840
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85604
XYLOCAINE JELLY 2%;
lidocaine hydrochloride 20 mg / ml;
1951-12-31;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00001694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=212
XYLOCAINE 2%;
lidocaine hydrochloride 20 mg / ml;
1954-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00036641
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=587
XYLOCAINE JELLY 2%;
lidocaine hydrochloride 20 mg / ml;
1978-12-31;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 00385484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2935
LIDOCAINE HYDROCHLORIDE INJECTION USP;
lidocaine hydrochloride 20 mg / ml;
1987-12-31;
Intravenous;
Solution;
24:04.04.08 – CLASS IB ANTIARRYTHMICS;
Ethical;
PFIZER CANADA ULC
DIN: 00436208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8351
LIDOCAINE HYDROCHLORIDE INJECTION USP;
lidocaine hydrochloride 20 mg / ml;
1994-12-31;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 01901982
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18012
LIDODAN JELLY 2%;
lidocaine hydrochloride 20 mg / ml;
2002-03-27;
Topical;
Jelly;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
ODAN LABORATORIES LTD
DIN: 02143879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31563
XYLOCAINE 2%;
lidocaine hydrochloride 20 mg / ml;
2009-01-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02302438
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78774
LIDOCAINE HYDROCHLORIDE INJECTION USP;
lidocaine hydrochloride 20 mg / ml;
2015-08-19;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02421992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90671
LIDOCAINE HYDROCHLORIDE INJECTION USP;
lidocaine hydrochloride 20 mg / ml;
2016-01-12;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02422026
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90672
JELIDO;
lidocaine hydrochloride 20 mg / ml;
2018-05-28;
Topical;
Gel;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02469146
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95780
LIDODAN 4% TOPICAL SOLUTION;
lidocaine hydrochloride 4 %;
2014-02-20;
Topical;
Solution;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Ethical;
ODAN LABORATORIES LTD
DIN: 02419505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90413
LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP;
lidocaine hydrochloride 4 % / w/v;
2020-03-02;
Topical;
Solution;
84:08.00 – ANTIPRURITICS AND LOCAL ANESTHETICS;
Otc;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02458128
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94517
XYLOCAINE 0.5%;
lidocaine hydrochloride 5 mg / ml;
2012-10-29;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
ASPEN PHARMACARE CANADA INC.
DIN: 02372983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85810
XIIDRA;
lifitegrast 5 % / w/v;
2018-02-12;
Ophthalmic;
Solution;
52:08.92 – ANTI-INFLAMMATORY AGENTS, MISCELLANEOUS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02471027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96012
CONSTELLA;
linaclotide 145 mcg;
2014-04-29;
Oral;
Capsule;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
ALLERGAN INC
DIN: 02417162
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90180
CONSTELLA;
linaclotide 290 mcg;
2014-12-17;
Oral;
Capsule;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
ALLERGAN INC
DIN: 02417170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90181
CONSTELLA;
linaclotide 72 mcg;
2018-04-02;
Oral;
Capsule;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
ALLERGAN INC
DIN: 02469510
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95831
TRAJENTA;
linagliptin 5 mg;
2011-09-13;
Oral;
Tablet;
68:20.05 – DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02370921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85612
ZYVOXAM;
linezolid 100 mg / 5 ml;
2010-08-04;
Oral;
Powder For Suspension;
08:12.28.24 – OXAZOLIDINONES;
Prescription;
PFIZER CANADA ULC
DIN: 02243686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67616
ZYVOXAM 2 MG/ML;
linezolid 2 mg / ml;
2001-06-07;
Intravenous;
Solution;
08:12.28.24 – OXAZOLIDINONES;
Prescription;
PFIZER CANADA ULC
DIN: 02243685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67615
LINEZOLID INJECTION;
linezolid 2 mg / ml;
2015-06-12;
Intravenous;
Solution;
08:12.28.24 – OXAZOLIDINONES;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02430827
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91526
LINEZOLID INJECTION;
linezolid 2 mg / ml;
2019-12-30;
Intravenous;
Solution;
08:12.28.24 – OXAZOLIDINONES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02481278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97176
SANDOZ LINEZOLID;
linezolid 600 mg;
2014-08-25;
Oral;
Tablet;
08:12.28.24 – OXAZOLIDINONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02422689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90735
APO-LINEZOLID;
linezolid 600 mg;
2014-08-19;
Oral;
Tablet;
08:12.28.24 – OXAZOLIDINONES;
Prescription;
APOTEX INC
DIN: 02426552
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91113
CYTOMEL;
liothyronine (liothyronine sodium) 25 mcg;
1993-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 01919466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15908
TEVA-LIOTHYRONINE;
liothyronine (liothyronine sodium) 25 mcg;
2020-07-10;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02494345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98437
CYTOMEL;
liothyronine (liothyronine sodium) 5 mcg;
1993-12-31;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 01919458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15909
TEVA-LIOTHYRONINE;
liothyronine (liothyronine sodium) 5 mcg;
2020-07-10;
Oral;
Tablet;
68:36.04 – THYROID AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02494337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98436
VICTOZA;
liraglutide 6 mg / ml;
2010-05-27;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02351064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83627
SAXENDA;
liraglutide 6 mg / ml;
2015-05-27;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
NOVO NORDISK CANADA INC
DIN: 02437899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92226
VYVANSE;
lisdexamfetamine dimesylate 10 mg;
2015-06-26;
Oral;
Capsule;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02439603
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92401
VYVANSE;
lisdexamfetamine dimesylate 10 mg;
2019-08-06;
Oral;
Tablet (Chewable);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02490226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98028
VYVANSE;
lisdexamfetamine dimesylate 20 mg;
2010-04-13;
Oral;
Capsule;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02347156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83254
VYVANSE;
lisdexamfetamine dimesylate 20 mg;
2019-08-06;
Oral;
Tablet (Chewable);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02490234
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98029
VYVANSE;
lisdexamfetamine dimesylate 30 mg;
2009-08-04;
Oral;
Capsule;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02322951
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80843
VYVANSE;
lisdexamfetamine dimesylate 30 mg;
2019-08-06;
Oral;
Tablet (Chewable);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02490242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98030
VYVANSE;
lisdexamfetamine dimesylate 40 mg;
2010-04-14;
Oral;
Capsule;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02347164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83255
VYVANSE;
lisdexamfetamine dimesylate 40 mg;
2019-08-06;
Oral;
Tablet (Chewable);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02490250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98031
VYVANSE;
lisdexamfetamine dimesylate 50 mg;
2009-08-04;
Oral;
Capsule;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02322978
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80844
VYVANSE;
lisdexamfetamine dimesylate 50 mg;
2019-08-06;
Oral;
Tablet (Chewable);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02490269
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98032
VYVANSE;
lisdexamfetamine dimesylate 60 mg;
2010-04-14;
Oral;
Capsule;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02347172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83256
VYVANSE;
lisdexamfetamine dimesylate 60 mg;
2019-08-06;
Oral;
Tablet (Chewable);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02490277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98033
VYVANSE;
lisdexamfetamine dimesylate 70 mg;
2017-01-05;
Oral;
Capsule;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02458071
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94514
RAN-LISINOPRIL;
lisinopril (lisinopril dihydrate) 10 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02294249
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77959
AURO-LISINOPRIL;
lisinopril (lisinopril dihydrate) 10 mg;
2013-02-12;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02394480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87964
RAN-LISINOPRIL;
lisinopril (lisinopril dihydrate) 20 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02294257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77960
AURO-LISINOPRIL;
lisinopril (lisinopril dihydrate) 20 mg;
2013-02-12;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02394499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87965
SANDOZ LISINOPRIL;
lisinopril (lisinopril dihydrate) 5 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02289199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77458
RAN-LISINOPRIL;
lisinopril (lisinopril dihydrate) 5 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02294230
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77958
AURO-LISINOPRIL;
lisinopril (lisinopril dihydrate) 5 mg;
2013-02-12;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02394472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87963
ZESTRIL;
lisinopril 10 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02049376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17215
APO-LISINOPRIL TABLET 10 MG;
lisinopril 10 mg;
1996-10-30;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02217503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43222
TEVA-LISINOPRIL (TYPE P);
lisinopril 10 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285088
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77060
TEVA-LISINOPRIL (TYPE Z);
lisinopril 10 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77063
PRO-LISINOPRIL – 10;
lisinopril 10 mg;
2008-07-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02310988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79659
LISINOPRIL;
lisinopril 10 mg;
2012-06-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87182
ZESTRIL;
lisinopril 20 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02049384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17123
APO-LISINOPRIL TABLET 20 MG;
lisinopril 20 mg;
1996-10-30;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02217511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43223
TEVA-LISINOPRIL (TYPE P);
lisinopril 20 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77061
TEVA-LISINOPRIL (TYPE Z);
lisinopril 20 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285134
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77064
PRO-LISINOPRIL – 20;
lisinopril 20 mg;
2008-07-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02310996
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79660
LISINOPRIL;
lisinopril 20 mg;
2012-06-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386259
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87183
ZESTRIL;
lisinopril 5 mg;
1994-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
DIN: 02049333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17126
APO-LISINOPRIL TABLET 5 MG;
lisinopril 5 mg;
1996-10-30;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
DIN: 02217481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43221
TEVA-LISINOPRIL (TYPE P);
lisinopril 5 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285061
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77059
TEVA-LISINOPRIL (TYPE Z);
lisinopril 5 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
DIN: 02285118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77062
PRO-LISINOPRIL – 5;
lisinopril 5 mg;
2008-07-03;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
DIN: 02310961
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79658
LISINOPRIL;
lisinopril 5 mg;
2012-06-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02386232
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87181
CARBOLITH;
lithium carbonate 150 mg;
1979-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00461733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3414
LITHANE;
lithium carbonate 150 mg;
1993-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
ERFA CANADA 2012 INC
DIN: 02013231
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13626
PMS-LITHIUM CARBONATE – CAP 150MG;
lithium carbonate 150 mg;
1996-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02216132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19894
APO-LITHIUM CARBONATE;
lithium carbonate 150 mg;
2001-02-12;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
APOTEX INC
DIN: 02242837
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66667
CARBOLITH;
lithium carbonate 300 mg;
1971-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00236683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1327
LITHANE;
lithium carbonate 300 mg;
1979-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00406775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3192
PMS-LITHIUM CARBONATE – CAP 300MG;
lithium carbonate 300 mg;
1996-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02216140
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19933
APO-LITHIUM CARBONATE;
lithium carbonate 300 mg;
2001-02-12;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
APOTEX INC
DIN: 02242838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66668
LITHMAX;
lithium carbonate 300 mg;
2005-04-06;
Oral;
Tablet (Extended-Release);
28:28.00 – ANTIMANIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 02266695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75210
CARBOLITH;
lithium carbonate 600 mg;
1992-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02011239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13429
PMS-LITHIUM CARBONATE – CAP 600MG;
lithium carbonate 600 mg;
1996-12-31;
Oral;
Capsule;
28:28.00 – ANTIMANIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02216159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19893
ADLYXINE;
lixisenatide 10 mcg / act;
2017-09-12;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02464276
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95243
ADLYXINE;
lixisenatide 20 mcg / act;
2017-09-12;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02464284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95244
ALOMIDE;
lodoxamide (lodoxamide tromethamine) 0.1 % / w/v;
1992-12-31;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00893560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13591
JUXTAPID;
lomitapide (lomitapide mesylate) 10 mg;
2014-05-06;
Oral;
Capsule;
24:06.92 – MISCELLANEOUS ANTILIPEMIC AGENTS;
Prescription;
AEGERION PHARMACEUTICALS CANADA LTD
DIN: 02420376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90496
JUXTAPID;
lomitapide (lomitapide mesylate) 20 mg;
2014-05-06;
Oral;
Capsule;
24:06.92 – MISCELLANEOUS ANTILIPEMIC AGENTS;
Prescription;
AEGERION PHARMACEUTICALS CANADA LTD
DIN: 02420384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90498
JUXTAPID;
lomitapide (lomitapide mesylate) 5 mg;
2014-05-06;
Oral;
Capsule;
24:06.92 – MISCELLANEOUS ANTILIPEMIC AGENTS;
Prescription;
AEGERION PHARMACEUTICALS CANADA LTD
DIN: 02420341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90495
CEENU;
lomustine 10 mg;
1976-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
DIN: 00360430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2531
CEENU;
lomustine 40 mg;
1976-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
DIN: 00360422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2530
PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML;
loperamide hydrochloride 0.2 mg / ml;
1993-12-31;
Oral;
Solution;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02016095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14567
TEVA-LOPERAMIDE;
loperamide hydrochloride 2 mg;
1995-12-31;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
TEVA CANADA LIMITED
DIN: 02132591
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18071
LOPERAMIDE-2;
loperamide hydrochloride 2 mg;
1997-11-05;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
PRO DOC LIMITEE
DIN: 02225182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43419
PMS-LOPERAMIDE – CAPLET 2MG;
loperamide hydrochloride 2 mg;
1996-09-12;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02228351
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43486
IMODIUM QUICK DISSOLVE;
loperamide hydrochloride 2 mg;
1997-09-24;
Oral;
Tablet (Orally Disintegrating);
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02230542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49614
RIVA-LOPERAMIDE;
loperamide hydrochloride 2 mg;
1998-08-27;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
LABORATOIRE RIVA INC.
DIN: 02238211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61604
DIARRHEA RELIEF;
loperamide hydrochloride 2 mg;
2004-06-11;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02248994
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73379
DIARRHEA RELIEF;
loperamide hydrochloride 2 mg;
2004-12-19;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02256452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74169
IMODIUM LIQUI-GELS;
loperamide hydrochloride 2 mg;
2013-07-02;
Oral;
Capsule;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02376016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86147
DIARRHEA RELIEF;
loperamide hydrochloride 2 mg;
2016-09-20;
Oral;
Tablet;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
LABORATOIRE RIVA INC.
DIN: 02453517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94007
IMODIUM CALMING LIQUID;
loperamide hydrochloride 2 mg / 15 ml;
2007-07-11;
Oral;
Solution;
56:08.00 – ANTIDIARRHEA AGENTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02291800
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77716
CLARITIN ALLERGY;
loratadine 10 mg;
1988-12-18;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
BAYER INC
DIN: 00782696
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10533
CLARITIN RAPID DISSOLVE;
loratadine 10 mg;
1998-05-05;
Oral;
Tablet (Orally Disintegrating);
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
BAYER INC
DIN: 02237734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61088
APO-LORATADINE;
loratadine 10 mg;
2001-06-27;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
DIN: 02243880
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67821
24 HOUR ALLERGY REMEDY;
loratadine 10 mg;
2006-07-28;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02280159
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76583
LORATADINE;
loratadine 10 mg;
2013-04-18;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
DIN: 02366444
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85127
ALLERGY REMEDY;
loratadine 10 mg;
2013-05-23;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
DIN: 02375990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86145
LORATADINE SOFT GEL CAPSULES;
loratadine 10 mg;
2012-09-07;
Oral;
Capsule;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
DIN: 02379481
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86538
ALLERTIN;
loratadine 10 mg;
2013-10-31;
Oral;
Capsule;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
DIN: 02390388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87582
CLARITIN LIQUID CAPSULES;
loratadine 10 mg;
2013-07-01;
Oral;
Capsule;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
BAYER INC
DIN: 02404494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88925
ALLERTIN;
loratadine 10 mg;
2018-10-09;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
APOTEX INC
DIN: 02418959
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90350
CLARITIN KIDS;
loratadine 5 mg / 5 ml;
2000-04-06;
Oral;
Syrup;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
BAYER INC
DIN: 02241523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65175
APO-LORAZEPAM TAB 0.5MG;
lorazepam 0.5 mg;
1985-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 00655740
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6295
PRO-LORAZEPAM;
lorazepam 0.5 mg;
1986-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
DIN: 00655643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6656
TEVA-LORAZEPAM;
lorazepam 0.5 mg;
1987-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
DIN: 00711101
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7314
PMS-LORAZEPAM TAB 0.5MG;
lorazepam 0.5 mg;
1988-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
DIN: 00728187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9349
ATIVAN;
lorazepam 0.5 mg;
1994-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02041413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16589
ATIVAN;
lorazepam 0.5 mg;
1995-12-31;
Sublingual;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02041456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17817
LORAZEPAM SUBLINGUAL;
lorazepam 0.5 mg;
2013-10-16;
Sublingual;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 02410745
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89541
TEVA-LORAZEPAM;
lorazepam 1 mg;
1985-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
DIN: 00637742
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6135
APO-LORAZEPAM TAB 1MG;
lorazepam 1 mg;
1985-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 00655759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6296
PRO-LORAZEPAM TAB 1.0MG;
lorazepam 1 mg;
1986-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
DIN: 00655651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6657
PMS-LORAZEPAM TAB 1MG;
lorazepam 1 mg;
1988-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
DIN: 00728195
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9423
ATIVAN;
lorazepam 1 mg;
1994-12-31;
Sublingual;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02041464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16118
ATIVAN;
lorazepam 1 mg;
1994-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02041421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16588
LORAZEPAM;
lorazepam 1 mg;
2010-06-15;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANIS HEALTH INC
DIN: 02351080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83629
LORAZEPAM SUBLINGUAL;
lorazepam 1 mg;
2013-10-16;
Sublingual;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 02410753
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89542
TEVA-LORAZEPAM;
lorazepam 2 mg;
1985-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TEVA CANADA LIMITED
DIN: 00637750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6136
APO-LORAZEPAM TAB 2MG;
lorazepam 2 mg;
1985-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
APOTEX INC
DIN: 00655767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6297
PRO-LORAZEPAM TAB 2MG;
lorazepam 2 mg;
1986-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PRO DOC LIMITEE
DIN: 00655678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6658
PMS-LORAZEPAM TAB 2MG;
lorazepam 2 mg;
1988-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PHARMASCIENCE INC
DIN: 00728209
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9424
ATIVAN;
lorazepam 2 mg;
1994-12-31;
Sublingual;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02041472
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16586
ATIVAN;
lorazepam 2 mg;
1994-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02041448
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16587
LORAZEPAM;
lorazepam 2 mg;
2010-06-15;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANIS HEALTH INC
DIN: 02351099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83630
LORAZEPAM SUBLINGUAL;
lorazepam 2 mg;
2013-10-16;
Sublingual;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 02410761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89543
LORAZEPAM INJECTION USP;
lorazepam 2 mg / ml;
2015-11-12;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANDOZ CANADA INCORPORATED
DIN: 02438704
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92310
LORAZEPAM INJECTION USP;
lorazepam 4 mg / ml;
2001-06-06;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANDOZ CANADA INCORPORATED
DIN: 02243278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67176
LORAZEPAM INJECTION USP;
lorazepam 4 mg / ml;
2014-06-10;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02388669
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87417
LORBRENA;
lorlatinib 100 mg;
2019-04-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02485974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97620
LORBRENA;
lorlatinib 25 mg;
2019-04-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02485966
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97619
COZAAR;
losartan potassium 100 mg;
1998-01-16;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02182882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44255
PMS-LOSARTAN;
losartan potassium 100 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02309777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79544
SANDOZ LOSARTAN;
losartan potassium 100 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02313359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79888
TEVA-LOSARTAN;
losartan potassium 100 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02357976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84305
LOSARTAN;
losartan potassium 100 mg;
2012-07-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87433
LOSARTAN;
losartan potassium 100 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02388898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87443
JAMP-LOSARTAN;
losartan potassium 100 mg;
2013-06-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02398850
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88377
AURO-LOSARTAN;
losartan potassium 100 mg;
2013-03-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02403358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88816
COZAAR;
losartan potassium 25 mg;
1995-12-31;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02182815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19167
PMS-LOSARTAN;
losartan potassium 25 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02309750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79542
SANDOZ LOSARTAN;
losartan potassium 25 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02313332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79886
TEVA-LOSARTAN;
losartan potassium 25 mg;
2012-02-28;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02380838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86659
LOSARTAN;
losartan potassium 25 mg;
2012-07-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87431
LOSARTAN;
losartan potassium 25 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02388863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87441
JAMP-LOSARTAN;
losartan potassium 25 mg;
2013-06-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02398834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88375
AURO-LOSARTAN;
losartan potassium 25 mg;
2013-03-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02403323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88814
COZAAR;
losartan potassium 50 mg;
1995-12-31;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
ORGANON CANADA INC.
DIN: 02182874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19168
PMS-LOSARTAN;
losartan potassium 50 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
DIN: 02309769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79543
SANDOZ LOSARTAN;
losartan potassium 50 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02313340
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79887
TEVA-LOSARTAN;
losartan potassium 50 mg;
2012-01-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02357968
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84304
LOSARTAN;
losartan potassium 50 mg;
2012-07-05;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02388804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87432
LOSARTAN;
losartan potassium 50 mg;
2012-07-20;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
SANIS HEALTH INC
DIN: 02388871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87442
JAMP-LOSARTAN;
losartan potassium 50 mg;
2013-06-11;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02398842
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88376
AURO-LOSARTAN;
losartan potassium 50 mg;
2013-03-26;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
AURO PHARMA INC
DIN: 02403331
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88815
PRIVA-LOSARTAN;
losartan potassium 50 mg;
2016-05-09;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
PHARMAPAR INC
DIN: 02446707
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93214
ALREX;
loteprednol etabonate 0.2 % / w/v;
2009-06-24;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH & LOMB INC
DIN: 02320924
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80634
LOTEMAX;
loteprednol etabonate 0.5 % / w/v;
2009-06-24;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH & LOMB INC
DIN: 02321114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80652
LOTEMAX OINTMENT;
loteprednol etabonate 0.5 % / w/w;
2014-10-29;
Ophthalmic;
Ointment;
52:08.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH & LOMB INC
DIN: 02421941
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90664
LOTEMAX GEL;
loteprednol etabonate 0.5 % / w/w;
2015-06-25;
Ophthalmic;
Gel;
52:08.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH & LOMB INC
DIN: 02435853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92020
LOVASTATIN;
lovastatin 20 mg;
1997-03-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02220172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43279
LOVASTATIN;
lovastatin 20 mg;
2010-07-26;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02353229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83844
LOVASTATIN;
lovastatin 40 mg;
1997-03-27;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02220180
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43280
LOVASTATIN;
lovastatin 40 mg;
2010-07-26;
Oral;
Tablet;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
DIN: 02353237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83845
LOXAPAC IM;
loxapine (loxapine hydrochloride) 50 mg / ml;
1997-06-13;
Intramuscular;
Liquid;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02169991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34560
XYLAC;
loxapine (loxapine succinate) 10 mg;
1998-04-16;
Oral;
Tablet;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02230838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50116
XYLAC;
loxapine (loxapine succinate) 2.5 mg;
2000-10-05;
Oral;
Tablet;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02242868
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66699
XYLAC;
loxapine (loxapine succinate) 25 mg;
1997-07-08;
Oral;
Tablet;
28:16.08.92 – MISCELLANEOUS ANTIPSYCHOTICS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02230839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50117
LATUDA;
lurasidone hydrochloride 120 mg;
2012-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
DIN: 02387786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87336
LATUDA;
lurasidone hydrochloride 20 mg;
2014-04-09;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
DIN: 02422050
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90675
LATUDA;
lurasidone hydrochloride 40 mg;
2012-09-06;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
DIN: 02387751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87334
LATUDA;
lurasidone hydrochloride 60 mg;
2014-03-14;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
DIN: 02413361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89804
LATUDA;
lurasidone hydrochloride 80 mg;
2012-09-05;
Oral;
Tablet;
28:16.08.04 – ATYPICAL ANTIPSYCHOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
DIN: 02387778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87335
REBLOZYL;
luspatercept 25 mg / vial;
2020-11-23;
Subcutaneous;
Powder For Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
CELGENE INC
DIN: 02505541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99492
REBLOZYL;
luspatercept 75 mg / vial;
2020-11-23;
Subcutaneous;
Powder For Solution;
20:04.00 – ANTIANEMIA DRUGS;
Prescription , Schedule D;
CELGENE INC
DIN: 02505568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99493
LUVERIS;
lutropin alfa 75 unit / vial;
2005-06-28;
Subcutaneous;
Powder For Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
DIN: 02269066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75446
ATGAM;
lymphocyte immunoglobulin anti-thymocyte globulin (equine) 50 mg / ml;
1998-12-04;
Intravenous;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Schedule D;
PFIZER CANADA ULC
DIN: 02234470
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55838
OPSUMIT;
macitentan 10 mg;
2014-01-15;
Oral;
Tablet;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
DIN: 02415690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90029
MAGNESIUM-45 0.5-4.5;
magnesium chloride 20.5 g / 4.5 l;
1996-12-31;
Dialysis;
Powder For Solution;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
DIN: 02219301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20112
MAGNESIUM SULFATE INJ 20% USP;
magnesium sulfate 200 mg / ml;
1978-12-31;
Intramuscular , Intravenous;
Liquid;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS , 40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00392618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3088
MAGNESIUM SULFATE INJECTION;
magnesium sulfate 500 mg / ml;
1992-12-31;
Intramuscular , Intravenous;
Solution;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS , 40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02139499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19701
MICRO MN;
manganese (manganese sulfate) 0.1 mg / ml;
1992-12-31;
Intravenous;
Solution;
40:12.00 – REPLACEMENT PREPARATIONS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00786942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13486
OSMITROL INJECTION 10%;
mannitol 10 %;
1989-12-31;
Intravenous;
Solution;
40:28.12 – OSMOTIC DIURETICS;
Ethical;
BAXTER CORPORATION
DIN: 00060410
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10517
MANNITOL INJECTION USP;
mannitol 20 %;
1963-12-31;
Intravenous;
Solution;
40:28.12 – OSMOTIC DIURETICS;
Ethical;
ICU MEDICAL CANADA INC
DIN: 00038016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1740
OSMITROL INJECTION 20%;
mannitol 20 %;
1989-12-31;
Intravenous;
Solution;
36:40.00 – KIDNEY FUNCTION;
Ethical;
BAXTER CORPORATION
DIN: 00060437
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10516
MANNITOL INJECTION USP;
mannitol 25 %;
1970-12-31;
Intravenous;
Solution;
40:28.12 – OSMOTIC DIURETICS;
Ethical;
PFIZER CANADA ULC
DIN: 00038024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1181
MANNITOL INJECTION;
mannitol 25 %;
2002-04-09;
Intravenous;
Solution;
40:28.12 – OSMOTIC DIURETICS;
Ethical;
FRESENIUS KABI CANADA LTD
DIN: 02243176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67055
CELSENTRI;
maraviroc 150 mg;
2007-09-26;
Oral;
Tablet;
08:18.08.04 – HIV FUSION INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02299844
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78519
CELSENTRI;
maraviroc 300 mg;
2007-09-26;
Oral;
Tablet;
08:18.08.04 – HIV FUSION INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
DIN: 02299852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78520
VERMOX;
mebendazole 100 mg;
1982-12-31;
Oral;
Tablet;
08:08.00 – ANTHELMINTICS;
Prescription;
JANSSEN INC
DIN: 00556734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4743
INCRELEX;
mecasermin 40 mg / 4 ml;
2021-03-01;
Subcutaneous;
Solution;
68:30.04 – SOMATOTROPIN AGONISTS*;
Prescription , Schedule D;
IPSEN BIOPHARMACEUTICALS CANADA INC
DIN: 02509733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99902
PROVERA 10MG TABLETS;
medroxyprogesterone acetate 10 mg;
1987-12-31;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
PFIZER CANADA ULC
DIN: 00729973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7480
TEVA-MEDROXYPROGESTERONE;
medroxyprogesterone acetate 10 mg;
1997-01-07;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
TEVA CANADA LIMITED
DIN: 02221306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43301
APO-MEDROXY;
medroxyprogesterone acetate 10 mg;
2007-01-10;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
APOTEX INC
DIN: 02277298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76294
APO-MEDROXY;
medroxyprogesterone acetate 100 mg;
2005-08-04;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
APOTEX INC
DIN: 02267640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75305
DEPO-PROVERA;
medroxyprogesterone acetate 150 mg / ml;
1995-12-31;
Intramuscular;
Suspension;
68:32.00 – PROGESTINS;
Prescription;
PFIZER CANADA ULC
DIN: 00585092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19667
PROVERA 2.5MG TABLETS;
medroxyprogesterone acetate 2.5 mg;
1992-12-31;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
PFIZER CANADA ULC
DIN: 00708917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13037
TEVA-MEDROXYPROGESTERONE;
medroxyprogesterone acetate 2.5 mg;
1997-01-07;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
TEVA CANADA LIMITED
DIN: 02221284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43299
APO-MEDROXY TABLETS;
medroxyprogesterone acetate 2.5 mg;
2002-04-22;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
APOTEX INC
DIN: 02244726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68715
PROVERA 5MG TABLETS;
medroxyprogesterone acetate 5 mg;
1961-12-31;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
PFIZER CANADA ULC
DIN: 00030937
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=430
TEVA-MEDROXYPROGESTERONE;
medroxyprogesterone acetate 5 mg;
1997-01-07;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
TEVA CANADA LIMITED
DIN: 02221292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43300
APO-MEDROXY TABLETS;
medroxyprogesterone acetate 5 mg;
2002-04-22;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
APOTEX INC
DIN: 02244727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68716
MEFENAMIC;
mefenamic acid 250 mg;
1996-11-06;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
DIN: 02229452
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47338
MEFLOQUINE;
mefloquine (mefloquine hydrochloride) 250 mg;
2002-07-23;
Oral;
Tablet;
08:30.08 – ANTIMALARIALS;
Prescription;
AA PHARMA INC
DIN: 02244366
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68334
MEGESTROL;
megestrol acetate 160 mg;
1995-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 02195925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20026
MEGESTROL;
megestrol acetate 40 mg;
1995-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AA PHARMA INC
DIN: 02195917
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20029
PMS-MELOXICAM;
meloxicam 15 mg;
2003-11-07;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02248268
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72607
APO-MELOXICAM;
meloxicam 15 mg;
2004-02-13;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 02248974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73356
ACT MELOXICAM;
meloxicam 15 mg;
2004-08-12;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02250020
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73484
TEVA-MELOXICAM;
meloxicam 15 mg;
2004-10-22;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02258323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74354
MELOXICAM;
meloxicam 15 mg;
2010-07-26;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02353156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83837
AURO-MELOXICAM;
meloxicam 15 mg;
2012-10-18;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AURO PHARMA INC
DIN: 02390892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87628
PMS-MELOXICAM;
meloxicam 7.5 mg;
2003-11-07;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02248267
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72606
APO-MELOXICAM;
meloxicam 7.5 mg;
2004-02-13;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 02248973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73355
ACT MELOXICAM;
meloxicam 7.5 mg;
2004-08-12;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02250012
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73483
TEVA-MELOXICAM;
meloxicam 7.5 mg;
2004-10-22;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02258315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74353
MELOXICAM;
meloxicam 7.5 mg;
2010-07-26;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02353148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83836
AURO-MELOXICAM;
meloxicam 7.5 mg;
2012-10-19;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AURO PHARMA INC
DIN: 02390884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87627
ALKERAN;
melphalan 2 mg;
1964-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 00004715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1195
EBIXA;
memantine hydrochloride 10 mg;
2004-12-16;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
LUNDBECK CANADA INC
DIN: 02260638
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74607
PMS-MEMANTINE;
memantine hydrochloride 10 mg;
2009-11-04;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02321130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80653
ACT MEMANTINE;
memantine hydrochloride 10 mg;
2010-02-18;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02324067
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80955
RIVA-MEMANTINE;
memantine hydrochloride 10 mg;
2010-06-14;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02348950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83428
APO-MEMANTINE;
memantine hydrochloride 10 mg;
2011-06-17;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
APOTEX INC
DIN: 02366487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85130
SANDOZ MEMANTINE FCT;
memantine hydrochloride 10 mg;
2014-07-17;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02375532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86095
MEMANTINE;
memantine hydrochloride 10 mg;
2015-07-22;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02443082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92762
MEMANTINE;
memantine hydrochloride 10 mg;
2015-10-07;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02446049
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93131
PMS-MEMANTINE;
memantine hydrochloride 5 mg;
2015-03-02;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02382830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86864
MENOPUR;
menotropins 75 unit / vial;
2006-09-19;
Subcutaneous;
Powder For Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FERRING INC
DIN: 02283093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76872
MEPERIDINE HYDROCHLORIDE INJECTION USP;
meperidine hydrochloride 50 mg / ml;
1987-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00725765
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8121
CARBOCAINE 1%;
mepivacaine hydrochloride 10 mg / ml;
2001-06-01;
Intracaudal , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 02241999
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65669
CARBOCAINE 1%;
mepivacaine hydrochloride 10 mg / ml;
2001-07-15;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 02242000
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65670
CARBOCAINE 2%;
mepivacaine hydrochloride 20 mg / ml;
2001-07-15;
Intracaudal , Epidural;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
PFIZER CANADA ULC
DIN: 02242001
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65671
ISOCAINE HCL INJ 3%;
mepivacaine hydrochloride 30 mg / ml;
1977-12-31;
Subcutaneous;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
NOVOCOL PHARMACEUTICAL OF CANADA INC
DIN: 00364304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2743
SCANDONEST 3% PLAIN INJ;
mepivacaine hydrochloride 30 mg / ml;
1980-12-31;
Block/Infiltration;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 00479934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3804
3% POLOCAINE DENTAL;
mepivacaine hydrochloride 30 mg / ml;
2009-10-19;
Block/Infiltration;
Liquid;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
DENTSPLY CANADA LIMITED
DIN: 02330733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81649
CARBOCAINE 3%;
mepivacaine hydrochloride 30 mg / ml;
2019-05-07;
Block/Infiltration;
Solution;
72:00.00 – LOCAL ANESTHETICS;
Ethical;
SEPTODONT
DIN: 02474174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96420
NUCALA;
mepolizumab 100 mg / ml;
2019-12-10;
Subcutaneous;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
GLAXOSMITHKLINE INC
DIN: 02492989
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98296
NUCALA;
mepolizumab 100 mg / ml;
2019-12-10;
Subcutaneous;
Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
GLAXOSMITHKLINE INC
DIN: 02492997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98297
NUCALA;
mepolizumab 100 mg / vial;
2016-03-14;
Subcutaneous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription , Schedule D;
GLAXOSMITHKLINE INC
DIN: 02449781
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93562
PURINETHOL;
mercaptopurine 50 mg;
1954-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00004723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=960
MERCAPTOPURINE TABLETS USP;
mercaptopurine 50 mg;
2013-11-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
STERIMAX INC
DIN: 02415275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89989
MEROPENEM FOR INJECTION;
meropenem (meropenem trihydrate) 1 g / vial;
2012-01-26;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02378795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86467
TARO-MEROPENEM;
meropenem (meropenem trihydrate) 1 g / vial;
2021-06-11;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02421526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90613
MEROPENEM FOR INJECTION USP;
meropenem (meropenem trihydrate) 1 g / vial;
2015-06-11;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
STERIMAX INC
DIN: 02436507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92084
MEROPENEM FOR INJECTION;
meropenem (meropenem trihydrate) 1 g / vial;
2017-10-20;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
AURO PHARMA INC
DIN: 02462893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95076
MEROPENEM FOR INJECTION;
meropenem (meropenem trihydrate) 1 g / vial;
2021-02-22;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
STERIMAX INC
DIN: 02493349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98336
MEROPENEM FOR INJECTION;
meropenem (meropenem trihydrate) 500 mg / vial;
2012-01-26;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02378787
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86463
TARO-MEROPENEM;
meropenem (meropenem trihydrate) 500 mg / vial;
2021-06-11;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02421518
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90612
MEROPENEM FOR INJECTION;
meropenem (meropenem trihydrate) 500 mg / vial;
2017-10-20;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
AURO PHARMA INC
DIN: 02462885
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95075
MEROPENEM FOR INJECTION;
meropenem (meropenem trihydrate) 500 mg / vial;
2021-05-25;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
STERIMAX INC
DIN: 02493330
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98335
MEROPENEM FOR INJECTION, USP;
meropenem 1 g / vial;
2014-06-05;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02415224
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89984
MEROPENEM FOR INJECTION, USP;
meropenem 500 mg / vial;
2014-10-20;
Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02415216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89983
PENTASA;
mesalazine 1 g;
1995-12-31;
Rectal;
Suppository;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
FERRING INC
DIN: 02153564
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18493
SALOFALK;
mesalazine 1 g;
2000-06-01;
Rectal;
Suppository;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02242146
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65824
PENTASA;
mesalazine 1 g;
2013-03-12;
Oral;
Tablet (Extended-Release);
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
FERRING INC
DIN: 02399466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88434
MEZERA;
mesalazine 1 g;
2018-07-13;
Rectal;
Suppository;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
AVIR PHARMA INC.
DIN: 02474018
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96402
MEZERA;
mesalazine 1 g / act;
2018-07-13;
Rectal;
Foam;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
AVIR PHARMA INC.
DIN: 02474026
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96403
PENTASA;
mesalazine 1 g / 100 ml;
1995-12-31;
Rectal;
Suspension;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
FERRING INC
DIN: 02153521
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18496
MEZAVANT;
mesalazine 1.2 g;
2007-07-27;
Oral;
Tablet (Delayed And Extended Release);
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAKEDA CANADA INC
DIN: 02297558
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78289
SALOFALK;
mesalazine 2 g / 60 ml;
1995-12-31;
Rectal;
Suspension;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02112795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18510
PENTASA;
mesalazine 4 g / 100 ml;
1995-12-31;
Rectal;
Suspension;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
FERRING INC
DIN: 02153556
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18494
SALOFALK;
mesalazine 4 g / 60 ml;
1995-12-31;
Rectal;
Suspension;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02112809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18509
TEVA-5 ASA;
mesalazine 400 mg;
1995-12-31;
Oral;
Tablet (Enteric-Coated);
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02171929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19524
PENTASA;
mesalazine 500 mg;
1994-12-31;
Oral;
Tablet (Extended-Release);
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
FERRING INC
DIN: 02099683
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16855
SALOFALK;
mesalazine 500 mg;
1995-12-31;
Rectal;
Suppository;
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02112760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18212
SALOFALK;
mesalazine 500 mg;
1995-12-31;
Oral;
Tablet (Delayed-Release);
56:36.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
APTALIS PHARMA CANADA ULC
DIN: 02112787
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18214
UROMITEXAN;
mesna 100 mg / ml;
2001-03-06;
Intravenous , Oral;
Solution;
92:56.00 – PROTECTIVE AGENTS;
Prescription;
BAXTER CORPORATION
DIN: 02241411
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65047
MESNA FOR INJECTION;
mesna 100 mg / ml;
2002-08-22;
Intravenous;
Solution;
92:56.00 – PROTECTIVE AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02244931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68929
UROMITEXAN;
mesna 100 mg / ml;
2012-04-13;
Intravenous;
Solution;
92:56.00 – PROTECTIVE AGENTS;
Prescription;
BAXTER CORPORATION
DIN: 02371839
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85696
GLUMETZA;
metformin hydrochloride 1000 mg;
2008-01-08;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02300451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78575
APO-METFORMIN ER;
metformin hydrochloride 1000 mg;
2017-10-02;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES;
Prescription;
APOTEX INC
DIN: 02460653
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94808
GLUCOPHAGE;
metformin hydrochloride 500 mg;
1995-12-31;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02099233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17104
PMS-METFORMIN – TAB 500MG;
metformin hydrochloride 500 mg;
1996-09-05;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
PHARMASCIENCE INC
DIN: 02223562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43371
RIVA-METFORMIN;
metformin hydrochloride 500 mg;
1999-05-31;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02239081
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62536
RATIO-METFORMIN;
metformin hydrochloride 500 mg;
2001-01-04;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02242974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66814
SANDOZ METFORMIN FC;
metformin hydrochloride 500 mg;
2002-12-20;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02246820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71020
ACT METFORMIN;
metformin hydrochloride 500 mg;
2004-11-05;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02257726
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74296
GLUMETZA;
metformin hydrochloride 500 mg;
2005-11-03;
Oral;
Tablet (Extended-Release);
68:20.04 – BIGUANIDES;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02268493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75387
RAN-METFORMIN;
metformin hydrochloride 500 mg;
2005-07-12;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02269031
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75444
PRO-METFORMIN;
metformin hydrochloride 500 mg;
2008-10-27;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
PRO DOC LIMITEE
DIN: 02314908
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80043
METFORMIN;
metformin hydrochloride 500 mg;
2010-07-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SANIS HEALTH INC
DIN: 02353377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83857
JAMP-METFORMIN;
metformin hydrochloride 500 mg;
2012-03-22;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02380196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86602
METFORMIN FC;
metformin hydrochloride 500 mg;
2012-06-10;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87098
AURO-METFORMIN;
metformin hydrochloride 500 mg;
2015-04-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
AURO PHARMA INC
DIN: 02438275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92264
GLUCOPHAGE;
metformin hydrochloride 850 mg;
1995-12-31;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 02162849
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18835
PMS-METFORMIN;
metformin hydrochloride 850 mg;
2000-07-28;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
PHARMASCIENCE INC
DIN: 02242589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66363
RIVA-METFORMIN;
metformin hydrochloride 850 mg;
2001-10-18;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02242783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66606
RATIO-METFORMIN;
metformin hydrochloride 850 mg;
2001-01-04;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02242931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66769
SANDOZ METFORMIN FC;
metformin hydrochloride 850 mg;
2002-12-20;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02246821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71021
ACT METFORMIN;
metformin hydrochloride 850 mg;
2004-11-05;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
TEVA CANADA LIMITED
DIN: 02257734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74297
RAN-METFORMIN;
metformin hydrochloride 850 mg;
2005-07-12;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
DIN: 02269058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75445
PRO-METFORMIN;
metformin hydrochloride 850 mg;
2008-10-27;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
PRO DOC LIMITEE
DIN: 02314894
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80042
METFORMIN;
metformin hydrochloride 850 mg;
2010-07-26;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SANIS HEALTH INC
DIN: 02353385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83858
JAMP-METFORMIN;
metformin hydrochloride 850 mg;
2012-03-22;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02380218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86603
METFORMIN FC;
metformin hydrochloride 850 mg;
2012-06-10;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02385368
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87099
AURO-METFORMIN;
metformin hydrochloride 850 mg;
2015-04-08;
Oral;
Tablet;
68:20.04 – BIGUANIDES;
Prescription;
AURO PHARMA INC
DIN: 02438283
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92265
PROVOCHOLINE;
methacholine chloride 100 mg / vial;
1999-04-01;
Inhalation;
Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
METHAPHARM INC
DIN: 02239656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63128
METHACHOLINE OMEGA;
methacholine chloride 100 mg / vial;
2006-03-27;
Inhalation;
Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02263890
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74930
PROVOCHOLINE;
methacholine chloride 1280 mg / vial;
2001-09-24;
Inhalation;
Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
METHAPHARM INC
DIN: 02243834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67775
PROVOCHOLINE;
methacholine chloride 160 mg / vial;
2003-03-12;
Inhalation;
Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
METHAPHARM INC
DIN: 02246492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70667
METHACHOLINE OMEGA;
methacholine chloride 1600 mg / vial;
2006-07-03;
Inhalation;
Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02263912
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74932
PROVOCHOLINE;
methacholine chloride 1600 mg / vial;
2008-02-28;
Inhalation;
Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
METHAPHARM INC
DIN: 02288826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77421
PROVOCHOLINE;
methacholine chloride 320 mg / vial;
2003-03-12;
Inhalation;
Powder For Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Prescription;
METHAPHARM INC
DIN: 02246493
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70668
METADOL;
methadone hydrochloride 1 mg;
2003-07-29;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02247698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71959
METADOL-D;
methadone hydrochloride 1 mg / ml;
2014-08-18;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02247374
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71619
METADOL;
methadone hydrochloride 1 mg / ml;
2003-07-11;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02247694
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71958
METADOL;
methadone hydrochloride 10 mg;
2003-07-29;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02247700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71964
METADOL;
methadone hydrochloride 10 mg / ml;
2000-05-05;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02241377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65010
METADOL-D;
methadone hydrochloride 10 mg / ml;
2001-08-03;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02244290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68257
METHADOSE;
methadone hydrochloride 10 mg / ml;
2013-01-03;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
MALLINCKRODT CANADA ULC
DIN: 02394596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87974
METHADOSE;
methadone hydrochloride 10 mg / ml;
2013-01-03;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
MALLINCKRODT CANADA ULC
DIN: 02394618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87975
SANDOZ METHADONE;
methadone hydrochloride 10 mg / ml;
2019-07-30;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02481979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97248
JAMP METHADONE ORAL CONCENTRATE;
methadone hydrochloride 10 mg / ml;
2020-10-30;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
JAMP PHARMA CORPORATION
DIN: 02495783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98568
ODAN-METHADONE;
methadone hydrochloride 10 mg / ml;
2020-06-17;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ODAN LABORATORIES LTD
DIN: 02495872
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98577
ODAN-METHADONE;
methadone hydrochloride 10 mg / ml;
2020-06-17;
Oral;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ODAN LABORATORIES LTD
DIN: 02495880
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98578
METADOL;
methadone hydrochloride 25 mg;
2003-07-29;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02247701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71965
METADOL;
methadone hydrochloride 5 mg;
2003-07-29;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 02247699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71963
METHAZOLAMIDE;
methazolamide 50 mg;
2002-07-25;
Oral;
Tablet;
52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02245882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69999
TAPAZOLE;
methimazole 10 mg;
2008-01-07;
Oral;
Tablet;
68:36.08 – ANTITHYROID AGENTS;
Prescription;
PALADIN LABS INC.
DIN: 02296039
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78139
MAR-METHIMAZOLE;
methimazole 10 mg;
2018-10-19;
Oral;
Tablet;
68:36.08 – ANTITHYROID AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02480115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97067
TAPAZOLE;
methimazole 5 mg;
1951-12-31;
Oral;
Tablet;
68:36.08 – ANTITHYROID AGENTS;
Prescription;
PALADIN LABS INC.
DIN: 00015741
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9
MAR-METHIMAZOLE;
methimazole 5 mg;
2018-10-19;
Oral;
Tablet;
68:36.08 – ANTITHYROID AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02480107
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97066
ROBAXIN;
methocarbamol 500 mg;
1958-12-31;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01930990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13297
ROBAXIN 750;
methocarbamol 750 mg;
1993-12-31;
Oral;
Tablet;
12:20.04 – CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN: 01932187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13624
PMS-METHOTREXATE;
methotrexate (methotrexate disodium) 2.5 mg;
1996-11-15;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02170698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44161
METHOTREXATE INJECTION USP;
methotrexate (methotrexate sodium) 10 mg / ml;
1997-07-30;
Intracerebroventricular , Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02182947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44261
METOJECT SUBCUTANEOUS;
methotrexate (methotrexate sodium) 10 mg / 0.2 ml;
2019-09-16;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02454831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94161
METHOTREXATE INJECTION, BP;
methotrexate (methotrexate sodium) 10 mg / 0.4 ml;
2014-05-08;
Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02422174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90688
METOJECT SUBCUTANEOUS;
methotrexate (methotrexate sodium) 12.5 mg / 0.25 ml;
2019-09-16;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02454750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94144
METOJECT SUBCUTANEOUS;
methotrexate (methotrexate sodium) 15 mg / 0.3 ml;
2018-11-30;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02454858
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94162
METHOTREXATE SUBCUTANEOUS;
methotrexate (methotrexate sodium) 15 mg / 0.3 ml;
2020-06-02;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02491311
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98132
METHOTREXATE INJECTION, BP;
methotrexate (methotrexate sodium) 15 mg / 0.6 ml;
2014-05-08;
Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02422182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90689
METOJECT SUBCUTANEOUS;
methotrexate (methotrexate sodium) 17.5 mg / 0.35 ml;
2016-12-02;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02454769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94145
METHOTREXATE SUBCUTANEOUS;
methotrexate (methotrexate sodium) 17.5 mg / 0.35 ml;
2020-02-28;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02491338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98133
METOJECT SUBCUTANEOUS;
methotrexate (methotrexate sodium) 20 mg / 0.4 ml;
2016-12-02;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02454866
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94163
METHOTREXATE SUBCUTANEOUS;
methotrexate (methotrexate sodium) 20 mg / 0.4 ml;
2020-02-28;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02491346
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98134
METHOTREXATE INJECTION, BP;
methotrexate (methotrexate sodium) 20 mg / 0.8 ml;
2014-05-08;
Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02422190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90690
METOJECT SUBCUTANEOUS;
methotrexate (methotrexate sodium) 22.5 mg / 0.45 ml;
2016-12-02;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02454777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94146
METHOTREXATE SUBCUTANEOUS;
methotrexate (methotrexate sodium) 22.5 mg / 0.45 ml;
2020-02-28;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02491354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98135
METHOTREXATE SODIUM INJECTION;
methotrexate (methotrexate sodium) 25 mg / ml;
1995-12-31;
Intracerebroventricular , Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02099705
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19681
METHOTREXATE INJECTION USP;
methotrexate (methotrexate sodium) 25 mg / ml;
1998-04-30;
Intra-Arterial , Intramuscular , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02182777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42844
METHOTREXATE INJECTION USP;
methotrexate (methotrexate sodium) 25 mg / ml;
1998-07-13;
Intracerebroventricular , Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02182955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44262
METHOTREXATE INJECTION USP;
methotrexate (methotrexate sodium) 25 mg / ml;
1997-07-30;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02182971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44264
METHOTREXATE INJECTION BP;
methotrexate (methotrexate sodium) 25 mg / ml;
2011-09-30;
Intracerebroventricular , Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02327236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81253
JAMP-METHOTREXATE;
methotrexate (methotrexate sodium) 25 mg / ml;
2014-03-12;
Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02419173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90372
METHOTREXATE INJECTION, BP;
methotrexate (methotrexate sodium) 25 mg / ml;
2014-05-08;
Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02422204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90691
METHOTREXATE INJECTION BP;
methotrexate (methotrexate sodium) 25 mg / ml;
2020-10-22;
Intra-Arterial , Intramuscular , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02464365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95252
METHOTREXATE INJECTION BP;
methotrexate (methotrexate sodium) 25 mg / ml;
2019-04-23;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02474735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96492
METHOTREXATE INJECTION BP;
methotrexate (methotrexate sodium) 25 mg / ml;
2019-04-23;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02474891
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96511
METOJECT SUBCUTANEOUS;
methotrexate (methotrexate sodium) 25 mg / 0.5 ml;
2016-12-02;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02454874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94164
METHOTREXATE SUBCUTANEOUS;
methotrexate (methotrexate sodium) 25 mg / 0.5 ml;
2020-02-28;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02491362
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98136
METHOTREXATE INJECTION, BP;
methotrexate (methotrexate sodium) 7.5 mg / 0.3 ml;
2014-05-08;
Intra-Arterial , Intramuscular , Intrathecal , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02422166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90687
METOJECT;
methotrexate (methotrexate sodium) 7.5 mg / 0.75 ml;
2009-01-26;
Intra-Arterial , Intramuscular , Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MEDEXUS INC
DIN: 02320029
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80549
METHOTREXATE TABLETS, USP;
methotrexate 10 mg;
2004-04-12;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
DIN: 02182750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42842
NOZINAN INJ 25MG/ML;
methotrimeprazine (methotrimeprazine hydrochloride) 25 mg / ml;
1958-12-31;
Intramuscular , Intravenous;
Solution;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 01927698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13163
METHOPRAZINE;
methotrimeprazine (methotrimeprazine maleate) 2 mg;
1998-07-20;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 02238403
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61820
METHOPRAZINE;
methotrimeprazine (methotrimeprazine maleate) 25 mg;
1998-07-20;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 02238405
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61822
METHOPRAZINE;
methotrimeprazine (methotrimeprazine maleate) 5 mg;
1998-07-20;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 02238404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61821
METHOPRAZINE;
methotrimeprazine (methotrimeprazine maleate) 50 mg;
1998-07-20;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
DIN: 02238406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61823
UVADEX;
methoxsalen 20 mcg / ml;
2013-12-09;
Extracorporeal;
Solution;
84:50.06 – PIGMENTING AGENTS;
Prescription;
THERAKOS INC
DIN: 02406233
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89096
PENTHROX;
methoxyflurane 99.9 %;
2018-06-13;
Inhalation;
Solution;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
PURDUE PHARMA
DIN: 02474719
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96490
PENTHROX;
methoxyflurane 99.9 %;
2018-06-12;
Inhalation;
Solution , Kit;
28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS;
Prescription;
PURDUE PHARMA
DIN: 02474727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96491
METVIX;
methyl aminolevulinate (methyl aminolevulinate hydrochloride) 168 mg / g;
2009-06-16;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
GALDERMA CANADA INC
DIN: 02323273
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80876
METHYLDOPA;
methyldopa 125 mg;
1980-04-02;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
AA PHARMA INC
DIN: 00360252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2470
METHYLDOPA;
methyldopa 250 mg;
1976-12-31;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
AA PHARMA INC
DIN: 00360260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2471
METHYLDOPA;
methyldopa 500 mg;
1978-12-31;
Oral;
Tablet;
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
AA PHARMA INC
DIN: 00426830
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2909
METHYLENE BLEU LIQ 1%;
methylene blue 1 %;
1951-12-31;
Oral;
Liquid;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Otc;
LABORATOIRE ATLAS INC
DIN: 00050466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68
METHYLENE BLUE INJECTION USP;
methylene blue 10 mg / ml;
2001-03-11;
Intravenous;
Liquid;
92:12.00 – ANTIDOTES;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02230770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50032
METHYLENE BLUE INJECTION USP;
methylene blue 10 mg / ml;
2016-02-19;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02431548
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91597
METHYLENE BLUE INJECTION;
methylene blue 10 mg / ml;
2020-09-22;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Ethical;
PHEBRA PTY LTD
DIN: 02487993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97817
METHYLENE BLEU LIQ 2%;
methylene blue 2 %;
1951-12-31;
Oral;
Liquid;
92:12.00 – ANTIDOTES;
Otc;
LABORATOIRE ATLAS INC
DIN: 00050474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69
RELISTOR;
methylnaltrexone bromide 20 mg / ml;
2008-05-07;
Subcutaneous;
Solution;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
SALIX PHARMACEUTICALS INC
DIN: 02308215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79388
RITALIN 10MG;
methylphenidate hydrochloride 10 mg;
1956-12-31;
Oral;
Tablet;
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00005606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=800
PMS-METHYLPHENIDATE;
methylphenidate hydrochloride 10 mg;
1990-12-31;
Oral;
Tablet;
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
PHARMASCIENCE INC
DIN: 00584991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10398
APO-METHYLPHENIDATE;
methylphenidate hydrochloride 10 mg;
2004-11-02;
Oral;
Tablet;
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02249324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73416
BIPHENTIN;
methylphenidate hydrochloride 10 mg;
2006-08-01;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76281
FOQUEST;
methylphenidate hydrochloride 100 mg;
2018-01-11;
Oral;
Capsule (Controlled Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02470357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95933
BIPHENTIN;
methylphenidate hydrochloride 15 mg;
2006-08-01;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76279
CONCERTA;
methylphenidate hydrochloride 18 mg;
2003-07-23;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
JANSSEN INC
DIN: 02247732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72012
ACT METHYLPHENIDATE ER;
methylphenidate hydrochloride 18 mg;
2017-10-26;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
TEVA CANADA LIMITED
DIN: 02441934
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92630
APO-METHYLPHENIDATE ER;
methylphenidate hydrochloride 18 mg;
2016-07-22;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02452731
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93914
RITALIN-SR TAB 20MG;
methylphenidate hydrochloride 20 mg;
1984-12-31;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00632775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6067
PMS-METHYLPHENIDATE;
methylphenidate hydrochloride 20 mg;
1990-12-31;
Oral;
Tablet;
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
PHARMASCIENCE INC
DIN: 00585009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10399
APO-METHYLPHENIDATE;
methylphenidate hydrochloride 20 mg;
2004-11-02;
Oral;
Tablet;
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02249332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73417
APO-METHYLPHENIDATE SR;
methylphenidate hydrochloride 20 mg;
2005-04-27;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02266687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75209
BIPHENTIN;
methylphenidate hydrochloride 20 mg;
2006-08-01;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277158
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76280
SANDOZ METHYLPHENIDATE SR;
methylphenidate hydrochloride 20 mg;
2008-12-23;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
SANDOZ CANADA INCORPORATED
DIN: 02320312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80575
FOQUEST;
methylphenidate hydrochloride 25 mg;
2017-12-14;
Oral;
Capsule (Controlled Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02470292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95927
CONCERTA;
methylphenidate hydrochloride 27 mg;
2005-01-06;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
JANSSEN INC
DIN: 02250241
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73505
ACT METHYLPHENIDATE ER;
methylphenidate hydrochloride 27 mg;
2017-10-26;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
TEVA CANADA LIMITED
DIN: 02441942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92631
APO-METHYLPHENIDATE ER;
methylphenidate hydrochloride 27 mg;
2016-07-22;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02452758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93915
BIPHENTIN;
methylphenidate hydrochloride 30 mg;
2006-08-01;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277174
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76282
FOQUEST;
methylphenidate hydrochloride 35 mg;
2017-12-14;
Oral;
Capsule (Controlled Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02470306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95928
CONCERTA;
methylphenidate hydrochloride 36 mg;
2003-07-23;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
JANSSEN INC
DIN: 02247733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72013
ACT METHYLPHENIDATE ER;
methylphenidate hydrochloride 36 mg;
2017-10-26;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
TEVA CANADA LIMITED
DIN: 02441950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92632
APO-METHYLPHENIDATE ER;
methylphenidate hydrochloride 36 mg;
2016-07-22;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02452766
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93916
BIPHENTIN;
methylphenidate hydrochloride 40 mg;
2006-08-01;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277182
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76283
FOQUEST;
methylphenidate hydrochloride 45 mg;
2017-12-14;
Oral;
Capsule (Controlled Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02470314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95929
PMS-METHYLPHENIDATE;
methylphenidate hydrochloride 5 mg;
1997-10-24;
Oral;
Tablet;
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
PHARMASCIENCE INC
DIN: 02234749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=55866
APO-METHYLPHENIDATE;
methylphenidate hydrochloride 5 mg;
2006-02-01;
Oral;
Tablet;
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02273950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75941
BIPHENTIN;
methylphenidate hydrochloride 50 mg;
2006-08-01;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277190
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76284
CONCERTA;
methylphenidate hydrochloride 54 mg;
2003-07-23;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
JANSSEN INC
DIN: 02247734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72014
APO-METHYLPHENIDATE ER;
methylphenidate hydrochloride 54 mg;
2016-07-22;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
APOTEX INC
DIN: 02330377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81611
ACT METHYLPHENIDATE ER;
methylphenidate hydrochloride 54 mg;
2017-10-26;
Oral;
Tablet (Extended-Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
TEVA CANADA LIMITED
DIN: 02441969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92633
FOQUEST;
methylphenidate hydrochloride 55 mg;
2017-12-14;
Oral;
Capsule (Controlled Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02470322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95930
BIPHENTIN;
methylphenidate hydrochloride 60 mg;
2006-08-01;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76285
FOQUEST;
methylphenidate hydrochloride 70 mg;
2017-12-14;
Oral;
Capsule (Controlled Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02470330
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95931
BIPHENTIN;
methylphenidate hydrochloride 80 mg;
2007-03-09;
Oral;
Capsule (Extended Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02277212
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76286
FOQUEST;
methylphenidate hydrochloride 85 mg;
2017-12-14;
Oral;
Capsule (Controlled Release);
28:20.32 – Respiratory and CNS Stimulants;
Schedule G (Cdsa Iii);
ELVIUM LIFE SCIENCES
DIN: 02470349
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95932
SOLU-MEDROL;
methylprednisolone (methylprednisolone sodium succinate) 1 g / vial;
1971-12-31;
Intramuscular , Intravenous;
Kit , Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00036137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1130
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION;
methylprednisolone (methylprednisolone sodium succinate) 1 g / vial;
2000-03-01;
Intramuscular , Intravenous;
Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
DIN: 02241229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64837
SOLU-MEDROL;
methylprednisolone (methylprednisolone sodium succinate) 1 g / vial;
2012-02-07;
Intramuscular , Intravenous;
Kit , Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 02367971
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85280
SOLU-MEDROL;
methylprednisolone (methylprednisolone sodium succinate) 125 mg / vial;
2012-01-18;
Intramuscular , Intravenous;
Kit , Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 02367955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85278
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION;
methylprednisolone (methylprednisolone sodium succinate) 40 mg / vial;
2000-03-01;
Intramuscular , Intravenous;
Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
DIN: 02231893
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51346
SOLU-MEDROL;
methylprednisolone (methylprednisolone sodium succinate) 40 mg / vial;
2012-01-11;
Intramuscular , Intravenous;
Kit , Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 02367947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85277
SOLU-MEDROL;
methylprednisolone (methylprednisolone sodium succinate) 500 mg / vial;
1970-12-31;
Intramuscular , Intravenous;
Kit , Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030678
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1132
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION;
methylprednisolone (methylprednisolone sodium succinate) 500 mg / vial;
2000-03-01;
Intramuscular , Intravenous;
Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
DIN: 02231895
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51348
SOLU-MEDROL;
methylprednisolone (methylprednisolone sodium succinate) 500 mg / vial;
2012-01-18;
Intramuscular , Intravenous;
Kit , Powder For Solution;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 02367963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85279
MEDROL 16 MG;
methylprednisolone 16 mg;
1968-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00036129
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1396
MEDROL 4 MG;
methylprednisolone 4 mg;
1960-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030988
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1397
DEPO-MEDROL (WITH PRESERVATIVE) 20 MG/ML;
methylprednisolone acetate 20 mg / ml;
1995-12-31;
Intra-Articular , Intralesional , Intramuscular , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 01934325
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18988
DEPO-MEDROL 40 MG/ML;
methylprednisolone acetate 40 mg / ml;
1960-12-31;
Intra-Articular , Intralesional , Intramuscular , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030759
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1134
DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML;
methylprednisolone acetate 40 mg / ml;
1994-12-31;
Intra-Articular , Intralesional , Intramuscular , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 01934333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16275
DEPO-MEDROL 80 MG/ML;
methylprednisolone acetate 80 mg / ml;
1969-12-31;
Intra-Articular , Intralesional , Intramuscular , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 00030767
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=789
DEPO-MEDROL (WITH PRESERVATIVE) 80 MG/ML;
methylprednisolone acetate 80 mg / ml;
1994-12-31;
Intra-Articular , Intralesional , Intramuscular , Intrasynovial;
Suspension;
68:04.00 – ADRENALS;
Prescription;
PFIZER CANADA ULC
DIN: 01934341
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16276
METONIA;
metoclopramide hydrochloride 5 mg;
1998-04-16;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02230431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49332
METOCLOPRAMIDE HYDROCHLORIDE INJECTION;
metoclopramide hydrochloride 5 mg / ml;
1995-12-31;
Intramuscular , Intravenous;
Liquid;
56:32.00 – PROKINETIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02185431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19409
METOCLOPRAMIDE OMEGA;
metoclopramide hydrochloride 5 mg / ml;
2001-04-30;
Intramuscular , Intravenous;
Liquid;
56:32.00 – PROKINETIC AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02243563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67481
METONIA;
metoclopramide hydrochloride 5 mg / 5 ml;
1997-02-25;
Oral;
Solution;
56:32.00 – PROKINETIC AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 02230433
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49340
ZAROXOLYN;
metolazone 2.5 mg;
1974-12-31;
Oral;
Tablet;
40:28.24 – THIAZIDE-LIKE DIURETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 00888400
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13126
METOPROLOL TARTRATE INJECTION USP;
metoprolol tartrate 1 mg / ml;
2019-07-08;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JUNO PHARMACEUTICALS CORP.
DIN: 02474271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96432
METOPROLOL TARTRATE INJECTION USP;
metoprolol tartrate 1 mg / 1 ml;
2005-07-20;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02267853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75326
APO-METOPROLOL;
metoprolol tartrate 100 mg;
1984-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00618640
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5819
LOPRESOR SR 100MG;
metoprolol tartrate 100 mg;
1985-12-31;
Oral;
Tablet (Extended-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00658855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6311
METOPROLOL-100;
metoprolol tartrate 100 mg;
1985-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 00648027
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6513
TEVA-METOPROLOL;
metoprolol tartrate 100 mg;
1986-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00648043
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6612
APO-METOPROLOL (TYPE L);
metoprolol tartrate 100 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00751170
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8602
TEVA-METOPROLOL;
metoprolol tartrate 100 mg;
1989-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00842656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9887
PMS-METOPROLOL-L;
metoprolol tartrate 100 mg;
1998-04-16;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02230804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50068
APO-METOPROLOL SR;
metoprolol tartrate 100 mg;
2007-07-30;
Oral;
Tablet (Extended-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02285169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77067
SANDOZ METOPROLOL SR;
metoprolol tartrate 100 mg;
2007-12-13;
Oral;
Tablet (Extended-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02303396
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78871
RIVA-METOPROLOL-L;
metoprolol tartrate 100 mg;
2008-09-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02315327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80087
METOPROLOL;
metoprolol tartrate 100 mg;
2010-05-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350408
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83561
METOPROLOL SR;
metoprolol tartrate 100 mg;
2010-10-15;
Oral;
Tablet (Extended-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02351404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83667
JAMP-METOPROLOL-L;
metoprolol tartrate 100 mg;
2010-10-21;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02356848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84196
METOPROLOL-L;
metoprolol tartrate 100 mg;
2015-07-09;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02442132
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92649
AG-METOPROLOL-L;
metoprolol tartrate 100 mg;
2018-12-27;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481324
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97181
LOPRESOR SR 200 MG;
metoprolol tartrate 200 mg;
1983-12-31;
Oral;
Tablet (Extended-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00534560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5091
SANDOZ METOPROLOL SR;
metoprolol tartrate 200 mg;
2007-12-13;
Oral;
Tablet (Extended-Release);
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02303418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78872
APO-METOPROLOL;
metoprolol tartrate 25 mg;
2002-10-08;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 02246010
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70136
PMS-METOPROLOL-L;
metoprolol tartrate 25 mg;
2004-03-19;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02248855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73226
TEVA-METOPROLOL;
metoprolol tartrate 25 mg;
2012-02-15;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02261898
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74725
METOPROLOL – 25;
metoprolol tartrate 25 mg;
2007-10-26;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02296713
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78208
RIVA-METOPROLOL-L;
metoprolol tartrate 25 mg;
2008-09-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02315300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80085
JAMP-METOPROLOL-L;
metoprolol tartrate 25 mg;
2010-10-21;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02356813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84194
AG-METOPROLOL-L;
metoprolol tartrate 25 mg;
2018-12-27;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481308
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97179
APO-METOPROLOL;
metoprolol tartrate 50 mg;
1984-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00618632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5818
METOPROLOL-50;
metoprolol tartrate 50 mg;
1985-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 00648019
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6512
TEVA-METOPROLOL;
metoprolol tartrate 50 mg;
1986-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00648035
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6611
APO-METOPROLOL (TYPE L);
metoprolol tartrate 50 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00749354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8603
TEVA-METOPROLOL;
metoprolol tartrate 50 mg;
1989-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00842648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9886
PMS-METOPROLOL-L;
metoprolol tartrate 50 mg;
1998-04-16;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
PHARMASCIENCE INC
DIN: 02230803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50067
RIVA-METOPROLOL-L;
metoprolol tartrate 50 mg;
2008-09-10;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02315319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80086
METOPROLOL;
metoprolol tartrate 50 mg;
2010-05-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83560
JAMP-METOPROLOL-L;
metoprolol tartrate 50 mg;
2010-10-21;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02356821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84195
METOPROLOL-L;
metoprolol tartrate 50 mg;
2015-07-09;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02442124
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92648
AG-METOPROLOL-L;
metoprolol tartrate 50 mg;
2018-12-27;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ANGITA PHARMA INC.
DIN: 02481316
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97180
METROGEL 0.75%;
metronidazole 0.75 %;
1994-12-31;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
GALDERMA CANADA INC
DIN: 02092832
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17824
NIDAGEL VAGINAL GEL 0.75%;
metronidazole 0.75 % / w/w;
1994-12-31;
Vaginal;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
VALEANT CANADA LP / VALEANT CANADA S.E.C.
DIN: 02125226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16852
METROGEL 1%;
metronidazole 1 %;
2007-12-20;
Topical;
Gel;
84:04.04 – ANTIBIOTICS;
Prescription;
GALDERMA CANADA INC
DIN: 02297809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78314
NORITATE;
metronidazole 1 % / w/w;
1995-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02156091
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19257
FLAGYL;
metronidazole 10 %;
1970-12-31;
Vaginal;
Cream;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Prescription;
SANOFI-AVENTIS CANADA INC
DIN: 01926861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12997
METRONIDAZOLE;
metronidazole 250 mg;
1982-12-31;
Oral;
Tablet;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
AA PHARMA INC
DIN: 00545066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4902
METRONIDAZOLE INJECTION USP;
metronidazole 5 mg / ml;
1987-12-31;
Intravenous;
Solution;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
PFIZER CANADA ULC
DIN: 00649074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7425
METRONIDAZOLE INJECTION, USP;
metronidazole 5 mg / ml;
1990-12-31;
Intravenous;
Solution;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
BAXTER CORPORATION
DIN: 00870420
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10871
PMS-METRONIDAZOLE;
metronidazole 500 mg;
1989-12-31;
Oral;
Capsule;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
PHARMASCIENCE INC
DIN: 00783137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9910
FLAGYL;
metronidazole 500 mg;
1979-12-31;
Oral;
Capsule;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
ODAN LABORATORIES LTD
DIN: 01926853
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12221
APO-METRONIDAZOLE;
metronidazole 500 mg;
2003-11-27;
Oral;
Capsule;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
APOTEX INC
DIN: 02248562
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72917
AURO-METRONIDAZOLE;
metronidazole 500 mg;
2018-04-03;
Oral;
Capsule;
08:30.92 – MISCELLANEOUS ANTIPROTOZOALS;
Prescription;
AURO PHARMA INC
DIN: 02470284
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95926
TEVA-MEXILETINE;
mexiletine hydrochloride 100 mg;
1997-03-17;
Oral;
Capsule;
24:04.04.08 – CLASS IB ANTIARRYTHMICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02230359
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49155
TEVA-MEXILETINE;
mexiletine hydrochloride 200 mg;
1997-02-17;
Oral;
Capsule;
24:04.04.08 – CLASS IB ANTIARRYTHMICS;
Prescription;
TEVA CANADA LIMITED
DIN: 02230360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49157
MYCAMINE;
micafungin sodium 100 mg / vial;
2009-12-17;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02311054
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79665
MYCAMINE;
micafungin sodium 50 mg / vial;
2007-09-18;
Intravenous;
Powder For Solution;
08:14.16 – ECHINOCANDINS;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02294222
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77957
MONISTAT 1 VAGINAL OVULE;
miconazole nitrate 1200 mg;
1999-02-26;
Vaginal;
Suppository;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02239601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63071
MONISTAT 7 VAGINAL CREAM;
miconazole nitrate 2 %;
1978-12-31;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02084309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16608
MONISTAT DERM CREAM;
miconazole nitrate 2 %;
1980-12-31;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02126567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17832
MICATIN POWDER SPRAY – UNSCENTED 2%;
miconazole nitrate 2 %;
1997-06-16;
Topical;
Aerosol;
84:04.08.08 – AZOLES;
Otc;
WELLSPRING PHARMACEUTICAL CANADA CORP
DIN: 02230304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49064
MICOZOLE;
miconazole nitrate 2 %;
1997-08-11;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02231106
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50390
MICONAZOLE NITRATE VAGINAL CREAM USP, 2%;
miconazole nitrate 2 %;
1997-08-12;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02231533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50876
MICONAZOLE NITRATE VAGINAL CREAM 2%;
miconazole nitrate 2 %;
2003-03-13;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02245546
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69637
MICATIN MICONAZOLE NITRATE CREAM 2% USP;
miconazole nitrate 2 % / w/w;
1974-12-31;
Topical;
Cream;
84:04.08.08 – AZOLES;
Otc;
WELLSPRING PHARMACEUTICAL CANADA CORP
DIN: 02085852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16609
MONISTAT 3 VAGINAL CREAM;
miconazole nitrate 4 %;
2001-10-10;
Vaginal;
Cream;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02244005
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67948
MONISTAT 3 VAGINAL OVULES;
miconazole nitrate 400 mg;
1981-12-31;
Vaginal;
Ovule;
84:04.08.08 – AZOLES;
Otc;
INSIGHT PHARMACEUTICALS, LLC
DIN: 02126605
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16612
MICONAZOLE 3 DAY OVULE TREATMENT 400MG;
miconazole nitrate 400 mg;
1996-12-31;
Vaginal;
Suppository;
84:04.08.08 – AZOLES;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02171775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19677
MIDAZOLAM INJECTION;
midazolam 1 mg / ml;
1999-07-21;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANDOZ CANADA INCORPORATED
DIN: 02240285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63823
MIDAZOLAM INJECTION;
midazolam 1 mg / ml;
2001-03-26;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
FRESENIUS KABI CANADA LTD
DIN: 02242904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66736
MIDAZOLAM INJECTION USP;
midazolam 1 mg / ml;
2015-03-30;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02382342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86819
MIDAZOLAM INJECTION USP;
midazolam 1 mg / ml;
2016-06-15;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02382377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86822
MIDAZOLAM INJECTION;
midazolam 1 mg / ml;
2015-03-31;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02423758
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90845
MIDAZOLAM INJECTION USP;
midazolam 1 mg / ml;
2020-10-26;
Intravenous;
Solution;
-;
Targeted (Cdsa Iv);
STERINOVA INC.
DIN: 02498022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98782
MIDAZOLAM INJECTION;
midazolam 5 mg / ml;
1999-07-21;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANDOZ CANADA INCORPORATED
DIN: 02240286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63824
MIDAZOLAM INJECTION;
midazolam 5 mg / ml;
2001-03-26;
Intramuscular , Intravenous;
Liquid;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
FRESENIUS KABI CANADA LTD
DIN: 02242905
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66737
MIDAZOLAM INJECTION USP;
midazolam 5 mg / ml;
2016-02-09;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02382350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86821
MIDAZOLAM INJECTION USP;
midazolam 5 mg / ml;
2016-02-16;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
PFIZER CANADA ULC
DIN: 02382385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86823
APO-MIDODRINE;
midodrine hydrochloride 2.5 mg;
2006-06-13;
Oral;
Tablet;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
APOTEX INC
DIN: 02278677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76425
MAR-MIDODRINE;
midodrine hydrochloride 2.5 mg;
2018-08-03;
Oral;
Tablet;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02473984
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96400
APO-MIDODRINE;
midodrine hydrochloride 5 mg;
2006-06-13;
Oral;
Tablet;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
APOTEX INC
DIN: 02278685
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76426
MAR-MIDODRINE;
midodrine hydrochloride 5 mg;
2018-08-03;
Oral;
Tablet;
12:12.04 – ALPHA-ADRENERGIC AGONISTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02473992
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96401
GALAFOLD;
migalastat (migalastat hydrochloride) 123 mg;
2018-01-15;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
AMICUS THERAPEUTICS UK LTD
DIN: 02468042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95640
ZAVESCA;
miglustat 100 mg;
2004-05-26;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
JANSSEN INC
DIN: 02250519
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73533
SANDOZ MIGLUSTAT;
miglustat 100 mg;
2020-04-20;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02456257
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94314
MILRINONE LACTATE INJECTION, USP;
milrinone (milrinone lactate) 1 mg / ml;
2003-07-03;
Intravenous;
Solution;
24:04.08 – CARDIOTONIC AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02244622
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68609
MILRINONE LACTATE INJECTION;
milrinone (milrinone lactate) 1 mg / ml;
2003-06-25;
Intravenous;
Solution;
24:04.08 – CARDIOTONIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02244854
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68844
MILRINONE LACTATE INJECTION;
milrinone (milrinone lactate) 1 mg / ml;
2018-12-24;
Intravenous;
Solution;
24:04.08 – CARDIOTONIC AGENTS;
Prescription;
AURO PHARMA INC
DIN: 02470047
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95899
FLEET ENEMA MINERAL OIL;
mineral oil 100 %;
1969-12-31;
Rectal;
Enema;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
C B FLEET COMPANY INC
DIN: 00107875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=721
MINERAL OIL (HEAVY);
mineral oil 100 %;
1991-12-31;
Oral;
Liquid;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
RW CONSUMER PRODUCTS LTD
DIN: 01935348
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11629
MINERAL OIL;
mineral oil 100 %;
1981-12-31;
Oral;
Liquid;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
DIN: 00485802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41536
HUILE MINERALE LOURDE LIQ 100% USP;
mineral oil 100 %;
1951-12-31;
Oral;
Liquid;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
LABORATOIRE ATLAS INC
DIN: 00704172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41698
EUCERIN AQUAPHOR HEALING OINTMENT;
mineral oil 52.74 % / w/w;
2020-09-18;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
BEIERSDORF CANADA INC
DIN: 02446189
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93145
LANSOYL GEL 78%;
mineral oil 78 %;
1975-12-31;
Oral;
Gel;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
AURIUM PHARMA INC.
DIN: 00608734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5792
LANSOYL SUGAR FREE – JELLY – 78%;
mineral oil 78 %;
1996-12-31;
Oral;
Gel;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
AURIUM PHARMA INC.
DIN: 02186926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20312
MINERAL OIL USP;
mineral oil 99.9 % / w/w;
2013-02-07;
Oral;
Solution;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
VI-JON, LLC
DIN: 02381834
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86767
MINERALE LEGERE HUILE;
mineral oil light 100 %;
1951-12-31;
Topical;
Liquid;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
LABORATOIRE ATLAS INC
DIN: 00050520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=57
LIGHT MINERAL OIL 100% NF;
mineral oil light 100 %;
1993-12-31;
Topical;
Liquid;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
RW CONSUMER PRODUCTS LTD
DIN: 01935321
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14042
STERILE LIGHT MINERAL OIL 100%;
mineral oil light 100 % / v/v;
2001-07-27;
Topical;
Oil;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
OMEGA LABORATORIES LTD
DIN: 02203375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36404
ARESTIN MICROSPHERES;
minocycline (minocycline hydrochloride) 1 mg / 4 mg;
2008-07-27;
Subgingival;
Powder (Extended Release);
52:04.04 – ANTIBACTERIALS;
Prescription;
ORAPHARMA INC
DIN: 02278219
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76380
MINOCYCLINE;
minocycline (minocycline hydrochloride) 100 mg;
1994-12-31;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
AA PHARMA INC
DIN: 02084104
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15925
MINOCYCLINE;
minocycline (minocycline hydrochloride) 50 mg;
1994-12-31;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
AA PHARMA INC
DIN: 02084090
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15927
LONITEN 10MG;
minoxidil 10 mg;
1980-12-31;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
PFIZER CANADA ULC
DIN: 00514500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4010
LONITEN 2.5MG;
minoxidil 2.5 mg;
1980-12-31;
Oral;
Tablet;
24:08.20 – DIRECT VASODILATORS;
Prescription;
PFIZER CANADA ULC
DIN: 00514497
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4011
MEN’S ROGAINE;
minoxidil 20 mg / ml;
1986-12-31;
Topical;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 00708925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7084
HAIR REGROWTH FORMULA;
minoxidil 20 mg / ml;
2011-04-15;
Topical;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Otc;
VITA HEALTH PRODUCTS INC
DIN: 02356597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84173
MEN’S ROGAINE FOAM 5%;
minoxidil 5 % / w/w;
2012-11-19;
Topical;
Aerosol, Foam;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02368684
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85367
WOMEN’S ROGAINE FOAM 5%;
minoxidil 5 % / w/w;
2015-03-16;
Topical;
Aerosol, Foam;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Otc;
JOHNSON & JOHNSON INC
DIN: 02424703
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90937
MYRBETRIQ;
mirabegron 25 mg;
2013-03-28;
Oral;
Tablet (Extended-Release);
86:12.08.12 – Selective Beta 3-Adrenergic Agonists;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02402874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88770
MYRBETRIQ;
mirabegron 50 mg;
2013-03-28;
Oral;
Tablet (Extended-Release);
86:12.08.12 – Selective Beta 3-Adrenergic Agonists;
Prescription;
ASTELLAS PHARMA CANADA INC
DIN: 02402882
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88771
REMERON RD;
mirtazapine 15 mg;
2003-12-22;
Oral;
Tablet (Orally Disintegrating);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ORGANON CANADA INC.
DIN: 02248542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72897
SANDOZ MIRTAZAPINE;
mirtazapine 15 mg;
2004-03-31;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02250594
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73540
MYLAN-MIRTAZAPINE;
mirtazapine 15 mg;
2004-08-17;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02256096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74133
PMS-MIRTAZAPINE;
mirtazapine 15 mg;
2005-11-30;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02273942
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75940
APO-MIRTAZAPINE;
mirtazapine 15 mg;
2006-10-04;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
DIN: 02286610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77206
AURO-MIRTAZAPINE OD;
mirtazapine 15 mg;
2010-12-20;
Oral;
Tablet (Orally Disintegrating);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
AURO PHARMA INC
DIN: 02299801
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78516
PRO-MIRTAZAPINE;
mirtazapine 15 mg;
2008-07-10;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02312778
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79829
AURO-MIRTAZAPINE;
mirtazapine 15 mg;
2013-10-16;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
AURO PHARMA INC
DIN: 02411695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89629
MIRTAZAPINE;
mirtazapine 15 mg;
2020-10-22;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02496666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98652
REMERON;
mirtazapine 30 mg;
2001-05-24;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ORGANON CANADA INC.
DIN: 02243910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67852
REMERON RD;
mirtazapine 30 mg;
2003-12-22;
Oral;
Tablet (Orally Disintegrating);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ORGANON CANADA INC.
DIN: 02248543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72898
PMS-MIRTAZAPINE;
mirtazapine 30 mg;
2004-01-14;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
PHARMASCIENCE INC
DIN: 02248762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73130
SANDOZ MIRTAZAPINE;
mirtazapine 30 mg;
2004-03-31;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02250608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73541
MYLAN-MIRTAZAPINE;
mirtazapine 30 mg;
2004-08-17;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02256118
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74134
TEVA-MIRTAZAPINE;
mirtazapine 30 mg;
2005-10-22;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02259354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74461
APO-MIRTAZAPINE;
mirtazapine 30 mg;
2006-10-04;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
DIN: 02286629
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77207
AURO-MIRTAZAPINE OD;
mirtazapine 30 mg;
2010-12-20;
Oral;
Tablet (Orally Disintegrating);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
AURO PHARMA INC
DIN: 02299828
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78517
PRO-MIRTAZAPINE;
mirtazapine 30 mg;
2008-07-10;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
PRO DOC LIMITEE
DIN: 02312786
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79830
MIRTAZAPINE;
mirtazapine 30 mg;
2011-09-21;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SANIS HEALTH INC
DIN: 02370689
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85581
AURO-MIRTAZAPINE;
mirtazapine 30 mg;
2013-10-16;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
AURO PHARMA INC
DIN: 02411709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89630
MIRTAZAPINE;
mirtazapine 30 mg;
2020-10-22;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02496674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98653
REMERON RD;
mirtazapine 45 mg;
2003-12-22;
Oral;
Tablet (Orally Disintegrating);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
ORGANON CANADA INC.
DIN: 02248544
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72899
MYLAN-MIRTAZAPINE;
mirtazapine 45 mg;
2004-08-17;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02256126
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74135
APO-MIRTAZAPINE;
mirtazapine 45 mg;
2006-10-04;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
APOTEX INC
DIN: 02286637
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77208
AURO-MIRTAZAPINE OD;
mirtazapine 45 mg;
2010-12-20;
Oral;
Tablet (Orally Disintegrating);
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
AURO PHARMA INC
DIN: 02299836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78518
AURO-MIRTAZAPINE;
mirtazapine 45 mg;
2013-10-16;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
AURO PHARMA INC
DIN: 02411717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89632
MIRTAZAPINE;
mirtazapine 45 mg;
2020-10-22;
Oral;
Tablet;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02496682
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98654
MISOPROSTOL;
misoprostol 100 mcg;
2001-06-18;
Oral;
Tablet;
56:28.28 – PROSTAGLANDINS;
Prescription;
AA PHARMA INC
DIN: 02244022
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67965
MISOPROSTOL;
misoprostol 200 mcg;
2001-06-18;
Oral;
Tablet;
56:28.28 – PROSTAGLANDINS;
Prescription;
AA PHARMA INC
DIN: 02244023
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67966
MITOMYCIN FOR INJECTION;
mitomycin 20 mg / vial;
1997-10-22;
Intravenous , Intravesical;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02230451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49400
MITOMYCIN FOR INJECTION USP;
mitomycin 20 mg / vial;
2018-04-30;
Intravenous , Intravesical;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02464691
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95282
LYSODREN;
mitotane 500 mg;
1979-12-31;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HRA PHARMA RARE DISEASES
DIN: 00463221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3348
MITOXANTRONE INJECTION;
mitoxantrone (mitoxantrone hydrochloride) 2 mg / ml;
2007-12-03;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02286300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77176
ADDERALL XR;
mixed salts amphetamine 10 mg;
2004-01-30;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02248809
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73178
ACT AMPHETAMINE XR;
mixed salts amphetamine 10 mg;
2015-10-02;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
DIN: 02439247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92363
APO-AMPHETAMINE XR;
mixed salts amphetamine 10 mg;
2019-04-15;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
APOTEX INC
DIN: 02445506
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93078
SANDOZ AMPHETAMINE XR;
mixed salts amphetamine 10 mg;
2016-12-22;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02457296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94436
ADDERALL XR;
mixed salts amphetamine 15 mg;
2004-01-30;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02248810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73179
ACT AMPHETAMINE XR;
mixed salts amphetamine 15 mg;
2015-10-02;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
DIN: 02439255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92364
APO-AMPHETAMINE XR;
mixed salts amphetamine 15 mg;
2019-04-15;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
APOTEX INC
DIN: 02445514
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93079
SANDOZ AMPHETAMINE XR;
mixed salts amphetamine 15 mg;
2016-12-22;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02457318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94437
ADDERALL XR;
mixed salts amphetamine 20 mg;
2004-01-30;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02248811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73180
ACT AMPHETAMINE XR;
mixed salts amphetamine 20 mg;
2015-10-02;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
DIN: 02439263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92365
APO-AMPHETAMINE XR;
mixed salts amphetamine 20 mg;
2019-04-26;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
APOTEX INC
DIN: 02445522
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93080
SANDOZ AMPHETAMINE XR;
mixed salts amphetamine 20 mg;
2016-12-22;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02457326
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94438
ADDERALL XR;
mixed salts amphetamine 25 mg;
2004-01-30;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02248812
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73181
ACT AMPHETAMINE XR;
mixed salts amphetamine 25 mg;
2015-10-02;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
DIN: 02439271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92366
APO-AMPHETAMINE XR;
mixed salts amphetamine 25 mg;
2019-04-15;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
APOTEX INC
DIN: 02445530
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93081
SANDOZ AMPHETAMINE XR;
mixed salts amphetamine 25 mg;
2016-12-22;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02457334
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94439
ADDERALL XR;
mixed salts amphetamine 30 mg;
2004-01-30;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02248813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73182
ACT AMPHETAMINE XR;
mixed salts amphetamine 30 mg;
2015-10-02;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
DIN: 02439298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92367
APO-AMPHETAMINE XR;
mixed salts amphetamine 30 mg;
2019-04-15;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
APOTEX INC
DIN: 02445549
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93082
SANDOZ AMPHETAMINE XR;
mixed salts amphetamine 30 mg;
2016-12-22;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02457342
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94440
ADDERALL XR;
mixed salts amphetamine 5 mg;
2004-01-30;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TAKEDA CANADA INC
DIN: 02248808
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73177
ACT AMPHETAMINE XR;
mixed salts amphetamine 5 mg;
2015-10-02;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
DIN: 02439239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92362
APO-AMPHETAMINE XR;
mixed salts amphetamine 5 mg;
2019-04-15;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
APOTEX INC
DIN: 02445492
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93077
SANDOZ AMPHETAMINE XR;
mixed salts amphetamine 5 mg;
2016-12-22;
Oral;
Capsule (Extended Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02457288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94435
MOCLOBEMIDE;
moclobemide 100 mg;
1997-09-18;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02232148
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51594
MANERIX;
moclobemide 150 mg;
1992-12-31;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 00899356
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13256
MOCLOBEMIDE;
moclobemide 150 mg;
1997-09-18;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02232150
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51595
MANERIX;
moclobemide 300 mg;
1995-12-31;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
BAUSCH HEALTH, CANADA INC.
DIN: 02166747
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18969
MOCLOBEMIDE;
moclobemide 300 mg;
1999-07-14;
Oral;
Tablet;
28:16.04.12 – MONOAMINE OXIDASE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 02240456
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64019
ALERTEC;
modafinil 100 mg;
1999-03-24;
Oral;
Tablet;
28:20.80 – Wakefulness-Promoting Agents;
Prescription;
TEVA CANADA LIMITED
DIN: 02239665
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63139
APO-MODAFINIL;
modafinil 100 mg;
2008-05-01;
Oral;
Tablet;
28:20.80 – Wakefulness-Promoting Agents;
Prescription;
APOTEX INC
DIN: 02285398
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77089
TEVA-MODAFINIL;
modafinil 100 mg;
2014-07-02;
Oral;
Tablet;
28:20.80 – Wakefulness-Promoting Agents;
Prescription;
TEVA CANADA LIMITED
DIN: 02420260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90485
AURO-MODAFINIL;
modafinil 100 mg;
2014-10-24;
Oral;
Tablet;
28:20.80 – Wakefulness-Promoting Agents;
Prescription;
AURO PHARMA INC
DIN: 02430487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91494
MAR-MODAFINIL;
modafinil 100 mg;
2015-01-09;
Oral;
Tablet;
28:20.80 – Wakefulness-Promoting Agents;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02432560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91701
JAMP MODAFINIL;
modafinil 100 mg;
2021-03-11;
Oral;
Tablet;
28:20.80 – Wakefulness-Promoting Agents;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02503727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99317
IMVAMUNE;
modified vaccinia virus (ankara-bavarian nordic) 50000000 ccid50 / 0.5 ml;
2015-06-15;
Subcutaneous;
Suspension;
80:12.00 – VACCINES;
Schedule D;
BAVARIAN NORDIC AS
DIN: 02416638
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90121
SANDOZ MOMETASONE;
mometasone furoate (mometasone furoate monohydrate) 50 mcg / act;
2016-07-27;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02449811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93568
ELOCOM;
mometasone furoate 0.1 %;
1991-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ORGANON CANADA INC.
DIN: 00851744
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11196
ELOCOM;
mometasone furoate 0.1 %;
1991-12-31;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ORGANON CANADA INC.
DIN: 00871095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11443
ELOCOM;
mometasone furoate 0.1 %;
1991-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
ORGANON CANADA INC.
DIN: 00851736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11444
TEVA-MOMETASONE;
mometasone furoate 0.1 %;
2003-11-04;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02248130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72459
TARO-MOMETASONE LOTION;
mometasone furoate 0.1 % / w/w;
2009-12-01;
Topical;
Lotion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02266385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75180
TARO-MOMETASONE CREAM;
mometasone furoate 0.1 % / w/w;
2011-06-08;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 02367157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85196
ASMANEX TWISTHALER;
mometasone furoate 100 mcg / act;
2015-04-08;
Inhalation;
Powder;
68:04.00 – ADRENALS;
Prescription;
ORGANON CANADA INC.
DIN: 02438690
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92309
ASMANEX TWISTHALER;
mometasone furoate 200 mcg / act;
2011-12-21;
Inhalation;
Powder;
68:04.00 – ADRENALS;
Prescription;
ORGANON CANADA INC.
DIN: 02243595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67513
ASMANEX TWISTHALER;
mometasone furoate 400 mcg / act;
2011-12-21;
Inhalation;
Powder;
68:04.00 – ADRENALS;
Prescription;
ORGANON CANADA INC.
DIN: 02243596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67514
NASONEX;
mometasone furoate 50 mcg / act;
1998-09-15;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
ORGANON CANADA INC.
DIN: 02238465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61885
APO-MOMETASONE;
mometasone furoate 50 mcg / act;
2013-03-25;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
APOTEX INC
DIN: 02403587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88837
TEVA-MOMETASONE;
mometasone furoate 50 mcg / act;
2018-10-02;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
TEVA CANADA LIMITED
DIN: 02475863
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96662
SINGULAIR;
montelukast (montelukast sodium) 10 mg;
1998-08-21;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
ORGANON CANADA INC.
DIN: 02238217
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61610
SANDOZ MONTELUKAST TABLET;
montelukast (montelukast sodium) 10 mg;
2011-10-11;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02328593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81411
TEVA-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2011-10-11;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
TEVA CANADA LIMITED
DIN: 02355523
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84075
PMS-MONTELUKAST FC;
montelukast (montelukast sodium) 10 mg;
2011-10-11;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
PHARMASCIENCE INC
DIN: 02373947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85916
APO-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2012-01-20;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
APOTEX INC
DIN: 02374609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85993
ACH-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2012-03-28;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02379236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86511
MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2012-03-21;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SANIS HEALTH INC
DIN: 02379333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86521
MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2012-03-29;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
PRO DOC LIMITEE
DIN: 02379856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86571
MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2012-06-10;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02382474
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86831
TARO-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2013-01-17;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SUN PHARMA CANADA INC
DIN: 02389517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87502
JAMP-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2012-09-21;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02391422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87677
RIVA-MONTELUKAST FC;
montelukast (montelukast sodium) 10 mg;
2013-01-17;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
LABORATOIRE RIVA INC.
DIN: 02398826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88374
MAR-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2013-12-30;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02399997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88483
AURO-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2013-03-04;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
AURO PHARMA INC
DIN: 02401274
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88618
MINT-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2013-10-17;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02408643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89338
PRIVA-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2018-11-07;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
PHARMAPAR INC
DIN: 02440350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92471
BIO-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2018-11-07;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
BIOMED PHARMA
DIN: 02445735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93101
AG-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2019-12-10;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
ANGITA PHARMA INC.
DIN: 02482835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97324
M-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2019-12-13;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
MANTRA PHARMA INC
DIN: 02488183
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97829
NRA-MONTELUKAST;
montelukast (montelukast sodium) 10 mg;
2019-12-28;
Oral;
Tablet;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
NORA PHARMA INC
DIN: 02489821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97990
SINGULAIR;
montelukast (montelukast sodium) 4 mg;
2001-04-09;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
ORGANON CANADA INC.
DIN: 02243602
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67521
SANDOZ MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2011-10-11;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02330385
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81612
PMS-MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2011-10-11;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
PHARMASCIENCE INC
DIN: 02354977
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84016
TEVA-MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2011-10-11;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
TEVA CANADA LIMITED
DIN: 02355507
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84073
APO-MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2013-02-15;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
APOTEX INC
DIN: 02377608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86341
MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2012-03-29;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
PRO DOC LIMITEE
DIN: 02379821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86569
MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2012-06-10;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02382458
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86829
MAR-MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2013-12-30;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02399865
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88471
MINT-MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2013-10-17;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02408627
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89336
JAMP-MONTELUKAST;
montelukast (montelukast sodium) 4 mg;
2018-11-09;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02442353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92672
SINGULAIR;
montelukast (montelukast sodium) 4 mg / sachet;
2004-02-20;
Oral;
Granules;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
ORGANON CANADA INC.
DIN: 02247997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72310
SANDOZ MONTELUKAST GRANULES;
montelukast (montelukast sodium) 4 mg / sachet;
2011-10-11;
Oral;
Granules;
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02358611
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84365
SINGULAIR;
montelukast (montelukast sodium) 5 mg;
1998-08-21;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
ORGANON CANADA INC.
DIN: 02238216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61609
SANDOZ MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2011-10-11;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02330393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81613
PMS-MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2011-10-11;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
PHARMASCIENCE INC
DIN: 02354985
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84017
TEVA-MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2011-10-11;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
TEVA CANADA LIMITED
DIN: 02355515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84074
APO-MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2013-02-15;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
APOTEX INC
DIN: 02377616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86342
MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2012-03-29;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
PRO DOC LIMITEE
DIN: 02379848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86570
MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2012-06-10;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
SIVEM PHARMACEUTICALS ULC
DIN: 02382466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86830
MAR-MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2013-12-30;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02399873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88472
MINT-MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2013-10-17;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02408635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89337
JAMP-MONTELUKAST;
montelukast (montelukast sodium) 5 mg;
2018-11-09;
Oral;
Tablet (Chewable);
48:10.24 – LEUKOTRIENE MODIFIERS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02442361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92673
XYNTHA SOLOFUSE;
moroctocog alfa 1000 unit / syr;
2012-04-13;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
DIN: 02374072
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85927
XYNTHA SOLOFUSE;
moroctocog alfa 2000 unit / syr;
2012-05-08;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
DIN: 02374080
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85928
XYNTHA;
moroctocog alfa 250 unit / vial;
2009-01-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
DIN: 02309483
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79508
XYNTHA SOLOFUSE;
moroctocog alfa 3000 unit / syr;
2012-05-08;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
DIN: 02374099
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85929
XYNTHA SOLOFUSE;
moroctocog alfa 500 unit / syr;
2019-09-27;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
DIN: 02374064
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85926
XYNTHA;
moroctocog alfa 500 unit / vial;
2009-01-23;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
PFIZER CANADA ULC
DIN: 02309491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79509
DOLORAL 1;
morphine hydrochloride 1 mg / ml;
1985-12-31;
Oral;
Syrup;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
LABORATOIRE ATLAS INC
DIN: 00614491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6171
DOLORAL 5 SIROP 5MG/ML;
morphine hydrochloride 5 mg / ml;
1991-12-31;
Oral;
Syrup;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
LABORATOIRE ATLAS INC
DIN: 00614505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11597
MORPHINE LP EPIDURAL;
morphine sulfate 0.5 mg / ml;
1993-12-31;
Intravenous , Subcutaneous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02021056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13966
MORPHINE SULFATE INJECTION EPIDURAL;
morphine sulfate 0.5 mg / ml;
2021-05-21;
Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02498278
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98805
MORPHINE LP EPIDURAL;
morphine sulfate 1 mg / ml;
1993-12-31;
Intravenous , Subcutaneous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02021048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14020
MORPHINE SULFATE INJECTION EPIDURAL;
morphine sulfate 1 mg / ml;
2021-06-02;
Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02498286
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98806
STATEX TAB 10MG;
morphine sulfate 10 mg;
1985-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 00594644
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6754
MS.IR;
morphine sulfate 10 mg;
1993-12-31;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014211
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14144
M-ESLON;
morphine sulfate 10 mg;
1993-12-31;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ETHYPHARM INC
DIN: 02019930
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14543
KADIAN;
morphine sulfate 10 mg;
2001-12-11;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
BGP PHARMA ULC
DIN: 02242163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65841
MORPHINE SULFATE INJ 10MG/ML USP;
morphine sulfate 10 mg / ml;
1978-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00392588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3043
MORPHINE SULFATE INJECTION SDZ;
morphine sulfate 10 mg / ml;
2012-10-18;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02382997
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86878
MORPHINE SULFATE INJECTION BP;
morphine sulfate 10 mg / ml;
2018-09-21;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
DIN: 02474980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96526
MORPHINE SULFATE INJECTION;
morphine sulfate 10 mg / ml;
2021-04-29;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
JAMP PHARMA CORPORATION
DIN: 02500728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99037
MORPHINE SULFATE INJECTION, USP;
morphine sulfate 10 mg / 1 ml;
2019-12-17;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
FRESENIUS KABI CANADA LTD
DIN: 02482746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97315
MS CONTIN SRT 100MG;
morphine sulfate 100 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14178
M-ESLON;
morphine sulfate 100 mg;
1993-12-31;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ETHYPHARM INC
DIN: 02019965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14541
KADIAN;
morphine sulfate 100 mg;
1996-10-25;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
BGP PHARMA ULC
DIN: 02184451
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42848
TEVA-MORPHINE SR;
morphine sulfate 100 mg;
2008-04-01;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02302799
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78811
SANDOZ MORPHINE SR;
morphine sulfate 100 mg;
2018-12-19;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02478889
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96959
MORPHINE SULFATE INJECTION USP;
morphine sulfate 100 mg / 100 ml;
2020-08-25;
Intravenous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERINOVA INC.
DIN: 02491931
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98194
MS CONTIN SRT 15MG;
morphine sulfate 15 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02015439
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14395
M-ESLON;
morphine sulfate 15 mg;
1995-12-31;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ETHYPHARM INC
DIN: 02177749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18878
SANDOZ MORPHINE SR;
morphine sulfate 15 mg;
2001-11-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02244790
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68780
TEVA-MORPHINE SR;
morphine sulfate 15 mg;
2009-03-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02302764
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78808
MORPHINE SULFATE INJ 15MG/ML USP;
morphine sulfate 15 mg / ml;
1978-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00392561
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3042
MORPHINE SULFATE INJECTION;
morphine sulfate 15 mg / ml;
2021-04-29;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
JAMP PHARMA CORPORATION
DIN: 02500736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99038
MORPHINE SULFATE INJECTION USP;
morphine sulfate 2 mg / ml;
2000-12-12;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02242484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66221
MORPHINE SULFATE INJECTION;
morphine sulfate 2 mg / ml;
2021-04-29;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
JAMP PHARMA CORPORATION
DIN: 02500701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99036
MORPHINE SULFATE INJECTION, USP;
morphine sulfate 2 mg / 1 ml;
2019-12-17;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
FRESENIUS KABI CANADA LTD
DIN: 02482681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97311
STATEX SUPPOSITORIES 20MG;
morphine sulfate 20 mg;
1985-12-31;
Rectal;
Suppository;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 00596965
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6129
MS.IR;
morphine sulfate 20 mg;
1991-12-31;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16480
KADIAN;
morphine sulfate 20 mg;
1996-10-25;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
BGP PHARMA ULC
DIN: 02184435
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42846
MS CONTIN SRT 200MG;
morphine sulfate 200 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014327
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14142
M-ESLON;
morphine sulfate 200 mg;
1995-12-31;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ETHYPHARM INC
DIN: 02177757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18877
TEVA-MORPHINE SR;
morphine sulfate 200 mg;
2008-04-01;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02302802
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78812
SANDOZ MORPHINE SR;
morphine sulfate 200 mg;
2018-12-19;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02478897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96961
STATEX TABLET 25MG;
morphine sulfate 25 mg;
1985-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 00594636
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6753
MS CONTIN SRT 30MG;
morphine sulfate 30 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14176
M-ESLON;
morphine sulfate 30 mg;
1993-12-31;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ETHYPHARM INC
DIN: 02019949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14502
MS.IR;
morphine sulfate 30 mg;
1991-12-31;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014254
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16481
STATEX SUPPOSITORIES 30MG;
morphine sulfate 30 mg;
1997-08-04;
Rectal;
Suppository;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 00639389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51392
SANDOZ MORPHINE SR;
morphine sulfate 30 mg;
2001-11-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02244791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68781
TEVA-MORPHINE SR;
morphine sulfate 30 mg;
2009-03-25;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02302772
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78809
STATEX TAB 5MG;
morphine sulfate 5 mg;
1985-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 00594652
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6755
MS.IR;
morphine sulfate 5 mg;
1991-12-31;
Oral;
Tablet (Immediate Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014203
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16102
STATEX TABLETS 50MG;
morphine sulfate 50 mg;
1986-12-31;
Oral;
Tablet;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PALADIN LABS INC.
DIN: 00675962
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6757
KADIAN;
morphine sulfate 50 mg;
1996-10-23;
Oral;
Capsule (Sustained-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
BGP PHARMA ULC
DIN: 02184443
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42847
MORPHINE HP 50 – 50MG/ML USP;
morphine sulfate 50 mg / ml;
1987-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 00617288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7421
MS CONTIN SRT 60MG;
morphine sulfate 60 mg;
1993-12-31;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PURDUE PHARMA
DIN: 02014300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14394
M-ESLON;
morphine sulfate 60 mg;
1993-12-31;
Oral;
Capsule (Extended Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
ETHYPHARM INC
DIN: 02019957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14542
SANDOZ MORPHINE SR;
morphine sulfate 60 mg;
2001-11-14;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
DIN: 02244792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68782
TEVA-MORPHINE SR;
morphine sulfate 60 mg;
2008-04-01;
Oral;
Tablet (Extended-Release);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
DIN: 02302780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78810
VIGAMOX;
moxifloxacin (moxifloxacin hydrochloride) 0.5 %;
2004-05-12;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02252260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73714
SANDOZ MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 0.5 %;
2015-10-29;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02411520
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89614
PMS-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 0.5 %;
2015-12-21;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
PHARMASCIENCE INC
DIN: 02432218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91667
ACT MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 0.5 % / w/v;
2015-11-04;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
TEVA CANADA LIMITED
DIN: 02404656
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88945
APO-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 0.5 % / w/v;
2015-11-19;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
APOTEX INC
DIN: 02406373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89109
JAMP-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 0.5 % / w/v;
2019-02-28;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02472120
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96141
AG-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 0.5 % / w/v;
2020-07-09;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
ANGITA PHARMA INC.
DIN: 02484757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97504
TEVA-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2015-11-04;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
TEVA CANADA LIMITED
DIN: 02375702
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86112
SANDOZ MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2017-11-30;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02383381
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86914
APO-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2016-01-11;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
APOTEX INC
DIN: 02404923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88976
AURO-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2015-11-04;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
AURO PHARMA INC
DIN: 02432242
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91672
JAMP-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2015-11-04;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02443929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92870
MAR-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2015-12-21;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02447053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93263
BIO-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2016-01-15;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
BIOMED PHARMA
DIN: 02447266
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93281
MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2017-04-20;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
PRO DOC LIMITEE
DIN: 02462974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95086
M-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2018-03-07;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
MANTRA PHARMA INC
DIN: 02472791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96210
AG-MOXIFLOXACIN;
moxifloxacin (moxifloxacin hydrochloride) 400 mg;
2018-07-23;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
ANGITA PHARMA INC.
DIN: 02478137
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96886
MOXIFLOXACIN INJECTION;
moxifloxacin (moxifloxacin hydrochloride) 400 mg / 250 ml;
2017-08-16;
Intravenous;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
FRESENIUS KABI CANADA LTD
DIN: 02433087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91749
COVID-19 VACCINE MODERNA;
mrna-1273 sars-cov-2 100 mcg / 0.5 ml;
2020-12-23;
Intramuscular;
Dispersion;
-;
Covid-19 – Io – Authorization , Schedule D;
MODERNATX, INC.
DIN: 02510014
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99927
STRAMUCIN;
mupirocin (mupirocin calcium) 2 % / w/w;
2019-06-05;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Otc;
GLENMARK PHARMACEUTICALS CANADA INC.
DIN: 02483459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97385
TARO-MUPIROCIN;
mupirocin 2 %;
2006-07-10;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Otc;
TARO PHARMACEUTICALS INC
DIN: 02279983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76560
CELLCEPT I.V.;
mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg / vial;
1999-12-20;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02240347
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63885
MYCOPHENOLATE MOFETIL FOR INJECTION, USP;
mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg / vial;
2019-04-23;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02444836
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93003
MYCOPHENOLATE MOFETIL FOR INJECTION USP;
mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg / vial;
2018-11-07;
Intravenous;
Powder For Solution;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
STERIMAX INC
DIN: 02479974
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97053
CELLCEPT;
mycophenolate mofetil 200 mg / ml;
2002-08-27;
Oral;
Powder For Suspension;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02242145
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65823
CELLCEPT;
mycophenolate mofetil 250 mg;
1995-12-31;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02192748
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19525
SANDOZ MYCOPHENOLATE MOFETIL;
mycophenolate mofetil 250 mg;
2011-11-30;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02320630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80604
APO-MYCOPHENOLATE;
mycophenolate mofetil 250 mg;
2011-12-01;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
APOTEX INC
DIN: 02352559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83781
TEVA-MYCOPHENOLATE;
mycophenolate mofetil 250 mg;
2011-11-30;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02364883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84976
ACH-MYCOPHENOLATE;
mycophenolate mofetil 250 mg;
2012-05-01;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02383780
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86955
JAMP-MYCOPHENOLATE CAPSULES;
mycophenolate mofetil 250 mg;
2012-06-13;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02386399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87198
MYCOPHENOLATE MOFETIL;
mycophenolate mofetil 250 mg;
2016-09-29;
Oral;
Capsule;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02457369
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94442
CELLCEPT;
mycophenolate mofetil 500 mg;
1998-11-11;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
DIN: 02237484
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60818
SANDOZ MYCOPHENOLATE MOFETIL;
mycophenolate mofetil 500 mg;
2011-11-30;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02313855
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79937
TEVA-MYCOPHENOLATE;
mycophenolate mofetil 500 mg;
2011-11-30;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02348675
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83402
APO-MYCOPHENOLATE;
mycophenolate mofetil 500 mg;
2011-12-01;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
APOTEX INC
DIN: 02352567
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83782
MYCOPHENOLATE MOFETIL TABLETS, USP;
mycophenolate mofetil 500 mg;
2012-02-16;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
ACCORD HEALTHCARE INC
DIN: 02378574
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86436
JAMP-MYCOPHENOLATE;
mycophenolate mofetil 500 mg;
2012-03-23;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02380382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86619
MYCOPHENOLATE MOFETIL;
mycophenolate mofetil 500 mg;
2016-09-29;
Oral;
Tablet;
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02457377
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94443
MYFORTIC;
mycophenolic acid (mycophenolate sodium) 180 mg;
2005-02-11;
Oral;
Tablet (Enteric-Coated);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02264560
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75000
APO-MYCOPHENOLIC ACID;
mycophenolic acid (mycophenolate sodium) 180 mg;
2014-07-02;
Oral;
Tablet (Enteric-Coated);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
APOTEX INC
DIN: 02372738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85782
MAR-MYCOPHENOLIC ACID;
mycophenolic acid (mycophenolate sodium) 180 mg;
2021-04-07;
Oral;
Tablet (Enteric-Coated);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02511673
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100086
MYFORTIC;
mycophenolic acid (mycophenolate sodium) 360 mg;
2005-02-11;
Oral;
Tablet (Enteric-Coated);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02264579
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75001
APO-MYCOPHENOLIC ACID;
mycophenolic acid (mycophenolate sodium) 360 mg;
2014-07-02;
Oral;
Tablet (Enteric-Coated);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
APOTEX INC
DIN: 02372746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85783
MAR-MYCOPHENOLIC ACID;
mycophenolic acid (mycophenolate sodium) 360 mg;
2021-04-07;
Oral;
Tablet (Enteric-Coated);
92:44.00 – IMMUNOSUPPRESSIVE AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02511681
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100087
CESAMET;
nabilone 0.25 mg;
2008-09-12;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
BAUSCH HEALTH, CANADA INC.
DIN: 02312263
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79778
PMS-NABILONE;
nabilone 0.25 mg;
2021-01-22;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
PHARMASCIENCE INC
DIN: 02380897
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86665
TEVA-NABILONE;
nabilone 0.25 mg;
2013-05-27;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
TEVA CANADA LIMITED
DIN: 02392925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87819
CESAMET;
nabilone 0.5 mg;
2004-09-16;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
BAUSCH HEALTH, CANADA INC.
DIN: 02256193
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74143
PMS-NABILONE;
nabilone 0.5 mg;
2012-03-26;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
PHARMASCIENCE INC
DIN: 02380900
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86666
TEVA-NABILONE;
nabilone 0.5 mg;
2012-05-23;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
TEVA CANADA LIMITED
DIN: 02384884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87056
ACT NABILONE;
nabilone 0.5 mg;
2012-10-02;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
TEVA CANADA LIMITED
DIN: 02393581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87880
CESAMET;
nabilone 1 mg;
1982-12-31;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
BAUSCH HEALTH, CANADA INC.
DIN: 00548375
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4941
PMS-NABILONE;
nabilone 1 mg;
2012-03-26;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
PHARMASCIENCE INC
DIN: 02380919
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86667
TEVA-NABILONE;
nabilone 1 mg;
2012-05-23;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
TEVA CANADA LIMITED
DIN: 02384892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87057
ACT NABILONE;
nabilone 1 mg;
2012-10-02;
Oral;
Capsule;
56:22.92 – MISCELLANEOUS ANTIEMETICS;
Narcotic (Cdsa Ii);
TEVA CANADA LIMITED
DIN: 02393603
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87881
NABUMETONE;
nabumetone 500 mg;
1998-08-21;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
DIN: 02238639
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62067
APO-NADOLOL;
nadolol 160 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00782475
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9177
APO-NADOLOL;
nadolol 40 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00782505
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9178
MINT-NADOLOL;
nadolol 40 mg;
2020-07-21;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02496380
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98626
APO-NADOLOL;
nadolol 80 mg;
1988-12-31;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
DIN: 00782467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9176
MINT-NADOLOL;
nadolol 80 mg;
2020-08-19;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
DIN: 02496399
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98627
FRAXIPARINE FORTE;
nadroparin calcium 19000 unit / ml;
1999-06-22;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02240114
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63628
FRAXIPARINE FORTE;
nadroparin calcium 19000 unit / ml;
1999-06-22;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02450666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93681
FRAXIPARINE FORTE;
nadroparin calcium 19000 unit / ml;
1999-06-22;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02450674
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93682
FRAXIPARINE;
nadroparin calcium 9500 unit / ml;
1998-02-05;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02236913
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60205
FRAXIPARINE;
nadroparin calcium 9500 unit / ml;
1998-02-05;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02450623
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93678
FRAXIPARINE;
nadroparin calcium 9500 unit / ml;
1998-02-05;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02450631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93679
FRAXIPARINE;
nadroparin calcium 9500 unit / ml;
1998-02-05;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
DIN: 02450658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93680
SYNAREL;
nafarelin (nafarelin acetate) 200 mcg / act;
1996-11-25;
Nasal;
Metered-Dose Aerosol;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription;
PFIZER CANADA ULC
DIN: 02188783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42902
NUBAIN INJECTION 10MG/ML;
nalbuphine hydrochloride 10 mg / ml;
1993-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:08.12 – OPIATE PARTIAL AGONISTS;
Schedule G (Cdsa Iv);
SANDOZ CANADA INCORPORATED
DIN: 01913980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13803
MOVANTIK;
naloxegol (naloxegol oxalate) 12.5 mg;
2015-08-27;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
KNIGHT THERAPEUTICS INC.
DIN: 02442167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92652
MOVANTIK;
naloxegol (naloxegol oxalate) 25 mg;
2015-08-27;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
KNIGHT THERAPEUTICS INC.
DIN: 02442175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92653
NALOXONE HYDROCHLORIDE INJECTION USP;
naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg / ml;
2014-01-09;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
TELIGENT OU
DIN: 02382482
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86832
NALOXONE HYDROCHLORIDE INJECTION;
naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg / ml;
2013-10-03;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02393034
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87828
INJECTABLE NALOXONE HYDROCHLORIDE;
naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg / ml;
2016-08-05;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:10.00 – OPIATE ANTAGONISTS;
Ethical;
OMEGA LABORATORIES LTD
DIN: 02455935
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94280
NALOXONE HYDROCHLORIDE INJECTION;
naloxone hydrochloride (naloxone hydrochloride dihydrate) 1 mg / ml;
2013-10-10;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02393042
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87829
NALOXONE HCL INJECTION – 0.4MG/ML USP;
naloxone hydrochloride 0.4 mg / ml;
1995-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02148706
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18025
S.O.S. NALOXONE HYDROCHLORIDE INJECTION;
naloxone hydrochloride 0.4 mg / ml;
2016-06-21;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:10.00 – OPIATE ANTAGONISTS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 02453258
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93978
NALOXONE INJECTABLE;
naloxone hydrochloride 0.4 mg / ml;
2018-06-12;
Intramuscular , Intravenous , Subcutaneous;
Solution;
28:10.00 – OPIATE ANTAGONISTS;
Ethical;
TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
DIN: 02458578
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94572
NALOXONE HCL INJECTION – 1MG/ML USP;
naloxone hydrochloride 1 mg / ml;
1995-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02148714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18024
NARCAN NASAL SPRAY;
naloxone hydrochloride 4 mg / 0.1 ml;
2017-07-07;
Nasal;
Spray, Metered Dose;
28:10.00 – OPIATE ANTAGONISTS;
Ethical;
EMERGENT OPERATIONS IRELAND LIMITED
DIN: 02458187
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94523
REVIA;
naltrexone hydrochloride 50 mg;
1997-10-23;
Oral;
Tablet;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02213826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43143
APO-NALTREXONE;
naltrexone hydrochloride 50 mg;
2015-11-10;
Oral;
Tablet;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
APOTEX INC
DIN: 02444275
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92924
NALTREXONE HYDROCHLORIDE TABLETS USP;
naltrexone hydrochloride 50 mg;
2017-05-30;
Oral;
Tablet;
28:10.00 – OPIATE ANTAGONISTS;
Prescription;
STERINOVA INC.
DIN: 02451883
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93829
CLEAR EYES;
naphazoline hydrochloride 0.012 %;
2004-03-24;
Ophthalmic;
Liquid;
52:32.00 – VASOCONSTRICTORS;
Otc;
PRESTIGE BRANDS INC
DIN: 02248060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72380
SOOTHE REDNESS;
naphazoline hydrochloride 0.012 % / w/v;
1988-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
BAUSCH & LOMB INC
DIN: 00764647
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8526
ALBALON;
naphazoline hydrochloride 0.1 %;
1970-12-31;
Ophthalmic;
Drops;
52:32.00 – VASOCONSTRICTORS;
Otc;
ALLERGAN INC
DIN: 00001147
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=934
REFRESH REDNESS RELIEF;
naphazoline hydrochloride 0.1 %;
2009-02-09;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
ALLERGAN INC
DIN: 02315920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80143
OPTI-TEARS RED EYE;
naphazoline hydrochloride 0.1 % / w/v;
2017-04-04;
Ophthalmic;
Solution;
52:32.00 – VASOCONSTRICTORS;
Otc;
ALCON CANADA INC
DIN: 02449609
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93543
PEDIAPHARM NAPROXEN SUSPENSION;
naproxen 25 mg / ml;
1996-12-31;
Oral;
Suspension;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
MEDEXUS PHARMACEUTICALS INC
DIN: 02162431
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19661
APO-NAPROXEN;
naproxen 250 mg;
1982-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 00522651
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4980
TEVA-NAPROXEN;
naproxen 250 mg;
1982-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00565350
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5036
NAPROXEN 250;
naproxen 250 mg;
1983-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 00590762
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5175
TEVA-NAPROXEN EC;
naproxen 250 mg;
2001-04-02;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02243312
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67215
APO-NAPROXEN EC TABLETS;
naproxen 250 mg;
2003-04-23;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 02246699
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70894
NAPROXEN;
naproxen 250 mg;
2010-06-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83596
NAPROXEN EC;
naproxen 250 mg;
2010-06-15;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350785
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83599
APO-NAPROXEN;
naproxen 375 mg;
1983-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 00600806
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5508
TEVA-NAPROXEN;
naproxen 375 mg;
1984-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00627097
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5860
NAPROXEN-375;
naproxen 375 mg;
1985-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 00655686
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6524
NAPROSYN;
naproxen 375 mg;
1995-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 02162415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19316
TEVA-NAPROXEN EC;
naproxen 375 mg;
2001-04-02;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02243313
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67216
APO-NAPROXEN EC;
naproxen 375 mg;
2003-04-23;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 02246700
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70895
NAPROXEN;
naproxen 375 mg;
2010-06-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83597
NAPROXEN EC;
naproxen 375 mg;
2010-06-15;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83600
TEVA-NAPROXEN;
naproxen 500 mg;
1983-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00589861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5183
APO-NAPROXEN;
naproxen 500 mg;
1983-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 00592277
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5222
NAPROXEN 500;
naproxen 500 mg;
1984-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 00618721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6266
NAPROSYN;
naproxen 500 mg;
1995-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 02162423
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19315
TEVA-NAPROXEN EC;
naproxen 500 mg;
2001-04-02;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02243314
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67217
APO-NAPROXEN EC;
naproxen 500 mg;
2003-04-23;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 02246701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70896
PRO-NAPROXEN EC;
naproxen 500 mg;
2008-07-04;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02310953
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79657
NAPROXEN;
naproxen 500 mg;
2010-06-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350777
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83598
NAPROXEN EC;
naproxen 500 mg;
2010-06-15;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02350807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83601
NAPROSYN;
naproxen 750 mg;
1995-12-31;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 02162466
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19314
ALEVE CAPLETS;
naproxen sodium 220 mg;
2009-06-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BAYER INC
DIN: 02301733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78704
ALEVE LIQUID GELS;
naproxen sodium 220 mg;
2011-09-12;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BAYER INC
DIN: 02361795
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84684
NAPROXEN;
naproxen sodium 220 mg;
2011-03-18;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02362430
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84744
MAXIDOL LIQUID GELS;
naproxen sodium 220 mg;
2012-05-17;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BAYER INC
DIN: 02372991
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85812
NAPROXEN;
naproxen sodium 220 mg;
2013-09-16;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PERRIGO INTERNATIONAL
DIN: 02378418
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86421
NAPROXEN MENSTRUAL PAIN RELIEF;
naproxen sodium 220 mg;
2014-01-24;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
PHARMASCIENCE INC
DIN: 02396009
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88106
ALEVE BACK AND BODY PAIN;
naproxen sodium 220 mg;
2015-06-30;
Oral;
Capsule;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
BAYER INC
DIN: 02436337
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92069
TEVA-NAPROXEN SODIUM;
naproxen sodium 275 mg;
1988-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 00778389
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9241
APO-NAPRO-NA;
naproxen sodium 275 mg;
1989-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 00784354
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10035
NAPROXEN-NA;
naproxen sodium 275 mg;
1995-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 00887056
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17199
ANAPROX;
naproxen sodium 275 mg;
1995-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 02162725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19446
NAPROXEN SODIUM;
naproxen sodium 275 mg;
2010-06-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02351013
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83619
TEVA-NAPROXEN SODIUM DS;
naproxen sodium 550 mg;
1993-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02026600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13848
APO-NAPRO-NA DS;
naproxen sodium 550 mg;
1993-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
DIN: 01940309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14048
ANAPROX DS;
naproxen sodium 550 mg;
1995-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
ATNAHS PHARMA UK LIMITED
DIN: 02162717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19313
NAPROXEN-NA DF;
naproxen sodium 550 mg;
1999-09-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
DIN: 02153386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44029
NAPROXEN SODIUM DS;
naproxen sodium 550 mg;
2010-06-15;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANIS HEALTH INC
DIN: 02351021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83620
AMERGE;
naratriptan (naratriptan hydrochloride) 1 mg;
1998-05-05;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02237820
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61179
TEVA-NARATRIPTAN;
naratriptan (naratriptan hydrochloride) 1 mg;
2009-12-02;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02314290
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79985
AMERGE;
naratriptan (naratriptan hydrochloride) 2.5 mg;
1998-05-05;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02237821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61180
TEVA-NARATRIPTAN;
naratriptan (naratriptan hydrochloride) 2.5 mg;
2009-12-01;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
DIN: 02314304
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79986
SANDOZ NARATRIPTAN;
naratriptan (naratriptan hydrochloride) 2.5 mg;
2010-04-08;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
DIN: 02322323
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80778
TYSABRI;
natalizumab 300 mg / 15 ml;
2006-11-21;
Intravenous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription , Schedule D;
BIOGEN CANADA INC
DIN: 02286386
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77184
BYSTOLIC;
nebivolol (nebivolol hydrochloride) 10 mg;
2013-04-02;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ALLERGAN INC
DIN: 02399016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88392
BYSTOLIC;
nebivolol (nebivolol hydrochloride) 2.5 mg;
2013-04-02;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ALLERGAN INC
DIN: 02398990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88390
BYSTOLIC;
nebivolol (nebivolol hydrochloride) 20 mg;
2013-04-02;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ALLERGAN INC
DIN: 02399024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88393
BYSTOLIC;
nebivolol (nebivolol hydrochloride) 5 mg;
2013-04-02;
Oral;
Tablet;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
ALLERGAN INC
DIN: 02399008
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88391
ATRIANCE;
nelarabine 5 mg / ml;
2008-01-17;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02299925
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78527
VIRACEPT -250MG;
nelfinavir (nelfinavir mesylate) 250 mg;
1998-09-21;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 02238617
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62045
VIRACEPT;
nelfinavir (nelfinavir mesylate) 625 mg;
2004-08-11;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
PFIZER CANADA ULC
DIN: 02248761
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73129
NEOSTIGMINE OMEGA;
neostigmine methylsulfate 0.5 mg / ml;
1999-05-28;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02230593
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49702
NEOSTIGMINE METHYLSULFATE INJECTION USP;
neostigmine methylsulfate 0.5 mg / ml;
2019-03-26;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02475480
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96586
NEOSTIGMINE OMEGA;
neostigmine methylsulfate 1 mg / ml;
1999-06-23;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02230592
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49701
NEOSTIGMINE METHYLSULFATE INJECTION USP;
neostigmine methylsulfate 1 mg / ml;
2019-03-26;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
DIN: 02475499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96587
NEOSTIGMINE OMEGA;
neostigmine methylsulfate 2.5 mg / ml;
2013-04-17;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
OMEGA LABORATORIES LTD
DIN: 02387166
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87274
NEVANAC;
nepafenac 0.1 % / w/v;
2008-08-21;
Ophthalmic;
Suspension;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02308983
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79459
ILEVRO;
nepafenac 0.3 % / w/v;
2014-06-01;
Ophthalmic;
Suspension;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02411393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89601
NERLYNX;
neratinib (neratinib maleate) 40 mg;
2019-12-20;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
KNIGHT THERAPEUTICS INC.
DIN: 02490536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98057
AURO-NEVIRAPINE;
nevirapine 200 mg;
2010-12-29;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
DIN: 02318601
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80408
MYLAN-NEVIRAPINE;
nevirapine 200 mg;
2012-06-20;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02387727
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87331
JAMP NEVIRAPINE;
nevirapine 200 mg;
2013-06-03;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02405776
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89053
NIFEDIPINE;
nifedipine 10 mg;
1988-12-31;
Oral;
Capsule;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
AA PHARMA INC
DIN: 00755907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8376
ADALAT XL – SRT 30MG;
nifedipine 30 mg;
1992-12-31;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
BAYER INC
DIN: 02155907
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19099
MYLAN-NIFEDIPINE EXTENDED RELEASE;
nifedipine 30 mg;
2010-04-23;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02349167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83448
PMS-NIFEDIPINE ER;
nifedipine 30 mg;
2015-03-17;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
DIN: 02418630
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90319
NIFEDIPINE ER;
nifedipine 30 mg;
2015-01-13;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PRO DOC LIMITEE
DIN: 02421631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90628
NIFEDIPINE;
nifedipine 5 mg;
1989-12-31;
Oral;
Capsule;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
AA PHARMA INC
DIN: 00725110
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9938
MYLAN-NIFEDIPINE EXTENDED RELEASE;
nifedipine 60 mg;
2008-12-30;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02321149
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80655
PMS-NIFEDIPINE ER;
nifedipine 60 mg;
2015-03-17;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PHARMASCIENCE INC
DIN: 02416301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90087
NIFEDIPINE ER;
nifedipine 60 mg;
2015-01-13;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
PRO DOC LIMITEE
DIN: 02421658
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90629
TASIGNA;
nilotinib (nilotinib hydrochloride monohydrate) 150 mg;
2011-07-15;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02368250
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85322
TASIGNA;
nilotinib (nilotinib hydrochloride monohydrate) 200 mg;
2008-09-30;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02315874
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80138
TASIGNA;
nilotinib (nilotinib hydrochloride monohydrate) 50 mg;
2019-05-17;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02481715
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97220
ANANDRON;
nilutamide 50 mg;
1997-08-20;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN: 02221861
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43312
NIMOTOP;
nimodipine 30 mg;
2009-07-24;
Oral;
Tablet;
24:28.08 – DIHYDROPYRIDINES;
Prescription;
BAYER INC
DIN: 02325926
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81127
OFEV;
nintedanib (nintedanib esilate) 100 mg;
2015-06-29;
Oral;
Capsule;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02443066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92756
OFEV;
nintedanib (nintedanib esilate) 150 mg;
2015-06-29;
Oral;
Capsule;
48:02.00 – ANTIFIBROTIC AGENTS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN: 02443074
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92761
ZEJULA;
niraparib (niraparib tosylate) 100 mg;
2020-01-09;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
GLAXOSMITHKLINE INC
DIN: 02489783
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97986
MDK-NITISINONE;
nitisinone 10 mg;
2016-10-20;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MENDELIKABS INC
DIN: 02457733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94477
NITISINONE TABLETS;
nitisinone 10 mg;
2016-12-19;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
CYCLE PHARMACEUTICALS LTD.
DIN: 02458632
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94578
ORFADIN;
nitisinone 10 mg;
2017-02-17;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SWEDISH ORPHAN BIOVITRUM AB (PUBL)
DIN: 02459728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94701
MDK-NITISINONE;
nitisinone 2 mg;
2016-10-20;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MENDELIKABS INC
DIN: 02457717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94475
NITISINONE TABLETS;
nitisinone 2 mg;
2017-01-13;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
CYCLE PHARMACEUTICALS LTD.
DIN: 02458616
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94576
ORFADIN;
nitisinone 2 mg;
2017-02-17;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SWEDISH ORPHAN BIOVITRUM AB (PUBL)
DIN: 02459698
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94699
ORFADIN;
nitisinone 20 mg;
2017-02-17;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SWEDISH ORPHAN BIOVITRUM AB (PUBL)
DIN: 02459736
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94702
ORFADIN;
nitisinone 4 mg / ml;
2018-07-10;
Oral;
Suspension;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SWEDISH ORPHAN BIOVITRUM AB (PUBL)
DIN: 02469693
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95850
MDK-NITISINONE;
nitisinone 5 mg;
2016-10-20;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MENDELIKABS INC
DIN: 02457725
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94476
NITISINONE TABLETS;
nitisinone 5 mg;
2017-01-13;
Oral;
Tablet;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
CYCLE PHARMACEUTICALS LTD.
DIN: 02458624
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94577
ORFADIN;
nitisinone 5 mg;
2017-02-17;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SWEDISH ORPHAN BIOVITRUM AB (PUBL)
DIN: 02459701
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94700
MOGADON;
nitrazepam 10 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 00511536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3992
MOGADON;
nitrazepam 5 mg;
1980-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
DIN: 00511528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3991
KINOX;
nitric oxide 100 ppm / cylr;
2016-05-03;
Inhalation;
Gas;
24:12.08 – NITRATES AND NITRITES;
Prescription;
AIRGAS USA LLC
DIN: 02451301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93756
INOMAX;
nitric oxide 800 ppm / cylr;
2005-11-23;
Inhalation;
Gas;
24:12.08 – NITRATES AND NITRITES;
Prescription;
INO THERAPEUTICS
DIN: 02270846
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75619
KINOX;
nitric oxide 800 ppm / cylr;
2016-05-03;
Inhalation;
Gas;
24:12.08 – NITRATES AND NITRITES;
Prescription;
AIRGAS USA LLC
DIN: 02451328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93757
NOXIVENT;
nitric oxide 800 ppm / cylr;
2016-03-10;
Inhalation;
Gas;
24:12.08 – NITRATES AND NITRITES;
Prescription;
PRAXAIR CANADA INC
DIN: 02451425
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93767
NITROFURANTOIN;
nitrofurantoin 100 mg;
1974-12-31;
Oral;
Tablet;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
AA PHARMA INC
DIN: 00312738
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2093
MACROBID;
nitrofurantoin 100 mg;
1993-12-31;
Oral;
Capsule;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
ALLERGAN INC
DIN: 02063662
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15173
TEVA-NITROFURANTOIN;
nitrofurantoin 100 mg;
1997-05-02;
Oral;
Capsule;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02231016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50297
PMS-NITROFURANTOIN BID;
nitrofurantoin 100 mg;
2018-04-25;
Oral;
Capsule;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
PHARMASCIENCE INC
DIN: 02455676
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94248
AURO-NITROFURANTOIN BID;
nitrofurantoin 100 mg;
2017-10-23;
Oral;
Capsule;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
AURO PHARMA INC
DIN: 02466392
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95474
NITROFURANTOIN;
nitrofurantoin 50 mg;
1974-12-31;
Oral;
Tablet;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
AA PHARMA INC
DIN: 00319511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2094
TEVA-NITROFURANTOIN;
nitrofurantoin 50 mg;
1997-05-02;
Oral;
Capsule;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
TEVA CANADA LIMITED
DIN: 02231015
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50295
NITROGEN 100%;
nitrogen 100 %;
1911-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR LIQUIDE CANADA INC.
DIN: 00572829
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5683
LIQUID NITROGEN NF;
nitrogen 100 %;
2008-01-21;
Topical;
Liquid;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
VITALAIRE CANADA INC
DIN: 02297248
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78261
LIQUID NITROGEN;
nitrogen 100 %;
2011-09-13;
Topical;
Liquid;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
N-TWO MEDICAL INC
DIN: 02368218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85318
LIQUID NITROGEN NF;
nitrogen 100 %;
2015-10-20;
Topical;
Liquid;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
CRYOGEN NITROGEN DELIVERIES LIMITED
DIN: 02436590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92092
GASEOUS NITROGEN 99.0%;
nitrogen 99 %;
1983-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
AIR PRODUCTS CANADA LTD/LTÉE.
DIN: 00591645
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5221
NITROGEN NF 99%;
nitrogen 99 %;
1993-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014394
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13882
NITROGEN N.F.;
nitrogen 99 %;
1995-12-31;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
MESSER CANADA INC.
DIN: 02154803
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19292
NITROGEN NF;
nitrogen 99.5 %;
2004-04-15;
Inhalation;
Gas;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Ethical;
VITALAIRE CANADA INC
DIN: 02248173
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72506
TRANSDERM-NITRO 0.2;
nitroglycerin 0.2 mg / hour;
1989-12-31;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00584223
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9858
NITRO-DUR 0.2;
nitroglycerin 0.2 mg / hour;
1991-12-31;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
USPHARMA LTD
DIN: 01911910
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11227
TRINIPATCH 0.2;
nitroglycerin 0.2 mg / hour;
1999-04-01;
Transdermal;
Patch;
24:12.08 – NITRATES AND NITRITES;
Ethical;
PALADIN LABS INC.
DIN: 02230732
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49993
MYLAN-NITRO PATCH 0.2;
nitroglycerin 0.2 mg / hour;
2013-06-04;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
MYLAN PHARMACEUTICALS ULC
DIN: 02407442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89213
NITROSTAT;
nitroglycerin 0.3 mg;
1972-12-31;
Sublingual;
Tablet;
24:12.08 – NITRATES AND NITRITES;
Ethical;
UPJOHN CANADA ULC
DIN: 00037613
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1254
NITROLINGUAL PUMPSPRAY;
nitroglycerin 0.4 mg / act;
1998-07-31;
Sublingual;
Metered-Dose Pump;
24:12.08 – NITRATES AND NITRITES;
Ethical;
SANOFI-AVENTIS CANADA INC
DIN: 02231441
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50758
RHO-NITRO PUMPSPRAY;
nitroglycerin 0.4 mg / act;
2001-12-20;
Sublingual;
Metered-Dose Pump;
24:12.08 – NITRATES AND NITRITES;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 02238998
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62447
MYLAN-NITRO SUBLINGUAL SPRAY;
nitroglycerin 0.4 mg / act;
2001-08-23;
Sublingual;
Metered-Dose Aerosol;
24:12.08 – NITRATES AND NITRITES;
Ethical;
MYLAN PHARMACEUTICALS ULC
DIN: 02243588
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67506
TRANSDERM-NITRO 0.4;
nitroglycerin 0.4 mg / hour;
1989-12-31;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 00852384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10116
NITRO-DUR 0.4;
nitroglycerin 0.4 mg / hour;
1991-12-31;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
USPHARMA LTD
DIN: 01911902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11225
TRINIPATCH 0.4;
nitroglycerin 0.4 mg / hour;
1999-04-01;
Transdermal;
Patch;
24:12.08 – NITRATES AND NITRITES;
Ethical;
PALADIN LABS INC.
DIN: 02230733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49995
MYLAN-NITRO PATCH 0.4;
nitroglycerin 0.4 mg / hour;
2013-06-04;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
MYLAN PHARMACEUTICALS ULC
DIN: 02407450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89214
NITROSTAT;
nitroglycerin 0.6 mg;
1972-12-31;
Sublingual;
Tablet;
24:12.08 – NITRATES AND NITRITES;
Ethical;
UPJOHN CANADA ULC
DIN: 00037621
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1253
NITRO-DUR 0.6;
nitroglycerin 0.6 mg / hour;
1991-12-31;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
USPHARMA LTD
DIN: 01911929
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11226
TRANSDERM-NITRO 0.6;
nitroglycerin 0.6 mg / hour;
1994-12-31;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
NOVARTIS PHARMACEUTICALS CANADA INC
DIN: 02046156
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15572
TRINIPATCH 0.6;
nitroglycerin 0.6 mg / hour;
1999-04-01;
Transdermal;
Patch;
24:12.08 – NITRATES AND NITRITES;
Ethical;
PALADIN LABS INC.
DIN: 02230734
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49996
MYLAN-NITRO PATCH 0.6;
nitroglycerin 0.6 mg / hour;
2013-06-04;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
MYLAN PHARMACEUTICALS ULC
DIN: 02407469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89215
NITRO-DUR 0.8;
nitroglycerin 0.8 mg / hour;
1993-12-31;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
USPHARMA LTD
DIN: 02011271
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14742
MYLAN-NITRO PATCH 0.8;
nitroglycerin 0.8 mg / hour;
2013-06-04;
Transdermal;
Patch (Extended Release);
24:12.08 – NITRATES AND NITRITES;
Ethical;
MYLAN PHARMACEUTICALS ULC
DIN: 02407477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89216
NITROJECT INJ 5MG/ML;
nitroglycerin 50 mg / 10 ml;
1988-12-31;
Intravenous;
Solution;
24:12.08 – NITRATES AND NITRITES;
Ethical;
OMEGA LABORATORIES LTD
DIN: 00778869
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10706
NITROUS OXIDE 100%;
nitrous oxide 100 %;
1911-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
AIR LIQUIDE CANADA INC.
DIN: 00572845
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5685
NITROUS OXIDE USP 99%;
nitrous oxide 99 %;
1993-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
PRAXAIR CANADA INC
DIN: 02014467
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13887
NITROUS OXIDE U.S.P.;
nitrous oxide 99 %;
1995-12-31;
Inhalation;
Gas;
28:04.16 – INHALATION ANESTHETICS;
Ethical;
MESSER CANADA INC.
DIN: 02154811
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19262
OPDIVO;
nivolumab 10 mg / ml;
2015-10-23;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
BRISTOL-MYERS SQUIBB CANADA
DIN: 02446626
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93204
OPDIVO;
nivolumab 10 mg / ml;
2015-10-23;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
BRISTOL-MYERS SQUIBB CANADA
DIN: 02446634
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93205
AXID;
nizatidine 150 mg;
1988-12-31;
Oral;
Capsule;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN: 00778338
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8915
ALLERGENIC EXTRACT NON POLLENS;
non pollen 100000 unit / ml;
1963-12-31;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
DIN: 00299979
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1913
NON STANDARDIZED ALLERGENIC EXTRACTS – NON POLLENS;
non pollen 40000 unit / ml;
2012-08-29;
Intradermal , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
DIN: 02372428
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85754
RIXUBIS;
nonacog gamma 1000 unit / vial;
2017-04-18;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
DIN: 02431947
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91641
RIXUBIS;
nonacog gamma 2000 unit / vial;
2017-04-18;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
DIN: 02431955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91642
RIXUBIS;
nonacog gamma 250 unit / vial;
2019-01-15;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
DIN: 02431920
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91639
RIXUBIS;
nonacog gamma 3000 unit / vial;
2018-09-25;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
DIN: 02431963
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91643
RIXUBIS;
nonacog gamma 500 unit / vial;
2017-05-02;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
TAKEDA CANADA INC
DIN: 02431939
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91640
NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP;
norepinephrine (norepinephrine bitartrate) 1 mg / ml;
1991-12-31;
Intravenous;
Liquid;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
SANDOZ CANADA INCORPORATED
DIN: 00893285
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11641
LEVOPHED;
norepinephrine (norepinephrine bitartrate) 1 mg / ml;
2001-10-01;
Intravenous;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
PFIZER CANADA ULC
DIN: 02241981
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65651
NOREPINEPHRINE BITARTRATE INJECTION USP;
norepinephrine (norepinephrine bitartrate) 1 mg / ml;
2020-05-04;
Intravenous;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
GENERIC MEDICAL PARTNERS INC
DIN: 02485680
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97591
MOVISSE;
norethindrone 0.35 mg;
2015-06-30;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
MYLAN PHARMACEUTICALS ULC
DIN: 02410303
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89495
JENCYCLA;
norethindrone 0.35 mg;
2015-09-14;
Oral;
Tablet;
68:12.00 – CONTRACEPTIVES;
Prescription;
LUPIN PHARMA CANADA LIMITED
DIN: 02441306
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92570
NORLUTATE;
norethindrone acetate 5 mg;
1961-12-31;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
ERFA CANADA 2012 INC
DIN: 00023760
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1401
NORFLOXACIN;
norfloxacin 400 mg;
1998-07-20;
Oral;
Tablet;
08:12.18 – QUINOLONES;
Prescription;
AA PHARMA INC
DIN: 02229524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47429
AVENTYL;
nortriptyline (nortriptyline hydrochloride) 10 mg;
1965-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00015229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15
AVENTYL;
nortriptyline (nortriptyline hydrochloride) 25 mg;
1965-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
DIN: 00015237
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16
SPINRAZA;
nusinersen (nusinersen sodium) 2.4 mg / ml;
2017-08-29;
Intrathecal;
Solution;
92:18.00 – ANTISENSE OLIGONUCLEOTIDES;
Prescription;
BIOGEN CANADA INC
DIN: 02465663
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95389
NYADERM CRM 100000UNIT/GM;
nystatin 100000 unit / g;
1979-12-31;
Topical;
Cream;
84:04.08.28 – POLYENES;
Otc;
TARO PHARMACEUTICALS INC
DIN: 00716871
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8977
TEVA-NYSTATIN;
nystatin 100000 unit / g;
1998-10-14;
Vaginal;
Cream;
84:04.08.28 – POLYENES;
Prescription;
TEVA CANADA LIMITED
DIN: 02194163
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35795
RATIO-NYSTATIN;
nystatin 100000 unit / g;
1996-11-28;
Topical;
Ointment;
84:04.08.28 – POLYENES;
Otc;
TEVA CANADA LIMITED
DIN: 02194228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35799
RATIO-NYSTATIN;
nystatin 100000 unit / g;
1996-09-12;
Topical;
Cream;
84:04.08.28 – POLYENES;
Otc;
TEVA CANADA LIMITED
DIN: 02194236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35800
PMS-NYSTATIN SUSPENSION 100000 UNIT/ML;
nystatin 100000 unit / ml;
1989-12-31;
Oral;
Suspension;
08:14.28 – POLYENES;
Prescription;
PHARMASCIENCE INC
DIN: 00792667
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9973
TEVA-NYSTATIN;
nystatin 100000 unit / ml;
1996-09-12;
Oral;
Suspension;
08:14.28 – POLYENES;
Prescription;
TEVA CANADA LIMITED
DIN: 02194201
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=35798
JAMP-NYSTATIN ORAL SUSPENSION USP;
nystatin 100000 unit / ml;
2015-01-09;
Oral;
Suspension;
08:14.28 – POLYENES;
Prescription;
JAMP PHARMA CORPORATION
DIN: 02433443
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91783
NYADERM VAG CRM 25000UNIT/GM;
nystatin 25000 unit / g;
1979-12-31;
Vaginal;
Cream;
84:04.08.28 – POLYENES;
Prescription;
TARO PHARMACEUTICALS INC
DIN: 00716901
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9277

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut